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Medical supplies for the expeditions 
of the heroic age of Antarctic 
exploration: Topical drugs 
Dr HR Guly FRCP, FCEM 
Retired consultant in emergency medicine, 
Derriford Hospital, Plymouth, PL6 8DH 
This paper describes the drugs for topical use on the skin 
and throat that were taken on Scott's and Shackleton's 
expeditions to the Antarctic. The commonest skin 
problem encountered was frostbite and the use of topical 
preparations for the treatment and prevention of this is 
also discussed. 
Drugs for use on the skin 
On the expeditions of the heroic age of Antarctic 
exploration, a variety of drugs were taken for use 
topically on the skin and throat. Ophthalrruc drugs were 
used topically but are discussed elsewhere. 1 The lotions, 
ointments, creams etc that were taken on the Discovery,2 
Terra Nova3·4 and Imperial Trans-Antarctic (ITAE)5 
expeditions are listed in Table 1 (pp.3-4). This table also 
compares these drugs with those required for ships by the 
Board of Trade in 1906.6 
I have divided these preparations into counter-irritants, 
antiseptics (preparations containing mercury, boric acid, 
carbolic acid and potassium permanganate), soothing 
preparations, and preparations used for treating disease of 
the skin. Obviously these categories are not mutually 
exclusive as antiseptics were used to treat skin infections, 
soothing compounds were added to antiseptics and 
iodine was often painted on the skin overlying 
musculoskeletal problems. 
Topical treatments on the Board of Trade list that are 
not mentioned in the list of topical treatments carried are 
sulphur ointment, linimentum calcis ( carron oil) and 
Friars balsam. 
In addition to topical applications, medicated 
dressings were also taken. Those taken on the Terra 
Nova are shown in table 2. 
Table 2. Medicated dressings taken to the Antarctic 
on the Terra Nova3,4 
Notes 
Alembroth gauze Mercuric chloride and 
ammonium chloride 
Compressed boric wool 
Compressed boric lint 
Compressed boric double Mercuric cyanide and zinc 
cyanide gauze cvanide 
Iodoform gauze 
In addition to these, the Terra Nova took various other 
cherrucals including 42 lb of magnesium sulphate and 9 
lb of carbolic acid crystals. These could have had a 
number ofuses but they also took 18 lb of Vaseline, four 
spatulas and two ointment slabs, presumably so that 
further ointment could be made from some of the 
cherrucals taken in solid form. 
Topical treatment of frostbite 
The commonest skin problem on the expeditions was 
frostbite which, on the face, was often associated with 
sunburn. Minor wounds were common and although 
wound infections were rare, they did occur, especially 
those sustained cutting up seals for meat and blubber. 
Wounds and their infections would have been taken very 
seriously in the pre-antibiotic era. 
The most important part of the treatment of frostbite is 
to reverse the freezing process but Dr Alexander Macklin 
(surgeon on two of Shackleton's expeditions) wrote that 
'A part that does not immediately come back to nonnal 
must be kept warm and dry, and the application of a little 
methylated spirit or turpentine is good. ' 7 However, if a 
blister forms or there is skin necrosis leading to an ulcer, 
this will need dressing. Dr Edward Atkinson (surgeon on 
Scott's Terra Nova expedition) wrote that 'the best 
treatment [ of frost bite] was to empty and pare away the 
blisters, and to keep the parts in baths of boracic lotion, 
the best dressing being hazeline cream or boracic 
ointment. '8 
On Scott's return from the South Pole, Edgar Evans 
developed severe frostbite of the fingers and Dr Edward 
Wilson's diary records 'Dressing Evans fingers everyday 
with boric Vaseline .. . '(a combination of boric acid and 
Vaseline).9 He presumably melted snow and boiled the 
water to clean the wound as Roald Amundsen left a 
broken hypsometer (an instrument to determine the 
temperature at which water boiled, from which they 
could deterrrune the atmospheric pressure and thus the 
altitude) at the South Pole and Wilson says, in his diary, 
'I took away the spirit lamp of it which I have wanted for 
sterilizing and making disinfectant lotion of s~ow.''° 
Boracic Vaseline was mentioned in the list of 
medications taken but is not mentioned in the list of 
medications taken in the sledging medical cases. 
Dr Jean-Baptiste Charcot, the leader of the two Fr~n~h 
expeditions of that era, recommended the use of p1cnc 
acid. 11 This was a recognised treatment for burns, 
perhaps more in France than Britain, 12 but coul~ also be 
used for other conditions. 13 'Newskin' (collodion) was 
also used to dress frostbite on occasion. 14 . 
Substances were sometimes applied to the skin to 
prevent frostbite. Wilhelm Filchner, the leader o~ the 
second German expedition wrote: 'During the wmted 
due to the cold it was recommended that one cease 
. , 1· , ... e ,,s On the 
washing and rub fat or Vase me on one s 1ac . . . 
Southern Cross expedition Louis Bernacchi wrote. 
'Before leaving camp glycerine was rubbed o~ the f~ce 
and hands as a prophylactic against frost-bit~ w~ch 
.. . was very effective' 16 and later, on the Disco .ry 
expedition he complained: 'One of the pro?lems WI~ 
which everyone was struggling was the discovery 0 
some method of protecting nose and cheeks t:: 
frostbite. I do not know why we had overlooke th 
excellent specific which had proved so val~abl,~/0 e 
Southern Cross winter party, a coat of glycerine. 
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Ta bi 1 ~ . l tr tm t t k d'. e op1ca ea en s a en on expe 1t1ons an d preparations considered essential by the Board of Trade 
Disco 
very 
Treatment Other names Notes 
Counter-irritants 
Blistering fluid Liquor epistasticus * 
Brown's sinapisrn A plaster or poultice of * 
mustard oil or powdered 
mustard seed. 
Camphor, spirit of Camphorated oil Also used internally * 
Crotonis oil Also used internally * 
Mustard leaves Charta sinaoia * 
Turpentine oil Oil terebithinae, 
Spirits of tuipentine 
Antiseptics 
Biniodide of Red mercury Smaller doses were also 
mercury used internally 
Borax Sodium borate Also occasionally used * 
internally 
Boric acid Also occasionally used 
internally 
Boric acid ointment Borofax IS a trade * 
name 
Carbolic acid Phenol * 
Corrosive sublimate Mercuric chloride Also used internally * 
Glycerine of boric 
acid 
Lanoline mercurial * 
ointment 
Magnesium Also used internally * 
sulphate 
Mercuric ammonia 'White precipitate' Used for various skin * 
ointment diseases 
Potassium * 
permanganate 
Zinc & vaseline 
carbolic ointment 
Zinc 
sulphocarbolate 
Soothing 
Gall with opium and * 
vaseline ointment 
Hazeline * 
Hazeline cream * 
lchthyol ointment * 
Lanoline * 
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Table 1. Topical treatments taken on expeditions and preparations considered essential by the Board ofTrade (continued) 
Board of Trade list 
Disco Terra IT Ships with- Ships with 
very Nova AE out doctors doctors 
Treatment Other names Notes 
Soothing (continued 
Lead acetate * * 
ointment 
Lead subacetate Lead solution, Astringent and antipruritic. * * * * 
Goulard's extract Also used on bruises and 
sprains 
Olive oil Piles and bums * * * 
Soap liniment Liniment saponis, * * * t * 
opodeldoc 
Vaseline Also lubricant and used to * * * * 
keep surgical instruments 
rust-free 
Treatment of diseases 
Belladonna Musculoskeletal pain * * * 
plasters 
Methylated Gout, neuralgia * 
liniment of aconite rheumatism 
Methylated Musculoskeletal pain, * * 
liniment of neuralgia, spasms 
belladonna 
Iodine tincture Skin disinfectant. Also * * * 
used for musculo-
skeletal pain 
Iodine liniment 
* * * * 
Iodoform Ulcers and wounds * * * * 
Silver nitrate Caustic Used on poorly healing * * * * * 
wounds 
Wound protection 
Burroughs & Probably the same as * 
Wellcome collodion 
protective skin 
Collodion 
* * * 
Court plaster 
* * * 
-
t Soap liniment may be called Opodeldoc. However the list of drugs prepared by the Board of Trade describes 
Opodeldoc as liniment of opium. 
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Macklin wrote that 'Vaseline and glycerine have been 
used on the face to protect it from strong winds, and 
apparently with success,' 18 but elsewhere writes: 'It is 
commonly believed that fats, oils and grease are good 
non-conductors of heat and if placed on the clothes or on 
the skin help to keep one warm. There was never a 
greater fallacy' 7 and he counsels against. Charcot says 
that 'It is extremely dangerous, in very cold temperatures, 
to cover the face with fat. That freezes at a relatively less 
low temperature, predisposing, therefore, to frostbites' an 
also points out that applying fat to the skin will make it 
more difficult to see the typical white patch of frostbite. 11 
Other conditions 
Hazeline cream was a general purpose soothing cream. In 
addition to its use in frostbite, as noted above, it was used 
for sunburnt and cracked lips19 and Ernest Shackleton says 
that on their boat journey from Elephant Island to South 
Georgia 'the insides of our thighs were rubbed raw, and the 
one tube of Hazeline cream in our medicine chest did not 
go far in alleviating our pain. '20 
On the Terra Nova Northern Party, Raymond Priestley 
wanted to take a photograph of a cave and tried to light it 
with magnesium powder but 'the whole show went off in 
my face burning it badly, singing off my eyelids and 
eyelashes and blinding me temporarily .... [Dr] Levick 
however dressed the face with boracaine and gave me a 
mixture of drugs to remove the pain and in a few minutes 
no trace of the accident remained except the scars. '21 I am 
uncertain as to what this preparation was but it sounds like 
a combination of boric acid with a local anaesthetic. (It 
cannot have been the local anaesthetic agent borocaine, 
which was not invented until 1925.)22 
George Abbott, part of the same group, cut his fingers 
while butchering a seal and so the wounds were 
contaminated. Dr Murray Levick dressed them with 
boracic wool and the following day washed them with 
mercuric chloride.23 
On the march, washing was difficult as all water had to 
be obtained by melting snow and fuel was limited. After the 
Terra Nova Northern party had been trapped all winter in a 
snow cave and had been unable to wash for that time, 
Levick wrote in his diary: 'I have recommended that 
everyone should have a wash down with hydrarg perchler 
[mercuric chloride] I in 1000 before a sledging trip.'24 
tincture of iodine and bandaged ... '26 Similar treatment had 
been given over 20 years earlier on the Dundee Antarctic 
Whaling Expedition when an enlarged lymph node and a 
painful clavicle were both painted with iodine.27,28 
I have not found any record of the use of gall and 
opium, belladonna or aconite but they were in the British 
Pharmacopoeia as they were assumed to have an 
analgesic effect. However research in 191 O stated: 'We 
have no hesitation in saying that none of these have any 
anaesthetic effect on the unbroken skin. Belladonna 
linaments and plasters have been ordered for generations, 
and glycerine of belladonna finds a place in the casualty 
room of most hospitals, but when tested by accurate 
methods they are quite unable to prevent or relieve pain 
except in so far as that effect may be produced by the 
support of any plaster, or the counter-irritation and 
massage obtained by the use of any simple liniment. '29 
This presumably is why they were not taken on 
Shackleton's second expedition which left in 1914. 
Topical treatment to the throat 
Topical treatment could al o be applied to tJ1c tJ1roat. 
When Shackleton developed a ore thr at, he wrote in hi 
diary: 'coughing all night kept me awake. argling 
Condy's pennanganate of Potash.' o 
The Discovery and Terra Nova al o t k Tab! id 
'Voice' containing potassium chlorate, borax and cocaine. 
Drugs for use in the throat might be applied with a brush 
and the BW&Co 251 medicine chest supplied to the 
expeditions contained two throat brushes. While I have found 
no reference to the use of these in the Heroic Age literature, 
there are a number of references to doing this in Bruce's 
medical diary of the Dundee Whaling Expedition 1893-4.28. 31 
Painful gums might be treated with iodine.32 
Authors address: The Shrubbery, Bedford Rd, 
Horrabridge, Yelverton, Devon, PL20 7QH; email 
hguly@aol.com 
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Ophthalmic Dosage Forms in 
Medieval Persia 
Mohamad M. Zarshenas 1.2, Ayda Hosseinkhani 1,2 
Annan Zargaran1.2.3, Gholamreza Kordafshari4 
' Abdolali Mohagheghzadeh3 
' 
1Student Research Committee, Shiraz University of 
Medical Sciences, Shiraz, Iran; 2 Research Office for the 
History of Persian Medicine, Shiraz University of Medical 
Sciences; 3 Department ofTraditional Pharmacy, Faculty of 
Pharmacy and Pharmaceutical Sciences Research 
Centre, Shiraz University of Medical Sciences; 4 Faculty of 
Traditional Medicine, Tehran University of Medical 
Sciences, Tehran, Iran 
Medicine and pharmacy have an old history in Persia 
which goes back to antiquity, and the written evidences of 
this fact are attributed to at least 500 BC. When Islam 
reached Persia, Islamic medicine received contributions 
from Persian scholars. Due to the prevalence of eye 
diseases in the Islamic empire, ophthalmology had a special 
place within medical knowledge. There are written 
evidences available today that ophthalmic dosage forms 
were developed and prescribed as a route of administration 
by Persian practitioners. In this article, various dosage 
forms and their general and specific preparation 
considerations are studied from Persia during the medieval 
time (9-18th centuries) based on common traditional 
Persian pharmaceutical and medical manuscripts. Most 
common ophthalmic dosage forms which are mentioned in 
these documents include eye drops ( Ghotoor), ophthahnic 
dusting powders (Zaroor), ophthalmic suppositories 
(Shiaj), eye washes (Ghasool), eye coolings (Barood) and 
kohl formulations (Ek-ha[). These findings reveal a part of 
history of pharmacy in medieval period. 
Introduction 
What is accepted in the Western world today is that 
pharmacy was officially separated from medicine f~r ~e 
first time in 1240 AD.2 However the remauung 
manuscripts of traditional Persian medicine show that 
Persians differentiated these two fields long before the 13th 
century. The holy book of Zoroastrians Avesta (about 500 
BC.) contains the pharmaceutical and medical concepts. 
These concepts had such strength that it is believed tha! the 
origin and root of the word "drug" in English is den~e<I 
from the word 'darav' in the Avestan language.3 Persian 
scientists of ancient Persia pushed the knowledge foi:v~d 
to the medieval ages and also collected the remammg 
knowledge of other ancient civilisations.4 In ~e earl~ 
Islamic era a group of Persian scholars such as Masaway 
in Jondishpour (8th century AD) were kno~ as 
pharmacists. Many pharmaceutical ?°°ks in parttci: 
were written by the Persian scientists either as s~ara~~ 
of a registry of drugs (Qarabadin books) or m m 1 
collections as separate chapters or volumes. ~or examp e, 
the most significant and influential scientistAV1cenna wrote 
. . h · the fifth volume his prec10us Canon (1037 AD), w ere m. ulary5 
one can see the complete pharmaceutical fonn ·f 
Various dosage forms with different routes 0 
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administration were mentioned in those books and 
ophthalmic formulas are one of these dosage forms. 
The history of ophthalmology and eye complications 
goes back to Antiquity. For example cataract operations 
were performed from 2457-2467 BC in Egypt, 6 some 
ophthalmic pharmaceutical tools such as Kohl bottles were 
found in Persia from 500 BC. Kohl was used as eye tonic 
and make-up in ancient Persia. Median Kings such as 
Astyages used it and in about the 6th century BC Cyrus the 
Great encouraged the use of kohl.7 Ophthalmic surgeries 
and therapeutic approaches were applied in Greek and 
Roman times (lst-7th century AD)8 and ophthalmology 
was a separate medical speciality in the Islamic era.9 In this 
regard, ophthalmic dosage forms were one of the 
phannaceutical remedies used by Persian practitioners. 10 In 
this study, these dosage forms and their special 
compounding and dispensing considerations in medieval 
Persia are considered and introduced to clarify 
phannaceutical knowledge of ophthalmic drugs in 
medieval period as a part of history of pharmacy. 
The research method employed in this article is based on 
the analysis of remaining manuscripts of medieval Persia 
from the 9th to 18th centuries AD, including medical and 
phannaceutical textbooks from this era. The chapters 
containing ophthalmologic information were investigated 
and the data was collected, categorised and analysed. 
Qarabadins, traditional pharmacopeias 
Qarabadins are traditional pharmacopeias which described 
the preparation considerations and procedures of 
compound medications. They include lists of drugs, 
formulations or prescriptions. The arrangement of the 
fonnulary varies from author to author. 11 The earliest 
remaining Qarabadin is Qarabadin-e-Kabir which was 
written by Shapur Sahl (869 AD), a Persian pharmacist 
from Jondishapur Medical University. 12 
suitable mortar with a specific liquid to make a solution 
or suspension form.16·17 The binder in these formulations 
would differ according to the kind of disorder the 
medication was meant for. 13 
Ghasool were liquid dosage forms formulated for 
washing body parts, including the eye. t3 The word 
Barood means cooling and these are the dosage forms 
meant to cool the eye s well as skin cuts and wounds due 
to the presence of cooling agents such as camphor in the 
formulation. 14·18 Later, traditional practitioners added 
other ingredients to this formulation to make a 
formulation suitable for other ophthalmic disorders. I3 
Kohl is a solid dosage form which mostly is considered 
as a cosmetic in today's practice. However it has been 
administered for medicinal purposes since antiquity in 
traditional pharmacy. t9,2o Kohl was applied in the eyes or 
on eyelids by means of an eye stick. It was meant for the 
eye to be exposed to the medicine several times unlike 
the Zaroor which is a single dose.15 The material which 
the eye stick was made of was different according to the 
ophthalmic disorder; it mainly was made up of gold or 
silver (Fig. 1 ). And the time of the day when Kohl was 
applied had s ecial rules as welt.21 
Traditional ophthalmic dosage forms Figure 1. Silverkohl bottle,7.andiehperiod(1750-1794), 
In Qarabadin books different ophthalmic formulations can be Museum of Shiraz University ofMedical Sciences. 
seen. Each dosage form was meant for a specific ophthalmic 
condition.'3 The most common dosage forms include eye General considerations in traditional eye 
drops (Ghotoor), ophthalmic dusting powders (Zaroor), formulations 
ophthalmic suppositories (Shiaf), eye washes (Ghasoo[), eye In Qarabadin books special considerations are mentioned 
cooling (Barood) and kohl formulations (Ek-ha[). '4,15 for ophthalmic preparations, even the timings. The best 
In Qarabadin books Ghotoor are defined as liquid dosage time in which ophthalmic preparation should be prepared 
forms meant to be applied in body cavities and orifices; these was in the early spring and for Zamor the late pring was 
were in the form of solutions, emulsions and suspensions. '6 also accepted since the ophthalinic medicine prepared at 
Zamor are solid dosage forms which were defined as these times was considered to have a longer helf life.21 
dusting powders which have the finest particle size Ingredients used in these medicati?ns were ~ainly 
amongst the ophthalmic dosage forms. '3 These were meant obtained from natural sources that included mmerals, 
to be applied in the eye or on skin cuts and wounds they stones, sea shells, herbs and animal parts. In all cases the 
were said to have shelf life of one year. 13 In a few ingredients needed to be powdered and passed through the 
Qarabadin books these powders were given mixed with finest sieves to prevent possible injuries to the eye due to the 
liquids or honey prior to use. 13 presence of foreign m~tter. If deeper penetrati_on of the 
Shiaf are defined as solid dosage forms which were medicaments was required then the partJcle size would 
prepared in biconvex shape and were meant to be applied have been reduced even more. It is noted that herbal 
m the rectum or they were storage forms of an ophthalmic ingredients should be obtained from fresh herbs containing 
preparation. In the latter case the solid dosage form of n~ dust and or impurities. ~the. ingredien~ needed _to be 
suppository was prepared to increase the shelf life of the dri~ they should be dried . m shade. As tmneral 
product and to provide easier transformation. At the time medi~ents such as C?pper, silver, ruby and pearl were 
of application each suppository was triturated in a used m eye formulations it was believed that these 
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medicines needed special modification called Tadaabir 
before application. In this regard, modifications included 
washing, burning and reduction in particle size.22 In the 
washing process the drug had to be dispersed thoroughly in 
a liquid. The supernatant was collected and the cake was 
washed with the liquid once again. Washed material was 
separated from the liquid phase and stored after drying.23 
Occasionally to achieve what is called today 'sterility', 
the ingredients were burnt. In recent research it was shown 
that a traditional ophthalmic formulation of Kohl which 
included burning the medicaments during its preparation 
called Kohl Al-Ethmed was not contaminated with any 
organisms and had no effect on bacterial growth.24 Besides 
achieving sterility, burning (Ehragh) was meant to alter the 
nature and the chemistry of the ingredients of ophthalmic 
preparation. A few ingredients needed to be completely 
milled before burning, a few others did not need particle 
size reduction prior to burning, or burning was a way of 
reducing their particle size. 13 Washing was then performed 
after this process if changes in the nature of the burnt 
substance were needed. In some cases the medicaments 
were only subjected to fire and not burnt thoroughly.23 In 
ophthalmic formulations, as well as the active components 
various other drugs have been used either as excipients or 
as means of reduction or increasing the potency of the main 
ingredient. Ophthalmic medicaments were often soaked in 
verjuice (Vitis vinifera L.) [sour grape juice], rainwater, 
anise juice (Pimpinella anisum L.), tanner's sumac (Rhus 
coriaria L.) and marjoram water ( Origanum majorana L.) 
and then dried and molded to increase their effect. 14 Some 
special ingredients such as musk were mixed with the main 
components as supplier or tracer. These ingredients were 
used to enhance the main component.21 
Conclusions 
For medieval ophthalmology, an extensive literature is 
available. The detailed explanations of the skilful 
diagnosis and treatments show the importance of this 
field in the medieval medicine. Various ophthalmic 
formulations were used in medieval Persia from the 9th-
18th century AD. Although the number of ophthalmic 
formulations increased during the period the dosage 
forms remained the same. As there were formulations 
which were repeated in several Qarabadins during this 
time, it is unlikely that adverse or toxic effects following 
the use of these formulations would not have been 
noticed or neglected and it is not possible that the 
formulations would have been used continuously 
throughout the history with no therapeutic effects. 
Accordingly the pharmaceutical validity of ophthalmic 
formulations in the medieval period cannot be denied. 
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The Treatment of Scabies in Ferrara 
(Italy) in the 19th Century 
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This work represents a continuation of our efforts to 
highlight the therapeutic approaches used in Ferrara in 
treating the typical illnesses of the 19th century such as 
tuberculosis, scrofula, syphilis and cholera. We describe 
approaches used against scabies, the remedies reported in 
Campana's Pharmacopoeiaferrarese as well as the other 
efficacious treatments employed in Ferrara in the 19th 
century. One of the most renowned remedies, Pommade 
d'Helmeric, is still used today. 
Introduction 
Tuberculosis, scrofula, syphilis and cholera, were typical 
19th century illnesses, and we examined recently the 
approaches in use in Ferrara. 1-5 In this paper we have 
investigated the remedies and the treatments employed in 
Ferrara against scabies, an illness of great concern for the 
public health of the time. 
We have chosen Campana's Pharmacopoeia as a good 
example to help us understand how the treatments, 
remedies and cures improved over the century. Antonio 
Campana (1751-1833), professor of Pharmaceutical 
Chemistry and Botany, wrote a successful pharma-
copoeia for the apothecaries in Ferrara, that was also used 
in several Italian editions and abroad from 1798 to 
1851.6,7The remedies for scabies adopted in the city were 
in line with those utilised in other countries. 
The Statistical Report from St Anna Hospital, 
compiled by Alessandro Bennati in 1871 and 1876, 8•9 
provides detailed and complete information about the 
treatments for scabies used in Ferrara. 
The sulphur remedies and the Pommade 
d'Helmeric 
Scabies is a contagious skin disease caused by the mite 
Sarcoptes scabiei. The parasitic aetiology of scabies was 
documented by the Italian physician Giovanni Cosimo 
Bonomo (1666-1696) and by Giacinto (or Diacinto) 
Testoni (1637-1718), an apothecary in Livomo. 
The use of sulphur against scabies had been well known 
for millennia. Reginald Campbell Thompson in The 
Assyrian Herbal (1824) reported the translation of 
inscriptions on Assyrian Babylonian tablets: against the 
scabies, an ointment made of sulphur and citron oil was 
recommended. 1 o In the Ricettario fiorentino 11 ( 1789) 
unguento da rogna, [scabies ointment] an ointment made 
of bay leaves, lard, and flowers of sulphur is reported. ~e 
use of sulphur was frequent in the Ferrara pharmacopoe1":'. 
_In the 1725 Pharmacopea ferrariensis 12 Francesco Mana 
N1grisoli described three unguentum ad scabiem (two were 
made of sulphur): storax, lead, sodium chloride, lemon; 
storax, turpentine, lemon, sodium chloride, sulphur 
powder; unguento rosaceo (made with rose petals), butter, 
sulphur, olio di tartaro (potassium carbonate). 
In the first edition of Campana 's F armacoped> two 
fonnulas were already present: unguento da rogna con 
zolfo, an ointment made of olive oil, lard, sulphur powder, 
lime, and sodium chloride, and unguento da rogna con 
tabacco, an ointment made of sulphur powder, tobacco, 
white hellebore (Veratrum album), maro (cat thyme, 
Teucrium marum), nerio - Nerium oleander, sodium 
chloride, and unguento rosato (made with rose petals). 
In the 1841 edition 7 acqua di Hartmann verde was a new 
entry. Infusion of fiori di zolfo ( flowers of sulphur), a flume 
crudo polv. (aluminium sulphate), verderame di Marsiglia 
( copper acetate) and acetic acid were applied externally. 
Pommade d'Helmeric was very successful in the 19th 
century, and was also used in medical practice in Ferrara. In 
the Revue medico-chirurgicale de Paris13 of 1851 Burdin, 
a physician at Groningen's military hospital, refers back to 
Helmerich and his secret pommade : 
Le Journal de medecine, chirurgie et pharmacie (fevrier 
1813) contient le Memoire de M. Burdin sur le traitment 
rapide de la gale [scabies], comminique par M. Percy. M. 
Burdin, medecin de l'hopital militaire de Groningue en 1812 
rapportait qu'un Hollandais, Helmerich, chirurgien an 125° 
regiment de ligne, etait possesseur d'une pommade (qu'il 
tenait secrete) avec laquelle on pouvait guerir la gale en moin 
de quarante-huit heures. 
The Dutch Helmerich, a French army surgeon, became 
famous for a pomade which was able to cure patients of 
scabies in 48 hours. The Dictionaire des sciences 
medicales14 (1816) gave more details of the fatty 
sulphurous pomade with prompt effects. It was . less 
adherent to clothing and could be washed out. It said he 
kept the formula secret out of amour-propre rather than 
cupidity since it was already known in Germany: ~urdin 
had analysed the pomade, which he found was sumlar to 
one described by Fox, 14 which could well have been 
known to Helmerich. The same was reported also in the 
1827 Bulletin des sciences medicates: 15 
The Pommade was well known and praised also in 
Italy, London, Dublin and Paris. 1?e Pomm~e 
d'Helmerich is cited in The Cyclopaedia of Practical 
Medicine 16 (London, 1834): 
M. Helmerich, a French army surgeon, became famous for a 
method of using sulphur which cured ... 
and in A practical treatise on diseases of the skin 17 
(Dublin, 1852): . 
. . . present day in France, and found to be more efficacious 
than when used alone: the combination was first introduced 
by M. Helmerich, and the ointment, which is called after him, 
Pommade d'Helmerich, is composed of two parts of sulphur, 
one of carbonate of potash, and eight of lard. The surface of 
the entire body, but more particularly of the aff~ted parts, 
should be first washed well with a strong solution o~ soft 
soap, the patient then placed for a quarter of an hour m an 
alkaline bath, containing a pound of the carbonate of potash 
to twenty gallons of water, at the te~perat_ure of 92°, the skin 
well dried, and this sulphuro-alkalme omtrnent afterwards 
thoroughly rubbed in; the disease may thus be effectually 
cured in two or three days, a single friction, preceded by the 
alkaline and saponaceous bath, being used daily. 
Omodei in the 1827 Annali universali di medicina18 
and Soresina in the 1867 Giornale Italiano de/le Malattie 
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veneree e de/le malattie de/la pelle19 stated that the addition 
of sapone nero (soft soap, made with potash and various 
animal and vegetable fats) allows the resolution of disease 
in 12 or 24 hours. The method reported in Archives gener. 
de med Avril. 1827 is also mentioned. 
The pomade was much used in the 19th century and 
many physicians strove to make improvements, such as: 
Dupuytren's lotion; Jadelot's liniment; Holmboe's 
treatment; unguentum sulphurus compositum of the 
London Pharmacopoeia ( containing sulphur, soft soap, 
nitre, veratrum, oil of bergamot, and lard); the 
preparation made of sulphuretted potash (sulphur and 
carbonate of potash) of the Dublin and Edinburgh 
Pharmacopoeias; Hardy's treatment; sulphuret of 
calcium ofVleminckx in Belgium; and so on.20-27 
At the Hospital St Louis of Paris, ointment (Pommade 
d'Helmerich) was employed28 (Figure 1): 
some patients having an inswmountable dislike to sulphur, 
were induced to try several ointments prepared with essential 
oils - as those of lavender, thyme, rosemary, &c., and 
likewise turpentine and mercurial ointment. None of these 
were effectual.23 
t,-~4'- ,4.~/,;,.,,.,,n•., .. . ,,.,t,I, .,• ,._ ...... . 
• 
, .J ' . / 
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Figure 1. Scabies dermatosis, table 55, standard or 
vesicular mange. 28 
In England scabies was more prevalent amongst the 
middle and upper classes; the increase is attributable to 
the introduction of the disease into a better class of 
society by the return of the army from the Crimea, but the 
hypothesis was unconfirmed. 24,25 
The Ferrarese Pharmacopoeia 
A larger variety of remedies was proposed in the 1841 
edition of Farmacopeaferrarese7. The first was scabious 
(Scabiosa arvensis), then cat thyme (maro) (Teucrium 
marum ), lupino (Lupinus a/bus as flour, washing), 
furnitory (Fumaria officinalis), wild rosemary (Ledum 
palustre, decoction), nerio - Nerium oleander (ointment 
made with oleander leaf powder), alloro - Laurus nobilis 
(laurel, leaves decoction), olio volatile di trementina also 
called olio etereo di treme~tina (turpentine essential oils), 
catrame (wood tar), chlonne, spirito di zolfo (sulphurous 
acid, baths), andfiori di zolfo (flowers of sulphur). 
In addition to the previously cited sulphur remedies 
(unguento da rogna con zolfo, unguento da rogna con 
tabacco and acqua di Hartmann verde) Campana included 
acqua contra la rogna also called acqua antipsorica 
( decoction; dried leaves of tobacco and sodium carbonate; 
frictions, twice a day). It does not smell or stain. 
Campana cited three sulphurous mineral springs: acqua 
di Voltri nel Genovesato (de/la Loira near the river Loira 
and de/la Penna that emerged in Mount Penna) and acqua 
di Rapolano somewhere around Siena (warm spring). 
Alessandro Bennati's Reports of the St 
Anna Hospital (1871, 1876) 
The 1841 Edition of Campana 's Pharmacopoeia and the 
Statistical Reports from St Anna Hospital, compiled by 
Alessandro Bennati in 1871 and 187 6, 8,9 helped to guide 
us in researching these treatments. 
In 1871 St Anna Hospital Medical and Surgical 
Division had rooms with 400-500 beds. Sala Nuova also 
called the Sala Chirurgica (new room, surgical room), 
was next to the hall of the hospital and it was reserved for 
critically ill patients and those unhealthy with fetid 
exhalations and scabies. In 1871 a Medical-Surgical 
Dispensary was opened. Poor persons were treated free 
of charge. It was open every day for out-patients. Those 
patients with contagious scabies were kept in. 
In the Report those admitted and discharged with scabies 
were reported for each month: 25 males and 25 females 
(Table 1 ). Good weather was considered favourable to 
scabies. In the Report a chapter is entirely devoted to 
bathing treatment ( Cure balnearie) (Figures 2, 3). 
Figure 2 Statistical Report from St Anna Hospital: 
Resoconto statistico Sanitario dell 'Arcispedale per 
l'anno 1871.8 
In 1871 50 scabies patients (Table 2) were hospitali.· sled 
. J and 11 ma es (14 males and 16 females m January- une 
and 9 females in July-December). 
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Table 1. Numbers of scabies patients at St. Anna 
Hospital in 1871.s 
Admitted Discharged Days of 
hospital 
Month M F M F stay 
Januarv 1 1 0 0 15 
Februarv 3 6 3 7 129 
March 5 2 5 2 96 
Aori l 3 6 1 3 48 
May 0 1 3 4 169 
June 4 1 2 0 62 
July 0 1 2 1 38 
AUQUSt 4 3 2 4 61 
September 2 0 2 0 34 
October 0 1 2 0 10 
November 3 2 2 2 42 
December 0 1 1 2 25 
25 25 25 25 729 
50 50 
Figure 3. St Anna Hospital, bathing treatment, Cure 
Balnearie.8 
In January-June 14 males (not yet in an advanced state) 
who were treated with Helmerich 's ointment and 
sap~maceous baths, left the hospital after 6-8 days; 6 
patients, treated externally with sulphur, were healed in 
Table 2. Scabies patients hospitali ed in St. Anna 
Hospital (Statistical Report, 1871 ). 
Male wards Female wards 
?Crust 
Simple ?Crusted Total Simple ed Total 
scabies scabies 1871 scabies scabies 1871 
Jan- 8 6 14 9 June 7 16 
Jui- 6 5 11 6 3 9 Dec 
25 25 
20-30 days. One decided to leave the ho pital. In July-
December 6 males (not yet in an advanced tate) left the 
hospital after 6-10 days; 5 patients with pruriginous 
complications left in 20-30 days with the ame treatments. 
In January-June 9 females (not yet in an advanced 
state) left the hospital after 8-10 day , 7 with prurigo after 
2-5 weeks; seriously affected patients were treated 
internally with rnagne ia powder and ulphur. Tore 
decided to leave the ho pital. In July-December 6 
females (not yet in an advanced tale) left the h pita) 
after 8-10 days; 5 patients with chronic cabie and 
prurigo in 14-16 days with ulphureou bath in addition. 
In summary, patients were treated with Helmerich 
ointment, saponaceous and general baths. In an advanced 
state of illness with prurigo, magnesia powders and sulphur 
were administered internally. Sulphureous baths were 
employed. These patients left the hospital after 6-30 days. 
In the 1876 Rendiconto, a concise report ofBennati, it 
was reported that cases decreased from 54-60 (before 
1871) to 48 (1876) (Figure 4). Four months' data were 
reported (Table 3): 25 males and 23 females were healed 
after 10-1 I days. The same treatments were adopted: 
general and saponaceous baths and Helmerich ointment. 
Conclusions 
The treatments and hygienic rules adopted in 19th 
century in Ferrara were efficacious: in 1871 among 
72 447 residents only 50 cases of cabie were regi tered. 
Scabies remains one of the commone t of kin di case 
seen in developing countrie . owaday in Italy, bie 
has reappeared perilou ly in ome familie , particularly 
41 
.. 
" 
" 
,. 
Figure 4. Scabies patients hospitali ed in t Anna 
Ho pital. (Statistical Report, 1876.)9 
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Table 3. Inveterate scabies patients hospitalised in St. 
Anna Hospital (Statistical Report, 1876)9 
Male wards Female Total 1876 
wards 
Jan-Apr 12 10 22 
May- 9 11 22 
Aug 
Sep-Dec 4 2 6 
Total 25 23 48 
the most vulnerable, in communities, and in hospitals, 
and also has its greatest impact on young children. 
Permethrin, crotarniton and benzyl benzoate are 
employed. It is thus no surprise that the Pomata di 
Helmerich is included in the 12th Edition (2008) of the 
Italian Phannacopoeia29 . However, with a few notable 
exceptions, it remains largely neglected as an important 
public health problem3o. 
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Porcupine Stones 
Dr Christopher J Duffin 
Sutton, Surrey 
Bezoar stones are masses of undigested organic and 
inorganic material, often within calcareous concretions, 
fonned within the gastrointestinal tract. Introduced into 
Europe from the Arabic medical tradition at the time of 
the Crusades, the name comes from the Persian word 
padzhar, which literally means 'antidote'. As early as th~ 
tenth century, the materia medica of Abu Mansur 
Muwaffak, compiled between 968 and 977 AD, 
commented on the bezoar, classifying it as a precious 
stone. 1 Different varieties of bezoar were recognised 
even at this early date; gathering information from a 
series of earlier authors, Al-Biruni (973-1048) describes 
at least five types, some of which may have been of 
mineralogical rather than animal origin, noting that they 
came predominantly from India and China.2 Bezoar 
stones, although quite rare, enjoyed a great deal of 
popularity as an alexipharmic (antidote to poison). 
The European Age of Discovery during the fifteenth and 
sixteenth centuries helped to establish trade routes to support 
Figure 3. Portrait of Caspar Bauhin (1560-
1624) who first nan,edLapis Malaccaen.sis in 
1613. Engraving from around 1600-1 (i()5. Title 
page of Appendix ad Theatrnm Anatomicwn. 
Reproduced by kind perrnis.sion of the WeUcome 
Library, London. 
a rapidly growing home mari<:et for exotic 
,, .,. ,, goods, including many plants, animals and 
de Go,., ,...,. N Ooa "Purlu.. minerals WillCh Were believed to have 
therapeutic properties. The English, Dutch, 
Spanish, Portuguese, and Italians vied for 
dominance in the ever expanding trade between 
Europe and India, China and South East Asia, 
including the Spice Islands or Moluccas. The 
estab-lishment of settlements, trading posts, and 
missionary programmes all helped to secure 
footl,olds in tl,e trading areas. 
Bezoar stones teadily increased in 
popularity. Garcia de Orta ( 149 1568), a 
Portuguese Jewi h phy ician and naturalist 
who studied medicine in pain, fled his 
home country for fear of the Inquisition, 
sailing to India as Chief Physician to the fleet 
of Viceroy Martim Afonso de Sousa ( circa 
1500-1571 ); he eventually settled in Goa. 
Here, he published his famous Co/6quios 
dos simples e drogas he cousas medicinais 
da f ndia ('Conversations on the simples, 
_ drugs and medicinal substances oflndia') in 
- 10 mm. 1563. In the seventeenth Colloquy, hestates:3 
10 mm. But the best medicine of all is three grains ofbezar 
Figure 1. Aufuenticlapis de Goa. Two Figure 2. Fakel.apis de Goa (Lapis stone, which the Pe:8ians call pazar. It is of such 
SJ)eeimens from tl,e collections of the de Goa Spurius). Royal use that 1t almost muaculously dilates the powers 
Royal Ph . . Ph tical Society Museum of the heart. I have had many patients who said to 
arrnaceutical Society Museum armaceu FML 
2
) me after taking it, not knowing what it was, that the 
(POS FML 1). (POS . 
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soul return to the 
body. 
As demand 
for this 
miraculous 
stone soared, 
the sources of 
supply came 
under pressure . 
Fake bezoars 
began to flood 
the market; one 
response was 
the invention of 
the Lapis de 
Goa by the 
Portuguese 
Jesuit, Gaspar 
Antonio, 
working in Goa 
(Fig. 1).4 Even 
'---------------' these were open 
Figure 4. Title page of Bauhin (1613). to fraud, the 
Google Books. carefully 
blended plant 
and animal products and comminuted precious stones 
overlain with polished gold leaf being replaced by coarse 
pebbles of fine sandstone (Fig. 2). Another response was 
diversification; a series of bezoars from a wide range of 
animals was identified and began to appear on the open 
market by the late sixteenth century. Indeed, the situation 
had progressed so far by the early 1600s that Bezoar stones 
were ripe for a review. The task fell to Caspar Bauhin ( also 
known as Gaspard; 1560-1624; Fig. 3), a famous Swiss 
botanist whose family fled to Switzerland from France 
when his father converted to Protestantism. Caspar studied 
medicine in Italy and Germany before returning to his 
hometown, Basel, in 1580, eventually holding professorial 
positions in anatomy, botany and the practice of medicine, 
as well as being city physician and rector of the 
university.5 In 1613, Bauhin published his De lapidibus 
Bezaar Orient. Et Occident (Fig. 4), touching on 
innumerable alexipharmic materials in the course of his 
discussion. Here, he also introduces Lapis malaccensis, 
the Porcupine Bezoar.6 
The Porcupine Bezoar 
Specimens 
I recently came across two specimens of Porcupine 
Bezoars in the collections of the Royal Pharmaceutical 
Society Museum. The specimens form part of an 
eighteenth century collection of Materia Medica which 
was presented to the Museum by the Royal College of 
Physicians in 1926. The collection was originally made 
by John Burges (1745-1807), a Londoner who studied at 
Westminster School before going up to Oxford, where he 
gained BA (1764), MA (1767), MB (1770), and MD 
degrees ( 1774). Appointed Physician to St George's 
Hospital, his rather delicate health precluded his entering 
general practice and led to a rather quiet existence living 
with his two unmarried sisters in Mortimer Street, 
Cavendish Square. His great passion was the collection 
and study of materia medica, aided by Sir James Bland 
Burges (1752-1824), author, barrister, Member of 
Parliament for Helston and eventually Knight Marshal 
for George IV. John was sufficiently well known in his 
day to warrant a caricature, dated 1795 (Fig. 5). 
Burges left the collection to former pupil Dr Everard 
Augustus Brande (1746-1834), originally from 
Mecklenburg in Germany, who later became naturalised, 
opened a shop at Kew and rose to serve as Apothecary to 
Queen Charlotte from 1783-1801. He, in turn, presented 
it to the Royal College of Physicians in 1809.7 
One item in the collection (1013) is labelled Lapis 
hystricis. Stored in a sealed glass jar, it consists of a dark, 
oval, somewhat granular ball measuring around 25 mm 
in length (Figs. 6A-C). 
_ ..... 
~:rt:!~-11 /"'"' ~ 
;;r;-'ol;;; ." J, f U'al'flN") 
Figure 5. Caricature of Dr. John Burges (l 74?-1807), 
standing on tiptoe outside a building in W~ck ~-
Coloured etching by J. Gillray, 1795. Published by · 
Humphrey 37 New Bond Street on 3rd July 1795· 
' Lib London. Reproduced by kind permission of the Wellcome 1 raIY, 
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A. 
Figure 6. Lapis hystricus from the John Burges eighteenth 
century materia medica collection (Royal Pharmaceutical 
Society Museum, 1013) (A) specimen jar with label facing 
forward; (B) Lapis hystricus (photographed through specimen 
jar); (C) specimen label contained in jar. 
By kind permission of the Royal Phannaceutical Society Musewn 
The second of the two specimens (POS FAP 2; Fig. 7) is 
the most interesting. It consists of two almost spherical, 
light fawn and grey to iron grey, mottled, relatively smooth 
balls measuring around 30 mm in diameter. Both stones are 
heavily fissured. Each stone is enclosed in a metal (silver?) 
cage. Each cage consists of two series of regular, deep 
petaloid loops radiating from the poles toward the centre of 
the stone. The two loop series are connected together in the 
equatorial region of the stone by means of a metal wire. At 
the bottom pole of the stone, the loops have their bases 
anchored together by means of a stud consisting of a group 
of small metal beads. At the top pole, the bases of the loops 
are connected together at a metal loop to which a metal 
chain is attached, anchoring the two stones together to fonn 
a single unit. 
It seems clear that the open metal cagework was to 
allow circulation of the surrounding fluid around the 
stone during its use as an infusion, and to allow a route 
for the bitter chemicals to leach out of the stone into the 
10mm. 
-
surrounding medium. The chain was a useful means of 
suspending the stone. A second stone could be seen as a 
handy replacement if the first began to lose its efficacy. 
The only other images of mounted Porcupine Bewars of 
which I am aware are found in Engelbert Kaempfer's 
(1712) Amamitatum exoticarum politico-physico-
medicarum fasciculi V,S and Albertus Seba's Locupletissimi 
rerum naturalium thesauri accurata description, published 
in four parts from 1734 to 17 65. IO Kaempfer ( 1651-1716) 
was a German naturalist and physician who joined the 
Dutch East India Company as chief surgeon in 1685. He 
travelled extensively, later becoming known as 'The 
Humboldt of the seventeenth century'. He spent nine 
months in Jakarta (September 1689 to May 1690) before 
travelling on to Japan. It was probably during his stay in 
Indonesia, studying local natural history, that he obtained 
the specimens illustrated in his book (Fig. 8). He pictures a 
mounted Malaccan Porcupine Stone (Pedro de porco vera 
sive lapis histricus; fig. l of Kaempfer), two purious 
Porcupine Stones from Sri Lanka (Kaempfer's fig . 2, 3) 
and a pig hairball ( bolus pilosus porcinus; Kaempfer fig. 4). 
The Porcupine Stone is enclo ed in a imple cage 
comprising four metal bands. It was suspended on a length 
of chain with a ring at either end. 
Born in Etzel, East Frisia (NW Germany), Albert.us 
Seba ( 1665-1736; Fig. 9) travelled widely through 
western Germany and Holland, studying to become an 
apothecary. Eventually settling in Amsterdam in 1699, he 
i!fYn.~_rL'f!JIJ.oaefjl o,a$/,re~ ~ 
Figure 8. Figures of Porcupine Ston · from Kaempfer 171 2.8 
became a wealthy man from hi pharmacy busi11es , and 
was a prominent citizen of the town. eba_ develo~ an 
interest in natural history and began collectrng specimens 
for his personal cabinet. Since his pharmacy was situat~ 
close to the harbour, he was able to gamer many exotic 
specimens for his rapidly increasing collection. He 
reputedly sold his first collection to Tsar Pe~er the Great 
(1672-1725) in 1717 (for 15,000 guilders), and 
immediately commenced accumulating a second.9 The 
beautifully illustrated catalogue of his cabinet, the final 
two parts of which were publi~hed P?sthumou~ly, 
Figure 7. Two Pedro de Porco from the John Burges contains illustrations of the porcuprne believed to give 
eighteenth century materia medica collection (Royal rise to the stones, and a number of porcupine stones 
Pharmaceutical Society Museum, POS F AP 2). themselves (Fig. 10).10 The tone which he figures come 
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Figure 9. Portrait of Albertus Seba (1665-1736) by 
Houbraken after Quinkhard. 
Reproduced by kind permission of the Wellcome Library, London. 
from Malacca ( called Koelida laudac by the Dutch at the 
time). One specimen (his fig. 5) is unmounted, and has a 
spherical shape with no surface detail. Two others (Seba's 
figs. 3 and 4; Fig. 10) are mounted in a similar style to the 
Royal Pharmaceutical Society Musewn specimen. The 
stones are somewhat oval in outline and the enclosing 
metal cagework consists of two groups of petaloid bands, 
one at either end, with several long connecting struts, 
each bearing a small floral decoration, running between 
them. One end of the specimen has a metal stud, whilst 
the other is characterised by a metal ring to which a chain 
is attached. 
In terms of other surviving specimens, I am only aware 
Figure 11. V23789, a Pedro del Porco encased in a 
gold :filigree cage. 
Reproduced by kind permission of the Museum Boemaave, 
Leiden. 
Borneo and Swnatra during the sixteenth to eighteenth 
centwy; the Common Porcupine (Hystrix brachyura 
Linnaeus 1758; Fig. 12), the Long-tailed Porcupine 
(Trichys fasciculata (Shaw, 1801) and the Thick-spined 
Porcupine (Thecurus crassispinis Gunther 1876). All 
three have been found to yield bezoars today.11 Hystrix 
brachyura ranges throughout South and South East Asia 
and is classified as vulnerable by the IUCN. It is a 
of one extant Porcupine Stone which is in the Boerhaave h Figure 12. Common Porcupine (Hystrix brae ,yura Musewn collection in Leiden. A single stone enclosed in 
a gold filigree case of similar style to that figured by Seba Linnaeus 1758). 
is illustrated in Fig. 11. b k 
nocturnal, forest dwelling forager of roots, tubei:s, ar 
Sources of the stone and fallen fruits occasionally eating carrion and insects. 
The porcupine stone was probably obtained from three The very bitter ~ste attributed to the Porcupine Bezoars 
species of porcupine endemic to the Malay Peninsula, is believed to come from the sap of 
.-----------------=------=-------Ly-. -
3
--, the liana, Leuconotis anceps Ja~} 
1825, which the rodents also. eat. 
Garcia da Orta refers in his ~Sth 
hi h '1s a Colloquy to a stone w c 
clear vermilion. It is bitt~r _to ~e 
taste, and to the _touch it I~~: 
French soap' and 1s formed 
· , kin 13 porcupme s s · . to 
L-----~---3..~:.....l,.::ll,.._--=..L3,.__:flt...ll,~11.1.).).)~.ll!..Jlll....!L1LcLl-...L_ ___ ___.J Considerable confusJOn seems 
. f th p pine Bezoar. 
Figure 10. Porcupine Stones (figs. 3-5). Detail of Seba 
( 1765), vol. 1, Plate LI. 
have arisen regarding the ori~ o e orcu_ --"ed Hog 
Pierre Pomet (1658-1699) believed that the S()-U:lll 
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Figure 13. Portrait ofGeorg Eberhard Rumpf(l627-
1702), from Rumphius (1705). 
Reproduced by kind permission of the Wellcome Libraiy, London. 
Stone was different from the Porcupine Stone, although 
Nicolas Lemery (1645-1715) suggested that they are 
synonymous, an opinion strongly supported by Sir John 
Hill (circa 1716-1775) in his History of the Materia 
Medico. 14 Charles Lockyer ( died 1752), chief accountant 
to the South Sea Company and who gave evidence to the 
House of Commons enquiry into the South Sea Bubble, 
indicated that the Hog Deer produces a bitter bezoar 
(Pedro de porco Siocco), 'valued at ten times its weight 
in gold ', and which is brown in colour with a smooth 
outer surface covering a fibrous interior. 'They swim on 
the water, and by infusion only, make it extream bitter'; 
the virtues of the stones included 'cleansing the Stomach, 
creating an Appetite, and sweetning the Blood' .15 He 
described the Porcupine Bezoar, by contrast, as being 
'redish and full of short transparent veins, something like 
the red sort of Marble' and that it sinks to the bottom of ~ water vessel, where it is left to steep for some time for 
its occult virtues to infuse the liquid. 16 Others have 
described the Porcupine Bezoar as being a yellowish 
brown stone whose external surface 'is covered in some 
Parts, with a kind of blackish scales, like nails' , but has 
'neither laminae nor membranes, is neither ponderous 
nor smooth'.17 George Motherby (1731-1793) recorded 
a sunilar description of the stone, saying that it consists 
of 'woolly fibres' and 'bitter, friable matter', was 
roundish in appearance, of pale, purple green or white 
colour, soft, smooth and slippery to the touch. 18 
The general consensus was that the Hog Stone and the 
Porcupine Stone were synonymous and that, amongst 
Porcupine Stones, those from Ceylon (now Sri Lanka) 
were by far the most inferior. The latter were 
designated Pedro de porco spurio, by Kaempfer 
(figs. 2 and 3 in Fig. 8). 
As to the parts of the rodent's anatomy which yielded the 
stone, in addition to the skin cited above, it has been 
ascribed to the liver, stomach and intestines, but most 
authors link it to the gall bladder. Albertus Seba, for 
example, states that 'this stone originates in the bitter fluid 
gall of the animal, a small grain the size of a pin-head 
gradually increasing to the size of the yolk of a hen's or a 
duck's egg.' 19 It is described as being the size of a filbert 
(Hazel nut), nutmeg, walnut and a hwnan fingemaif. 20 
Georg Eberhard Rwnpf (1627-1702; Fig. 13) was born in 
Germany, set sail for Brazil and then spent 3 years in 
Portugal before joining the Dutch East India mpany. He 
arrived at Batavia (Jakarta) in 1653 and quickly tab Ii hed 
a reputation as a botanist, becoming known as Plinius 
Indicus - the Pliny of the Indies. In pite of blindn 
caused by glaucoma, and much personal tragedy, he 
completed his Amboinsche Roriteitkamer (Amboina 
Curiosity Cabinet), eventually to be publi hed in 1705. In 
this work, he pays considerable attention to Porcupine 
Bezoars, stating that they are small in size - up to that of 
musket balls21 - this feature distinguishing them from the 
larger Pig Bezoars. 
Value of the stone 
Writing to wealthy banker Philip Eduard Fugger (1546-
1615), Christoph Hyeble (1551-1600; also known as 
Christoph Hieblin) wrote: 
This stone should be held in high esteem and may be used with 
c:onficlence not only by those fucing imminent death, but also in 
other dangers, be it at home or abroad, particularly in our present 
time in which many godless and wicked people have stealthily 
murdered several noble persons with deadly poison. For this 
reason, it is advisable for all to obtain a bewar stone, regardless of 
how much effort and money it may take, and to have it readily 
available at all times as a precious treasure and antidotc.12 
With such a ringing endorsement of bezoar ton , it i 
no wonder that they, and porcupine bczoars in particular, 
should command such high contemporary prices.23 e 
specimen was given by Ferdinando I de Medici ( 1549-
1609) Grand Duke of Tuscany, to Eleonora de Medici 
(1567~1611) Duchess of Mantua, whilst others were 
' M 
auctioned as part of the estates of the Dutch upper classes. 
Rwnphius records that Porcupine Bezoars were sold 
locally for up to 200 ducats and I 00 Rixdollars apiece, and 
Edmund Chishull (1671-1733) notes in his diary whilst 
acting as Chaplain to the Levant Company, that a single 
stone fetched 100 ducats. Alfred Hart Everett ( 1848-1898), 
a British civil servant and administrator in Borneo, and an 
accomplished naturalist, wrote ~bout the 'G~iga landak' or 
Porcupine Stone from Borneo m 1879, noting that, at the 
time, it cost up to $4 per 'amas'.25 Peter Borschberg ~as 
recently calculated that, assuming an average porcupine 
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bezoar to weigh 7 g, market values would have been up to forty 
times its own weight in gold 
Walter William Skeat (1866-1953) was an English 
anthropologist who, following a classical education at Christ's 
College, Cambridge, joined the civil seivice of the state of 
Selangor in the Malay Peninsula in 1891. Writing about 
Porcupine Stones in his classic study of Malay magic, he 
records having been asked for $200 for a small stone which 
the owner kept protected in cotton wool in a small tin box. 
The stone was surrounded by grains of rice, which the vendor 
swore the stone fed upon!26 
The German physician and student of Hermann 
Boerhaave, Hieronymus David Gaubius (1705- 1780) 
uses the Porcupine Bezoar as an example of a medicine 
of high price but 'otherwise ofno great efficacy' .27 Those 
who could not afford to buy their own stone could always 
rent from an apothecary. Specimens mounted in gold 
cages were available for hire at the sum of one ducat for 
a full day from various German druggists.28 
Tests of veracity 
Commanding such high prices, it is little wonder that 
counterfeits began to flood the market, some of which 
were positively dangerous (sometimes containing mercury 
or antimony), bringing the question of how to tell an 
authentic stone to the fore. 29 Pedro Teixeira ( circa 1570--
1641 ), the famous Portuguese explorer, traveled to Goa 
sometime after 1586. Travelling on to Persia, he learned the 
language, and collected books and manuscripts on the 
history of the country. Teixeira translated and summarised 
the Tarikh-i rawzat al-safa ('History of the kings of Persia') 
by Mir Khvand, Muhammad ibn Khavandshah (1433-
1498), a Persian chronicle of the kings of Hurmuz, and 
published an account of his own voyage from India to Italy 
in 1600-01. Captain John Stevens ( died 1726), a prolific 
translator of Spanish and Portuguese books, produced a 
highly embellished English version in 1715, which is the 
volume consulted for this study.30 Two tests of authenticity 
are given in this work: 
The first is to take in one's hand a little lime worked up with 
water, and sprinkle the stone therewith, and if the lime turns 
yellow, and the stone is not wasted, it is genuine. The second test 
is better and ~urer, that is, to weigh the stone, put it into a vessel 
of wa_t.cr, l~ve it ~ere six or seven hours, take it out, and weigh 
It agarn. If It keeps Its form and weight, it is good, but if it breaks 
up, or melts, or gains weight, it is counterfeit. 
Walter Skeat records31 that, on enquiring how he could 
be certain that a very expensive specimen offered to him for 
sale was, indeed, genuine, he was told that 'if it were placed 
on an inverted tumbler and touched with the point of a k 'ris 
( dagger) or a lime fruit it would commence to move about' . 
Once performed, the test duly confirmed the authenticity of 
the stone, but Skeat was not deceived by the sleight of hand 
used by the salesman to bring about its movement. It seems 
that fakes were proclaimed real by the trickery of fraudsters! 
Synonyms of the stone: the following names were 
encountered for this stone during the course of this study: 
Porcupine Bezoar; Hystricum; Bezoar Hystricis; Bezoar 
Hystricum; Lapis Hystricis; Hystricites; Pila Hystricis; 
Bezoar Porci; Pedro de] Porco; Piedra de Puerco; Pedro 
Figure 14. Portrait of Robert Boyle (1627-1691 ). Line 
engraving 17 44 by Frederic Kerseboom after Bernard Baron. 
Reproduced by kind permis.5ion of the Wellcome Librazy, London. 
de Vasso; Hog Stone; Hog Bezoar; Boar Bezoar; Lapis 
porcinus; Malacca Stone; Lapis Malaccensis; Malacensis 
Lapis; Mastricha de Soha; Mastica de Soho; Indian 
Porcupine-Stone; Pedra de porco Siacca; Pedra de porco 
d'Espinha; Culiga landha; Humala.32 
Therapeutic uses of the stone 
Jakob de Bondt ( 15 91-1631) gained his MD from Leiden 
in 1614, and joined the Dutch East India Company ~-1626 
as Doctor, Dispenser and Inspector of Surgeons. Sailing t_o 
the East Indies in 1627 he wrote the manuscript of his 
famous De Medicina Jndinorum over the next four years. 
Its publication was posthumous, however, appearing in 
1642, eleven years after his death at Batavia (no~ Jakart_a). 
A second, expanded edition was produced by Willem P1so 
in 1658, and an English translation appeared in 1769._33 De 
Bondt described the Malacca Stone as being formed ID the 
'stomachs of porcupines with long feathers' (i.~. spines~, 
and as being 'soft and fat to the touch, like Spamsb soap· 
· · fi rthe He recommended that the stone be 'infused m wme O . 
cholera'. This disease went under the name of Mordexi, 
Mordixim, or Mordechi by the Jocais,34 and de Bondt n~ted 
that it was capable of killing within a few hours of infection. 
He also gave the warning that the stone proved to be. an 
abortifacient if infusions were prescribed dunnt ogf 
· th even pregnancy; indeed, he reported that, m e h Id the 
suffering menstrual problems, women had only to 0 
stone in their hands in order to receive some benefit. 
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'Infinite medicinal virtues' were ascribed to the 
porcupine bezoar by local people, whilst Sir Tancred 
Robinson (1647/8-1748) is credited with the observation 
that it is 'an excellent Alexiphannic'. 35 
Whilst medical men from classical times onward 
described the actions of various plant, animal and mineral 
materials in term of their 'hidden vertues' or 'occult 
qualities', Robert Boyle (1627-1691; Fig. 14) attempted to 
put this onto a scientific footing with his Doctrine of 
Eflluviums. He envisaged that 'the Effluvia of Bodies may 
consist of Particles extremely small' , and that these 
'invisible Agents' might act upon 'Bodies', causing them 
to change; he used the 'divers effects of bodies that are 
applied immediately to ours' as examples to support his 
thesis - 'Bloodstones, Comelians, Nephritik-stones, Lapis 
malacensis and some Amulets' - 'the subtle Emanations 
that pass thorow the Pores of the Skin to the inward parts of 
the Body' producing the therapeutic effect. He marvelled at 
the fact that a person holding a Spanish Blister Beetle 
(Cantharides) in their hand 'have Grievous Pains produced 
in their Urinary parts, as it has happened to me as well as to 
many others'. 36 
Following his medical studies at Leiden, Paul Barbette 
(1620-1666?) went on to practice both medicine and 
surgery in Amsterdam. A prolific author, he comments 
that the Porcupine Stone is useful as a sudorific against 
the fevers produced by the Plague. He recommends that 
it ' it be steeped for a while in your ordinary drink'; an 
added benefit is that it supposedly refreshes the heart. 
One drawback identified by Barbette is that 'every time 
it is infused, it abates somewhat of its quantity' .37 
Albertus Seba notes that they were prescribed for 
burning fevers, acute and malignant diseases, 'le pourpre' 
(possibly the acute febrile illness caused by Rickettsia and 
spread by means of infected ticks in North and South 
America), small pox, measles, jaundice, bilious and other 
ailments, and hysterical and splenetic conditions. He 
envisaged that 'a corrupted bile' was the source of these 
disorders.38 Assuming that the stone was true and the 
preparation of the prescription good, Seba was confident in 
the efficacy of this stone to 'calm the agitation of the blood 
... revive the vital spirits and excite a gentle sweat' . He 
commended using it as an infusion in rain water, distilled 
water, Honey water, Thistle water, Linden flower water or 
Greater Celandine water. 
The famous Leiden physician, Frederick Dekkers ( 1648-
1720), commended 6 grains of finely ground Porcupine 
Stone mixed with 5 grains each of pearls and Stag's Hom 
(Comu cervi) for all malignant and acute diseases.39 
Michael Bernhard Valentini (1657-1729) illustrated and 
~ommented on a specimen of 'Lap is Malacensis' (Fig. 15) 
in the catalogue of his wunderkammer, which was 
published in three volumes over a time span of ten years.40 
He comments that it is a most effective remedy for poisons 
and a strong sudorific when fine grains are taken in cordial 
water or real wine. 
!he Porcupine Bezoar has been used as an almost 
uruversal medicine, especially in cases of poisoning and 
LAPIS MALACE..NSIS 
Figure 15. Specimen of Lapis Malacensis from 
Michael Bernhard Valentini 's Museum Museorum 
(1704-1714). 
malignant fevers.41 Hermann Boerhaave ( 1668-1738), the 
celebrated Dutch scientist who studied, qualified and then 
taught at Leiden, states that, although credited witl1 great 
powers, he never came across a Porcupine tone used in 
Prescriptions.42 However, it was sti ll being recommended 
in 1755, infused in Carduus water (thistle water) or Rheni h 
Wine for biliousness.43 Ephraim Chambers (circa 16 0-
1740), the English writer and encyclopaedi t, tat that it 
was often used against the plague and many other diseases, 
and commonly kept in gold boxes for infusion into a liquor 
(for only a few minutes 'till it communicates a bitterness to 
it').44 Others indicate that several hours of soaking is 
needed, however, before giving rise to a greenish tincture 
which was used against 'severish distempers' and with 
some success for 'strengthening the stornach'.45 
Echoing Barbette's observations, Seba concurs that the 
stone loses some of its potency with each use. He cites that 
15 minutes is sufficient time for the liquid to be infused 
with the virtue and bitter taste of the stone on the occasion 
of its first soaking, but that the time period needed to deliver 
the healing qualities doubles with each use. He notes that 
drying the stones after use results in their developing a 
white and shiny surface and that, altl10ugh seemingly 
exhausted ofits powers, 3 grains taken in wine have proved 
still to be very effective for those that could afford it. 
The most extensive Ii t of therapeutic application of the 
Porcupine Stone is given by Eberhard Rumpf, repeating 
information from his colleague Albertu Polonus, who 
commends it for kidney stones, pleuri y, cholera, fevers, 
palpitations of tile heart, epilepsy, intestinal worms, the 
bloody flux, colic, flatulence, poisoning, internal abscesses 
(apostems) and stomach pains.46 In addition, it has been 
recorded as being used against intestinal obstructions, 
jaundice and chicken pox.47 
It may even have been used amuletically as a 
prophylactic. Peter Borschberg has suggested that bezoars 
mounted in gold filigree cages were worn around the neck 
in order to ward off disease, and perhaps to advertise the 
fact that the bearer was sufficiently rich and important to 
carry an antidote to any poison that a would-be assassin 
might care to use against them.48 
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Conclusion 
One eighteenth century dictionary of natural history 
concludes that 'there is scarcely an animal of the 
frugivorous kind which does not produce some of these 
concretions; and probably those of one creature are 
equally as efficacious as those ofanother'.49 Of the range 
of bezoars which appeared in the western materia 
medica, the Porcupine Stone was certainly one of the 
most highly prized and expensive. Whilst the market for 
them was driven partly by their exotic nature and, to 
some extent, medical fashion, it occupied a position of 
considerable esteem in the apothecarial arsenal for 
almost 200 years, at least for those who could afford it. 
It is Albertus Seba's expression of wonder that most 
fittingly summarises the reverence in which this stone 
was held: 
From everything we have said is it not clear how great the 
bounty of God has been to have placed in these vile animals 
such an exceUent medicine for our use? A stone born of 
morbific (disease-causing) origins in this animal, given to 
humans as an incomparable remedy for the most pressing and 
dangerous diseases whilst he is down here.50 
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Theriac: A European panacea in 
Japan 
Sabine Anagnostou 
Marburg, Germany 
Theriac one of the oldest European remedies, looks 
back o~ a more than thousand-year-old continuous 
medical-pharmaceutical tradition.' For centuries 
theriac was regarded as a panacea that could cure any 
kind of sickness, especially severe and fatal illnesses 
like the plague2, smallpox, rabies and poisoning, and 
could even prolong human life. As a result of 
intercultural exchange and - from the early modem 
period - of European expansion,. theriac :,vas 
distributed all over the world and mtegrated mto 
many materia medica systems, often in a specified 
local composition. 3 
Theriac was developed from the famous Mithridat(i)um 
created by the King of Pontos, Mithridates VI Eupator ( c. 
132-63 BC), that was meant to protect him from poisoning 
- whether from the attacks of his enemies or poisonous 
animals. The exact composition of the original substance is 
not known, but the Romans developed many variations, 
which were handed down by Galenos of Pergamon (129-
c. 201AD) in his work De Antidotis.4 Andromachos the 
elder, who was the personal physician of the emperor 
Nero (54-68), finally created the classical composition 
for the dark-brown electuary containing 64 ingredients 
including the obligatory and characteristic compounds 
flesh of vipers and opium. During the following centuries 
this so-called Theriaca Andromachi or Electuarium 
Theriaca became one of the most appreciated remedies 
in Europe and was even called 'domina medicinarum'.5 
It was believed to be a miracle cure, especially during the 
time of the Black Death (plague) in the Middle Ages. The 
classical formula by Andromachos was often modified 
over the centuries and the number of compounds grew to 
nearly 400 in the 17th century. From the 18th century on 
theriac gradually lost its great popularity, but it remained an 
element of the official material medica and was still listed 
in the Ergiinzungs!JUch zum Deutschen Arznei!JUch 6 (EB 
6) in 1941. 6 Of course, by then the classical composition 
had changed significantly- the number of compounds was 
reduced drastically and the composition no longer included 
either vipers or opium. Even today theriac is a compound 
of the famous Schwedenbitter nach Maria Treben, but the 
formula of this theriac bears little resemblance to 
Andromachos' ancient composition. 
The universal remedy was also introduced into Arabian-
Islamic culture and mentioned in most of the celebrated 
medical-pharmaceutical works like the Canon medicinae 
by Avicenna (980-1037), while other Arabian scholars 
such as Ibn Gugul (943/44- c. 994) created a special 
literature about theriac. 7 
Theriac was probably brought to China in the 7th century 
either from Persia by commercial contacts or from 
Byzantium by political relations, and Arabic-Islamic 
treatises. The famous Chinese work on medicinal drugs 
Xinxiu bencao mentions a remedy named diyejia, which 
Figure. 1: Glass vessel containing theriac, 18th C. 
© Pharmaziemuseum Brixen [Bressanone ]: Photo: 0 . Peer 
was brought to China by strangers from time to time.8 
Diyejia has been identified as theriac even though ~e 
description of this composition leaves doubts about ~s 
identification. Theriac was evidently not incorporated mto 
the Chinese material medica in its classical composition, 
while the word diyejia itself developed into a category for 
antidotes without referring to a special remedy.9 
With the European expansion in early modern times the 
use of the classical panacea was introduced by 
missionaries, merchants and physicians use in manf 
different regions around the globe.. In ~~' Jesrut 
missionaries even developed a special vanatton caµec1 
Brazilian theriac which contained genuine Amencan 
medicinal plants that were thought to have them same 
efficacy as the traditional compounds of the European 
theriac. 10 
It is not exactly known when the universal remedy 
arrived in Japan. It may have already formed a part of the 
16th century trade in commodities between the Portu~ese 
and the Japanese or missionaries may have brought it 1? 
Japan.11 Around 1557 the Portuguese physician an? Jesrut 
Luis Almeida (1525-1583) founded the first hospital and 
leprosarium in Japan,12 and as theriac was used ~ a 
· d f · kn even the life-panacea to treat any kin o sic ess, 
threatening ones we may suppose that it was among ~e 
remedies Almeida used to treat his patients. Indeed thena~ 
was a part of the basic medical equipment of the J~ 
missionaries, as a manuscript from 1664 reco1?1?:ie 
them to carry at least four ounces of theriac on therr JO th Y 
. . 11 · th ample off a er to the overseas mtss1ons, fo owmg e ex ears 
Heinrich Roth (1620-1668), who worked for many Y this 
in the Asian mission, to provide themselv~ ~~ the 
universal remedy and to be able to care for the sick. blhed 
endofthe 16thcenturytheFranciscanshadalso~ta K ' to 
hospitals and leprosaria in Japan, for example ~ Y~ 
Nagasaki and Osaka. 14 It is likely that the Franciscans 
used the classical European panacea. 
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THB&IACA DIAT1lSS#.J!.ON 
Masv:at. 
Bt· Radicum Arill:olochiz rotundz, 
Gc:otianz, 
Baccaram Lauri, 
Myrrha:, ana V ncias duas. 
Mellis defpumati Libras duas. 
F. f."· I!i4lJu""""1. 
Figure 2. Recipe for Theriaca Diatessaron. 
Pharrnacopoea Amstelredamensis, 1636. 
Universitiitsbibliothek Marburg. 
question arises of how far information about the different 
types of theriac like the theriaca diatessaron and their 
compositions was also provided or influenced by the 
reception of Chinese medical-phannaceutical knowledge. 
Conclusion 
The. hi~tory of theriac in Japan is an intriguing and 
fascmatmg field of ~e~earch especially for the history of 
pharmacy and ~edicme. Many aspects concerning the 
form of reception, the distribution, different uses, 
development of local formulas, influences of cross-
~ultural exchange and reception, incorporation of terms 
mto lan~ges and much more could be the topic of 
future s~dies_. ~e ?ope that our contribution will inspire 
further mterdisc1plinary and international research on the 
introduction, dissemination and establishing of theriac in 
Japanese medicine and pharmacy. 
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In the 17th century, however, theriac was one of the 
elements of the intercultural transfer between the Japanese 
and the Dutch. Official lists of medicaments for the 
surgeons of the Dutch East Indian Company (1676, 1691, 
1771, 1772) show that they used Theriaca Andromachi 
~erapeuti~lly. 15 Japanese physicians were obviously 
mterested m European medicine and were even taught by 
Dutch surgeons who presented them with theriac as well as 
other European remedies. A Japanese manuscript in the 
librID?' of the Medical Faculty of the Kyushu University 
descnbes Dutch surgery (Oranda geka seiden) and recipes 
o~ ~tch S1:1f8ery (Oranda-<len geka ruiho). Though 
ongmally dating from the 17th century and handed down in 
a copy from the 18th, the author mentions theriac among 
other remedies such as plasters, ointments, oils, flowers, 
and roots. He states that the Dutch surgeon, however, had 
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Civil War Pharmacy: Historical 
parallels and implications for 
disaster preparedness 
Heath Ford, PharmD, CGP and Prof. Randall 
L. Tackett, PhD 
University of Georgia College of Pharmacy, 
Athens, Georgia, USA 
The effects of devastating warfare are not unprecedented 
in the American South. Drug shortages, supply and 
transportation disruptions, and lack of medical personnel 
became increasingly common in the Southern 
Confederacy near the midpoint of the Civil War (1861-
1865), particularly as the Federal 'Anaconda' blockade 
of southern sea ports gradually tightened. 1 The burning 
of Richmond and Atlanta also illustrate the degree of 
desolation that intensified the strain on resources and 
medical infrastructure. 
The modem era is marred with disasters similar to 
those faced by Confederate citizens during the Civil War. 
While terrorism is an unconventional method of warfare, 
the effects of terrorist attacks may nonetheless consume 
government and medical resources. Widespread bio-
terrorism and nuclear detonation are examples of 
possible scenarios that could cripple the economies of 
major cities as well as threaten the viability of a relatively 
healthy American medical system. 
In light of efforts to combat terrorism, the history of the 
pharmacy profession during the American Civil War is 
an especially relevant topic to consider. Though 
pharmacists' interest in disaster preparedness activities 
have been relatively quiescent prior to the events of 
September 11, 2001, terrorist attacks and foiled plots 
occurring within the past decade have reawakened an 
interest in pharmacy's role(s) in disasters. Numerous 
disaster preparedness and response roles for pharmacists 
could be elucidated from the profession's activities 
during the Civil War. This article discusses the main 
functions of pharmacists as performed by medical 
storekeepers, medical purveyors, hospital stewards, and 
Southern civilian druggists - four roles that have 
substantial applicability to the 21 st century pharmacy 
disaster response. 
The war-era offices of medical storekeeper, medical pur-
veyor, and hospital steward form a framewmk for present day 
pharmacy practice. The medical storekeeper was charged 
with storing, guarding, and issuing drug supplies when 
requested by medical pUIVeyors, who were respo~ible for 
medication procurement, quality controL packaging, and 
distribution. Hospital stewards were administrators of :fi~ld 
and post hospitals but were chiefly occupied with ~omnn~ 
pharmacist duties such as compounding prescnptions an 
managing medical supplies. 1 
Medical support for the contending armies becill?e 
increasingly important as the war progressed and the size 
of the armies grew. The Federal army, for example, 
increased from 16,000 to approximately 1 milli~n. ~y th~ 
end of the war. 1 The magnitude of the responsibility 0 
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medical storekeepers and purveyors to provide for a rapidly the duties presented by APhA by noting pharmacists' 
growing force emphasise the importance of maintaining capacity to act as an administrator or as a supervisor of 
acces.s to medications in the event of disasters, particularly pharmacy, laboratory, or central supply in the absence of 
through pharmacy logistics.1 adequate manpower.7 Cohen similarly emphasises clinical 
Pincock et al. describe a disaster-readiness preparedness and leadership roles of pharmacists in disasters by 
model to better prepare pharmacists and disaster planners for describing the development of a Pharmacy Emergency 
future disasters.2 One pharmacist role provides logistical Response Team (PERD whose mission is to 
support through medication procurement, storage, inventory, maintain, prepare, mobilize, distribute, and track [the 
distribution, and dispensing. The types of pharmacists hospital's] stockpile and provide targeted pharmaceutical 
proposed to carry out these activities include a pharmacy care intelligence needed to assist in the detection and 
readiness logistician, a weapons of mass destruction/ mitigation of victims exposed to [ chemical, biologic, 
pandemic readiness pharmacist, and a pharmacist readiness radiologic, and nuclear] agents.8 
manager.2 Several articles in the pharmacy literature support That the duties of early pharmacists - namely, the 
the importance of pharmacy logistics in disaster medical hospital stewards and medical purveyors - contributed 
response. For example, the importance of chug acquisition greatly to the effectiveness of the medical response is best 
and distribution for hospital employees and their families, summarised in the following quote: 
medication procurement, repackaging, distribution, controL The ability of the surgeon in the field and hospital was 
and dispensing site layout, and the development of drug directly dependent on the administrative effectiveness of the 
distnbution systems in disaster settings all certify the supply and provisioning system. 1 
importance of pharmacy logistics.3--5 The procurement and These pharmacist-oriented duties, some of which have 
distribution roles of medical storekeepers and purveyors been translated into the modem context, remain vital to 
remain an integral component of an effective medical an effective disaster response. 
response and may offer more than historical interest by Civilian pharmacists, particularly in many locales 
serving as an important precedent for pharmacist logisticians. within the Confederacy, were the only healthcare 
Hospital stewards during the Civil War offer singular provider available and often acted as both pharmacist and 
examples of the administrative responsibilities that may be physician.1 Flannery notes that ' the larger and richer 
assumed by pharmacists. Flannery notes that: economies of the North permitted civilian health care to 
Virtually everyone, except physicians, reported to the proceed independently of the war effort,' but this was not 
steward, who served as the hospital's chief administrator. On the case in the South. 1 To increase the size of the army 
the instructions of the senior medical officer, all issues of and remedy the shortage of medical personnel, the 
order and security, light and ventilation, quality and quantity Confederate Congress passed the 1862 Conscription Act, 
offood, cleanliness and orderliness of the wards and grounds which exempted from military service 'in each 
devolved to the steward. [ .. . ]he was to receive 'obedience apothecary store now established and doing business one 
from all non-commissioned officers, enlisted men, and apothecary in good standing, who is a practical 
citizen nurses in the hospital.' 1 druggist'. 1 While a medical manpower shortage due to 
Aside from managerial duties, the core function of the disaster is not unrealistic in modem America, one 
hospital steward remained that of a pharmacist It is worth noteworthy example of medical system shortages and 
noting that chief surgeons often appointed men to perform the collapse is Ontario's response to the Severe Acute 
duties ofhospital steward who were not necessarily trained in Respiratory Syndrome (SARS) crisis of 2004. 
the skills of an apothecary.1 Some hospital stewards may During the SARS crisis in Ontario, Canada, many 
initially have been unskilled in pharmacy practice, but their hospitals and clinics closed to prevent the spread of the 
efforts in developing compounding and medication virus to the community. As a result, pharmacies that 
management skills centralised their role in the management of remained open for business became the city's healthcare 
field and post hospitals. Although the hospital steward may centres and pharmacists the primary healthcare provider. 
have had considerably more authority compared to most Toe authors concluded that in times of crisis, pharmacists 
modem-day pharmacists, the duties of the hospital steward begin to assume duties beyond their traditional scope of 
~ Y. be considered more clinically-oriented than the practice and that pharmacists would do well to cross-train 
distribution responsibilities of medical storekeepers and with allied health professionals before an event occurred 
PlllVeyors. to maximise role flexibility.9 This recent report not only 
Several examples of clinical pharmacy duties in disaster reaches back to the resiliency of Southern civilian 
management, like those of hospital stewards, have recently pharmacists but also corroborates well with 
resurfaced. Though 'modem' when compared to the Civil Schwerman's 1967 description of pharmacists acting as 
War era, the 1966 statementbytheAmericanPharmaceutical 'house doctors ' in the absence of the physician and 
Association (APhA) on disaster preparedness encourages APhA's 1966 statement encouraging pharmacists to be 
Pharmacists, among other duties, to assume leadership pre-trained to handle various contingencies normally 
respoi:15ibilities in the development and maintenance of an performed by other disciplines.7•6 
Orgarused nuclear fallout shelter, to offer medical aid in the Understanding and appreciating history is important 
absence of a physician or other medical personneL and to be not only to avoid repeating past failures but to employ 
J)n}-trained to perform an array of duties that traditionally past successes to present contingencies. The profession 
are subsumed by other disciplines.6 Schwerman echoes of pharmacy continues to find new ways to enhance the 
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medical care of patients, and in many cases this involves 
incoiporating innovative specialisations into pharmacy 
practice. 10 Current disaster roles embody the historical 
themes established by medical storekeepers, medical 
purveyors, hospital stewards, and Confederate civilian 
pharmacists. Greater pharmacist involvement, however, 
may eventually be warranted in disasters that drain 
healthcare resources. With our eyes on the examples set 
by our Civil War pharmacy forebears, modem-day 
pharmacists can meet future disasters remembering that 
lessons from the past may illumine the path forward. 
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Medical supplies for the expeditions 
of the heroic age of Antarctic 
exploration: Injections, inhalations 
and suppositories 
Dr HR Guly FRCP, FCEM 
Retired consultant in emergency medicine 
Derriford Hospital , Plymouth, PL6 8DH ' 
This paper describes the injection equipment and the 
drugs given by injection, inhalation and suppository, on 
Scott and Shackleton's expeditions to the Antarctic. 
A large number of drugs were taken on the expeditions 
of the her~i~ age of Antarctic exploration, with the drugs 
for the Bntlsh and Australian expeditions mostly being 
supplied ~y . B~oughs Well come & Co (BW &Co). 
Drugs for mJection were often supplied, together with a 
syringe, in small pocket cases. This paper describes the 
drugs ~en for use by injection, inhalation and by 
suppository and also the injection cases supplied to the 
expeditions. It also describes how drugs were used but 
this information is very limited. 
Injection cases 
Discovery expedition 1901-4 
The drugs supplied to the Discovery included a No. 7 
hypodermic case (Fig. 1) and some additional supplies 
for hypodermic use1 which are described below. 
No . 7 . H Y f>ODER ,I\IC "TABLOID" B RAND P0C1'H~_CA'S!: 
:'\o. 7. Hvrout:kMI<: 'TABLOID' BRA~·o 
POC1<£T•CASE 
Wkhs~l'det,i,ch-
able aseptic frame cf 
novel desisn, and re-
,·olviog rack (nickel· 
plated). Fitted with 
t welve tubes of 
' T abloid' tlypoder-
m i c products, a 
H. W. & Co. pa1ent 
nickel-plated ,yringe, 
one exploring and 1wo 
re~lllr steel needles. 
This Case, after che 
r<0moval or the tubes 
of H ypod",rinlC pro-
d ucu, may· be steril-
ised ,.-ith use. In 
Gun-metal, ,\lun>i· 
nium , or Silver. 
Figure 1. No. 7 hypodermic case from: Anon. The 
Evolution of Antiseptic Surgery. London: BW&Co, 
1910: 120. 
Terra Nova expedition 1910-3 
In his description of the medical equipment taken by the 
Terra Nova, Dr Edward Atkinson says that they were 
supplied with three No. 7 hypodermic cases ea~h 
containing a syringe with 12 tubes of hypodemuc 
products and he also describes a no. 10 hypodermic case 
(Fig. 2) containing five tubes of hypodermic produc~-2 
However Burroughs Wellcome say that they supplied 
three No. 7 cases and a number 32 case (Fig. 3), 
containing five tubes of tabloids, in each of 12 canvas 
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NO. 10 . ASEPTIC HYPODE'RMIC 'TABLOID' BRA!CD 
POCKeT -CASI! 
This Case is a model or com~ct completeness, It is made of nickel. 
plated metal, each edge and 
corneT being smoothly rouflded. 
h conta.iM the B. \V, & Co. 
All•GIUI • .\Hpric H>1,odemiic 
Syringe, witll deuchable nickel-
plated ftna:er-grip, and two rc.:u• 
l:1rs1ee\ needles enclosed in• pro-
tective tube. E~h psrt o( the 
syringe is Mpar•tely held in a 
holdfut clip. 
No. 10. ASEPTIC Hv•ouo:1u11c 
'TABLOID' BRASD P~11:r·C...s& 
lleuun:mrtlU : ~ X If X J tn. 
The tubes of' Tabloid' Hn,o--
dermic producu, five in number, 
are carried in a hinpd rack, 
which secure!)· holds them when 
th" case i1 closed, and which, 
wheo swu~ outwards, allo"-s o( 
the ensy withdr:uval of the desired 
tube. Complete with does!.:ln 
awer. 
Figure 2. No. I O hypodermic case from: Anon. The 
Evolution of Antiseptic Surgery. London: BW &Co, 
1910: 120. 
No • .32 . ASEPTIC HYPODERMIC 'TABLOID ' BRANO 
POCKET•CAS E (The M11asel Shell) 
_I , . .. , iili1 , 
·,( ' -- 1 
r ' '•·· . -- ~. - .· ·=--
1 
~ ''; "'JI(' . 
,t '• · · "·- · I --if -' JI 1 11 ,. ·, · r . 
;lllit.~. 11,· . DI , .. Ill rl · · 
. I . r :' . ·_ l i.. 
' ' ··--1 I . ,.,.! ... JIZ .:_ ~ 
i J I fl~ . . 'i. 
. . '. J~.-
OPLJ>l CLOSEU 
~0- 32. ..\se.-rtc Hnoot:R~uc 'TAet.010' B><As o Poc1>a:r-C.-..si,:; 
( The .lf M.fUI Siu://) 
:i..:ea1 w-cme,m - 3! X lf )< ! in . 
~lade of nickel-vlatcd meLal , occupies ,·er)· littl" spa....,, a.nd is con,·er,ienil}' 
sh•ped for the pocket. Fitted with nickcl-pla1ed hrp0<.h:rmic: srringc, 
one upJoring am.I two regular steel needi~ :md fire tubes of 'Tabloid ' 
Hypodermic products. This Ca.,;e is also supplied fitted with a B. W. & Co. 
All-Glass A~J)(iC Hrpodermic Syringe, etc. (a.s illuslr,rfm'), but ,,,itlt,1111 
' Tabloid ' Hypodermic Products. Complete -.·i1h le.at her oc- doeskio cover. 
Figure 3. No. 32 hypodermic case from: Anon. The 
Evolution of Antiseptic Surgery. London: BW&Co, 
1910: 122. 
sledging cases.3 However the contents of the injection 
cases described in the two sources are identical. 
Imperial Trans-Antarctic Expedition 1914-7 (ITAE) 
The list of equipment supplied by Burroughs Wellcome4 
to this expedition is divided into equipment for the 
Weddell Sea Party, the Ross Sea Party, the plateau sledge 
and the two ships. The drugs and equipment for the 
Weddell Sea party included a No 7 'Tabloid hypodermic 
case'. A No. 254 'Tabloid' medical case containing 
'HYPodermic products' was supplied for the plateau 
sledge. There is no specific number attached to these, but 
the contents are the same as the No. 32 (or No. 10) 
hypodermic case mentioned above. In addition there 
were two 2 canvas sledging cases, each of which 
contained a 'No. 3 hypodermic case' (Fig. 4) This has 12 
tubes of tabloid hypodermic products. 
Injections were almost invariably given subcutaneously 
(hypodermic). Drugs for injection came as solid 'tabloids' 
which needed to be dissolved The instructions read: 
Draw about I O minims of sterile water into the syringe, 
remove the nozzle and drop a 'Tabloid' hypodermic product 
into the barrel. Replace the nozzle .. . expel all air . . . shake 
gently . . . solution takes place almost immediately . . . the 
needle is then fitted .. . 5 
The Royal Geographical Society's Hints for 
Travellers , (copies of which were taken on the British 
and Australian expeditions), advised: 
The hypodermic syringe and needle must by perfectly 
cleaned; they may be boiled, or an antiseptic lotion, or alcohol 
(brandy or whisky) syringed through them. The solution to be 
injected should be made in a clean, ie boiled, spoon, by 
adding the drug to boiled water. .. 6 
The drug contents of these cases are shown in Table I. 
Each tube contained either 12 or 20 'tabloids '. In addition 
each case contained a syringe and needles and a pestle 
and mortar, indicating that these drugs might need to be 
ground up to assist solution. 
Dr Murray Levick ( on the Terra Nova expedition) also 
ordered: an 'Imperial dental syringe (complete)' and '2 x 
50 Novocain Dental Tablets'7 which presumably were 
for injection. I have described the dental equipment taken 
in more detail elsewhere. 8 
Indications for the drugs 
Some of these drugs ( or their uses) may be unfamiliar so 
I give the uses as suggested by Burroughs Wellcome who 
provided them. 5 These are the indications for injection; 
the same drug given orally may have different uses. 
Apomorphine was used as an emetic. 
Atropine was often administered before chloroform 
anaesthesia, to prevent inhibition of the heart and was 
also said to anta onise the de ressant effects of 
NO. 3 . HYPOOEll.\llC ' TAB l. 0 10 ' BR AND PO C Kl T CASt 
:-.; o. 3. Hvtoo21uuc 'TAut.n1u ' H,:,.,.a , 
POCK ET·C ASE 
Jn Cowhide, Pii:skin, 
Crocodile , Morocco, Seal 
3nd 01her fttte leather,. 
Fined with t"ehe tube~ 
of • Tabloid' H rP<Jdcrmic 
products, 13. W. & Co. 
pMenl nickel- plat ed hy po , 
Figure 4. No. 3 hypodermic case from: Anon. The 
Evolution of Antiseptic Surgery. London: BW &Co, 
1910: 119. 
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Table 1. Drug contents of hypodermic cases 
No. 7 cases No.10 Additional supplies not 
Tube each 'Tabloid' Hypodermic Discovery, 
Products Terra Nova 
Apomorphine Hydrochloride gr. 1/io * 
Atropine Sulphate gr. 1h00 * 
Cocaine Hydrochloride gr. Yi * 
Cocaine Hydrochloride gr. 1/4 
Digitalin gr. 1/ioo * 
Ergotinine Citrate gr. 1 /zoo * 
Hyoscine Hydrobromide gr. 1/zoo * 
Morphine Sulphate gr. 1/4 * 
Morphine Hydrochloride gr. 1/4 
Morphine Sulphate gr. 1/6 and Atropine * 
Sulphate, gr. 1/iso 
Pilocarpine Nitrate gr. 1/6 * 
Strychnine Sulphate gr. 1/ioo * 
Aconitine Nitrate gr. 1/z60 * 
Anaesthetic Compound B (cocaine * 
gr. 1/s + morphine gr. 1/so) 
Caffeine Sodio-Salicylate gr. Yi * 
Digitalin, gr. 1/ioo, and Strychnine * 
Sulphate, gr. 1/ 100 
Eucaine Hydrochloride gr. 1/J * 
Morphine Hydrochloride gr. v.i * 
Hyoscine compound A (Hyoscine gr. 
1/ 100, Morphine gr. 1/4 and Atropine gr. 
1/1so) 
Eserine salicylate gr. 1/ 100 
Homatropine hydrochloride gr. 1/25 
morp~e on the respiratory centre. This, presumably, 
explams the combined preparation. 
Ergotinine was 'used . . . subcutaneously, in uterine 
haemorrhage and haemorrhages generally. Action 
enhan~ed by addition of strychnine; frequently 
prescnbed with morphine.' 
Hyoscine was a 'powerful sedative used in cerebral 
excitement, mania and epilepsy. . . Combined with 
morphine, or morphine and atropine, has been used 
cases in special cases 
ITAE Terra Nova Discovery, ITAE 
Terra Nova 
* 
* * 
* * * 
* 
* * 
* 
* 
* 2 Discovery 2 * 
Terra Nova 5 
* 
* * * 
* 
* * * * 
* 
* * 
* 
* 
2 * 
* 
* 
hypodermically as analgesic during labour and 
previous to induction of general anaesthesia.' 
Pilocarpine. It is difficult to see why this was taken as 
an injection. It was said that it 'Increases salivary 
secretion, produces profuse sweating, increases 
secretion from nasal and bronchial mucous 
membranes and promotes activity of gastric and 
intestinal secretory glands. . . Diaphoretic in bronchial 
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catarrh, and uraemic convulsions. Must be used with 
caution, as it causes inhibition of the heart.' 
Strychnine was 'given hypodennically in cardiac 
syncope.' 
Aconitine 'slows and weakens the heart's action by 
stimulating the vagus centre, reduces temperature, and 
is diaphoretic, anodyne and sedative.' 
The dose of morphine in anaesthetic compound B is 
very low (gr.1/50 [1.5 mg] compared to the 
hypodennic dose of gr.1/4 [16.2 mg]) and so this was 
presumably being given in the belief that opiates had 
some kind of local anaesthetic action rather than for 
any systemic effect. 
Caffeine sodio-salicylate was given more for the 
sodium salicylate content, as an analgesic. 
Eserine (physostigrnine) 'powerfully stimulates 
intestinal peristalsis. Has been suggested as a 
hypodermic purgative, but the fact that it produces 
vomiting and griping in purgative doses has prevented 
its general use. In paralytic distension of the bowel it 
was formerly the only remedy available, but the use of 
pituitary extract ... has displaced it of recent years'. 
However, to learn how it was intended that these drugs 
should be used, it may be more instructive to turn to the 
diaries of the non-medical expedition members. On the 
Ross Sea Party, there was no doctor: John Cope, the 
biologist, acted as doctor but Arnold Spencer-Smith and 
Irvine Gaze wrote themselves notes on the use of the 
drugs that they had with them. Perhaps they had received 
a tutorial from a doctor in Australia once it was known 
that there was no doctor in their party. 
. Arn~ld Spencer Smith's notes on the injectables9 
(mcluding spelling mistakes) are: 
Eucaine Hydroachloride: Cocaine as Anaesthetic. 2% 
solution. To be used for relieving pain in Eye. Toothache 
2-4%. Local anaesthetic 4%. 1 Tab in 12 min. aq[ua]. = 2% 
solution. 
Hyocine Hydrobromide Sedative (combined with 
morphine produces general anaesthesia). l Tab in 15 min aq. 
= 1%sol. 
Strychnine sulphate Heart Failure. 1 tab in 20 min aq. 
Morph. Atrop. Sulp. Analg[esic]. & sedative. Must not be 
used in bronchitis & congestion of brain. 1 Tab in 12 min. aq. 
Table 2. Drugs given by inhalation' 
Brand name Drug Notes 
Vaporole Amyl nitrate 
Vereker Ammonium chloride 
Vaporole Ammonium chloride 
Digitalis Cardiac tonic. 1 in 5 min. aq 
~naesthetic comp. I in 110 min. aq (dangerous) 
Irvine Gaze's notes10 are very similar and had clearly 
been obtained from the same source. 
The use of the drugs 
! ~av_e found very little reference to the use of any 
InJectJ.ons and so it is difficult to know how much was 
used but it is clear that some was, as Atkinson says that 
more supplies of morphine and atropine, strychnine and 
anaesthetic compound B would have been desirable on 
the Terra Nova expedition.2 
~owever, the only reference to morphine injection 
bemg used on that expedition, that I have found, was to 
Thomas Clissold who sustained a head injury after he fell 
off an iceberg, 11 though on the Discovery expedition, Dr 
Edward Wilson wrote of snow-blindness: 'sleep was the 
best and quickest cure of all, even if an injection of 
morphine had to be given to produce it. ' 12 I have found 
no reference to the use of injectable strychnine or 
anaesthetic compound B on either expedition but on the 
Scotia expedition, when Allan Ramsay was dying of 
heart failure, Dr Harvey Pirie administered morphine and 
strychnine but to no avail 13 and on the Australian 
expedition, Dr Archibald McLean wrote 'Nirmis came in 
and told us about a dog with epileptic fits. [Dr] Jones 
gave it a hypodermic injection of morphine without 
result.' 14 
Comparison 
Ships at sea have some similarities to an Antarctic 
expedition in that the environment may be hostile, and a 
single handed doctor (or ship's captain, when there is no 
doctor) is unable to refer any seriously ill or injured 
person to a hospital. At that time, with no radio 
communication, they were also unable to obtain advice. 
Indeed the first and final parts of all of these expeditions 
were long sea journeys, but the Antarctic explorers were 
away for considerably longer periods. Nevertheless it is 
interesting to compare the drugs taken with those 
required by the Board of Trade. In 1906, for ships of 100 
passengers on a voyage of under l 00 days, they only 
required four injections:15 
Indication Discovery Terra Nova ITAE 
See text * * 
Catarrh * 
Catarrh * 
Vaporole Menthol snuff Catarrh * * 
~ 
Menthol cones Catarrh * * 
-
~Vaporole Aromatic ammonia Sal volatile Smelling salts * 
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Drug Number 
Morphine tartrate gr. 1 / 4 24 
Atropine sulphate gr. 1/i oo 12 
Cocaine hydrochloride gr. 'ho 24 
Apomorphine gr. 1 ho 1 tube 
The French equivalent (Ministre de la Marine et des 
Colonies) in 1908 seems only to have required injections 
of caffeine and cocaine. Morphine chlorhydrate is 
mentioned for the first time but it is not specified that this 
is an injection, though morphine injection is mentioned 
in 1926.16 
Inhaled drugs 
A number of drugs were given by inhalation ( excluding 
anaesthetic agents). These are shown in Table 2 (p.31 ). 
'Vaporole' and 'Vereker' were two brand names used 
by BW &Co. Vaporole products were for inhalation, 
external application or injection. Amyl nitrate and 
aromatic ammonia were both supplied in glass capsules 
contained within absorbent material. When the capsule 
was broken, the contents could be inhaled. 
'Vereker' was a brand name for the Vereker 
ammonium chloride inhaler designed for delivering 
ammonium chloride though it could also be used for 
delivery of other inhaled products such as eucalyptus oil 
or pine oil. 17 
In 1910 BW&Co developed a new system for 
producing ammonium chloride in which they supplied 
Ttl.4't lt \11!1 
~ ' VAPOROLE ' 
Ammonium Chloride 
INHAL ER 
P.:rl'« dy rac-utr.al ,·ar,,u r tn111:rtd by 
m -.• of rrtt'isrfy aJj1..c1ed, d1;i.rgH 
uf • \' .1r11ro, le' Ur.uu! AdJ ;,nJ 
(h:u'it ~ into tl.r ~ ·Let, 
~ {,I ir~ f!u iJJ. ··- •ri:t. 
l~Jl>R(JUCH:t WU.t.r.o,\t: & e,;o , LO:'llt'OX 
S..,... Vt l'tf "<•1lrl'O, $n)'$C'f C..,11 T,~ 
0• .,; 
Figure 5. Advertisement for Vaporole inhaler. The 
Medical Officer 1911 ; 7 Jan: viii. 
Table 3. Drugs supplied as suppositories 
Brand name Drug Size Notes 
Enule Gall & Tannic acid 
opmm & opium 
Enule Glycerin 
Enule Morphia gr Yi 
Enule Tannic acid 
'Vaporole acid' (hydrochloric acid) and 'Vaporole alkali' 
(an ammonium salt) in an inhaler to produce ammonium 
chloride for inhalation. 18 
Amyl nitrate had uses other than for angina pectoris. It 
was a 'powerful dilator of peripheral vessels; employed 
in angina pectoris, conditions due to heightened arterial 
tension, haemoptysis, menorrhagia and other 
haemorrhages, tetanus, neuralgia, asthma, cocaine and 
strychnine poisoning, and to check excessive sweating. '5 
Menthol snuff contained: ammonium chloride, 
bismuth oxychloride, 'Epinine' [adrenaline], eucaine, 
camphor and lycopodium powder. 5 
In addition to these, all three expeditions took spirits of 
turpentine ( oleum terebinthinae) which could be used 
internally or inhaled for catarrh or other respiratory 
problems. 
I have found no evidence of these preparations being 
used. Many writers commented that the expedition 
members generally did not suffer from colds. Dr 
Alexander Macklin (surgeon on two of Shackleton's 
expeditions) wrote "Bacterial affections are rare. 'Colds 
in the head' hardly ever occur .. . "19 and Dr Erik Ekelof 
(surgeon to the Swedish expedition) said "None of the 
wintering parties suffered from any of the common forms 
of' colds' such as catarrhs of the nose, larynx, trachea and 
bronchi ... "20 
However they did occur. Herbert Ponting (the 
photographer on the Terra Nova expedition) wrote: 
I have read in books that there are no genns in the polar 
regions; that colds and such affliction~ are 
unknown ... . Whilst sleeping in my reindeer-skin sleeping bag 
that night, I caught an awful cold and for the whole of the next 
day . . . I suffered from paroxysms of sneezing. ~r that 
experience no one will ever convince me that rrucrobes 
cannot stand the rigours of those regions.21 
These 'colds' were usually associated with ope~g 
stored clothing or similar items. Thus Dr Eric Marshall m 
his medical report of the Nimrod expedition wrote: 
Members of the expedition did not suffer from colds · · · sa~e 
in August 1908, when a bale of new clothing was opened Ill 
the hut and the men were at once seized with acute nasal 
' 
catarrh.22 
Wilhelm Filchner (leader of the second German 
expedition) described the same thing after some bales ~f 
canvas were opened23 and there are other ex~ples. It !s 
known that parainflenza viruses do not survive for this 
length of time in the Antarctic environment24 and so there 
-
Indication Discovery Terra Nova ITAE 
-
Haemorrhoids, * * 
fissure 
-
Constipation * * * 
-
* * * Analgesia 
-
Haemorrhoids, * * * 
fissure 
-
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must be doubt as to whether other viruses can remain 
viable. It is possible that these were allergic reactions to 
some constituent of the dust25 or organic toxic dust 
syndrome.26 Whatever the diagnosis, the only treatment 
that I have seen recorded for these 'colds' was 'a dose of 
hot-Toddy before going to bed',27 but it is likely that 
some of these inhalants were used. 
Suppositories 
Table 3 (p. 32) shows the drugs supplied as suppositories. 
The gall and opium suppositories probably reflect the 
belief that topical opiates had analgesic properties. This 
myth was exploded in 191028 which may explain why 
they were not taken on the ITAE which started in 1914. 
Again, I do not know that any of these were actually 
used but a number of people are recorded as suffering 
from haemorrhoids and so it is likely that some were. 
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Since ancient times, medical preparations of natural 
medicaments have been used for their therapeutic effects. 
Many medical and pharmaceutical documents are found 
in the history of Persia and a number of pharmaceutical 
dosage forms have been reported in traditional Persian 
manuscripts. Linctuses (Laooq) are examples of such 
dosage forms which are relatively neglected in 
~ontemp~~ medicine. However they were widely used 
m _Traditio1:al Persian Medicine, especially for 
r~sprratory ailments. The current study aims to present 
different ~ao~q formulations along with their preparation 
and app.hcanons. The most popular pharmaceutical 
manuscnpts of Persian medicine from the 9th to 18th 
centuries AD have been studied by searching for 
linctuses by using the term Laooq. 
_Traditi~nal ~ctuses (Laooq) are viscous preparations 
with a v1scos1ty between a syrup and electuary and 
s~ould be taken orally by licking. Overall around 150 
diffe~e!ltLaooq formulations have been noted by Persian 
practitioners and honey was the base ingredient. Rose 
syrup (Jullaab ), grape concentrated juice, almond oil and 
cow butt~r tr.1ay be used in.this dosage form. The Laooq 
fortr.1ulation 1s not only a kind of traditional dosage form 
but 1t may also be a good candidate for formulation of 
ne~ respiratory medicines. As the form can release the 
active component gradually it can be used as a retard 
formulation. This study presents the traditional 
pharmacological approaches for respiratory diseases. 
Thereby reported natural preparations can be selected for 
new research in complementary medicine. 
Introduction 
The history of drug therapy goes back to long ago when 
h~~s. used natural medicines.' At the dawn of 
c1~ilisat1on three natural sources (herbal, animal and 
~era!) were ?ommon in therapeutic preparations2 
which were ~ainly used within compound remedies. 
Herb~! re_medi~s were applied either individually or in 
combmation with other natural medicaments. Because of 
recent pharmac~utical advances a wide variety of dosage 
forms are available today with specific routes of 
adminis~tion. M~dical an? pharmaceutical manuscripts 
by m~di.eval Pe~1an practi~oners flourished by adding 
the _eXIst1ng ex~enences achieved by other civilisations to 
their own findings.3• 4 Before the official separation of 
pharmacy from medicine around 1240 ADS Persian 
scholars like '."-vi~enna 3:11d Rhazes had dedicated large 
parts of their rrnpress1ve works to pharmaceutical 
prac~ces.6 ~o v~~us pharmaceutical dosage forms are 
mentioned m traditio_n.al Persian medicine manuscripts. 
One of these traditional compounds is Laooq which 
appears to be almost similar to Linctus. These remedies 
are widely prescribed in contemporary medicine for 
respiratory system ailments.7 The traditional medicine 
m~uscripts give numerous formulations of Laooq 
which can be considered as opportunities for 
investigation in pharmaceutical science. The current 
study a~ to intr?duce different formulations of Laooq 
along with special related considerations and their 
indications. 
Research method 
:nus investigation is based on searching through some 
rrnportant traditional pharmaceutical manuscripts 
(Qarabadins) which were written between the 9th and 
18th centuries AD. Qarabadins are formularies which 
generally present drug recipes and their indications.8 
Selected manuscripts are described. As the first part of 
this study, about 150 various laooq formulations were 
extracted from the books. Since those most cited 
possessed a better value for further research, a selection 
of them was analysed. In the second step, their 
ingredients' effects were extracted from a large 
traditional pharmacopoeia 'Makhzan-ol-advieh 'J to 
determine each ingredient's role in each formulation. In 
the third step the scientific names of materia medica in 
formulations were determined using other textbooks 
such as Dictionary of Medicinal Plants, Popular 
Medicinal Plants of Iran, Pharmacographia Indica and 
Indian Medicinal Plants.10-13 
Results 
Laooq (Linctus) as a dosage form is a combination of 
powdered medicines in honey, viscous syrup or other 
sweet additives. t4 Although this dosage form was 
generally specified for the respiratory system, some 
Laooq formulations were used in psychotic disorders, 
insomnia and constipation. 14 Today linctuses are defined 
as oral liquids which are mainly used as demulcent, 
expectorant, sedative or antimicrobial agents. 15 
Examples are pholcodine, methadone and simple 
paediatric linctuses, 16, 17 which are principally applied in 
the treatment of cough and other respiratory disorders 
due to their soothing effects on inflamed mucous 
membranesl8 These viscous preparations contain sugar 
or other sweeteners. 16 
According to traditional manuscripts Laooq is 
prepared with a special viscosity between syrup and 
electuary. 19 This lincture is taken orally by licking7•20 and 
. d 1· 2tA its goo taste helps increase the patient's comp 1ance. 
demulcent effect is essential for those used for the 
respiratory system. 20 
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Holding the preparation in the mouth is advisable so 
that the active components will release gradually. 19 
Keeping the patient in a horizontal position patient during 
licking the drug increases the transit time of medicaments 
through the oesophagus.22 Therefore it appears that 
Laooq was used as a selective retard dosage form for the 
respiratory system. It was considered that as the 
respiratory system is closely attached to gastrointestinal 
system, the onset of drug action would be the time of 
passing from the oesophagus.14 
Traditional Linctuses are categorised in four groups 
based on the therapeutic potency of their ingredients. It 
was noted that the potency and temperament of 
medicaments are associated and so the drug potencies 
will be divided into four levels. The first level is named 
absolute food. The second and third are called medicinal 
foods and nutritional medicine, respectively. The last one 
is absolute medicine.9 
The first group of traditional linctuses contains the 
lowest potency medicines such as bean, roasted linseed 
or almond in combination with honey. The second 
category includes cucumber seeds, honeydew ( Cucumis 
melo) and squash (Cucurbita maxima). In some cases 
rose oil or bitter almond oil with honey could be added to 
the formulation. The third group contains more potent 
drugs such as bitter almond, fenugreek, Indian 
frankincense or squill oxymel. Finally the most potent 
drugs such as pepper, cumin, or iris root are used in the 
last group.20,22 
Medicinal plants in Laooq formulations were either 
used individually or in addition to other medicaments. 19· 
23
· 
24 The object of preparing compound remedies could 
be reduction of side effects, increase of the main 
ingredient's potency, taste improvement, enhancement of 
potency and correction of harmful properties. 14 Table 1 
(p. 36) represents the reported medicinal plants which 
were used solely with basic ingredients such as honey, 
sugar or other non-medicinal accompanirnents.9 Selected 
Laooq formulations with their ingredients, indications 
and compounding methods are shown in Table 2 (p. 37). 
The main indication of Laooq formulations is 
respiratory system diseases in which respiratory secretion 
disorders are common. Specific ingredients of this 
dosage form are able to improve the secretion process 
and expectoration. Almost all laooq dosage forms have 
honey as the basic ingredient for this purpose. Honey acts 
as a demulcent and facilitates mucus secretion.22 Recent 
findings prove the expectorant property of honey. 25 Other 
bases such as rose syrup, grape concentrated juice, 
almond oil and cow butter are also used.20,21 
Discussion and conclusion 
Laooq formulations which had been well-considered by 
traditional Persian practitioners, were applied widely for 
respiratory system complications. Recent researches 
?rove relevant pharmacological effects of their 
mgredients. Adiantum capillus-veneris as an expectorant 
and demulcent brings up the phlegm and enhances 
respiratory system secretions.26 Allium sativum is 
prescribed in chronic bronchitis, influenza and recurrent 
upper respiratory tract infections.27 The effectiveness of 
Althea officinalis in cough and bronchitis was approved 
by the German Commission E. Demulcent effects of 
almond preparations and antitussive activity of saffron 
are noted in modem medicine.26 Phenolic compounds in 
Cydonia oblonga have anti-influenza viral activity.28 
Muscle relaxant activity of Elaeagnus angustifolia29 is 
beneficial for bronchospasm and asthma. The potent 
anti-inflammatory effect of fig leaves30 confirm its use in 
asthma and cough. The antiallergic effects of liquorice is 
useful for asthma.31 Modulatory effects of Mentha 
piperita on lung carcinogenicity in animal models are 
clues for its correct usage in related complications. 32 
Active components of Myrtus communis with potent 
anti-inflammatory effects offer a new therapeutic 
approach for acute pulmonary inflammation. 33 Plantago 
ovata that had been given for pleurisy was evaluated as 
effective on respiratory tract inflammation. 34 Sesamum 
indicum acts as an angiogenesis inhibitor and stops 
progress of lung tumour adenocarcinoma.35 An 
antitussive effect of Portulaca oleracea was affirmed by 
recent animal studies.36 
Laooq in Persian traditional manuscripts is not only a 
traditional dosage form but it could also be considered as 
a good candidate for new respiratory medicines. Since 
they gradually release their active component, they could 
be prescribed as retard formulations. Besides the 
historical study on traditional Persian medicine and 
pharmacy, this study presents the pharmacological 
approaches of traditional practitioners and reported 
natural simple and compound preparations which can be 
selected for new researches in complementary medicine. 
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Table 1. Most often reported plants used solely in form of Laooq for respiratory ailments. 
Linctus (Laooq) Traditional name Respiratory diseases Part(s) used 
Acacia arabica L. Samgh-e arabi Cough, Haemoptysis, Lung ulcers Gum 
Adiantum capillus-veneris L. Barsiavashan Asthma, Catarrh, Thoracalgia Aerial part ( cooked) 
Alhagi maurorum Medik. Taraniebin Cough, Thoracalgia Manna 
Allium sativum L. Soom Asthma, Dysphonia Bulb 
Althea officinalis L. Khatmi Cough, Dysphonia, Laryngitis Aerial parts (with honey) 
Amvf!dalus communis L. Badam Asthma, Cough, Pleurisy Oil (with sugar) 
Astraf!alus soo. Katira Cough, Dysphonia, Haemoptysis Gum 
Boswellia serrata Triana & Kondor Cough, Dysphonia, Haemoptysis Oleo gum resin 
Planch. 
Brassica nigra L. Khardal-e-siah Asthma, Cough Seed (with honey) 
Brassica oleracea L. Kornob Cough (chronic) Fruit (cooked) 
Carthamus tinctorius L. Gholranf! Dysphonia Seed (extract) with honey 
Carum carvi L. komoun Dyspnea, Orthopnoea Seed (with vinegar) 
Commiphora opobalsamum L. belsan Cough Seed 
Cordia myxa L. Sepestan Cough (warm& dry), Dysphonia Fruit 
Crocus sativus L. Zafaran Cough, Pleurisy Stamens 
Cucurbita maxima Duchesne Ghar'a Cough (warm), Thoracalgia Seed ( cooked with olive oil) 
Cvdonia oblonf!a Mill. behdaneh Cough ( drv & warm) Seed 
Ficus carica L. Tin Asthma, Cough, Thoracalgia Fruit, leaf 
Glycyrrhiza f![abra L. Shirin baian Asthma, Cough, Dysphonia Root 
Hyssopus ofjicinalis L. Zoofa-ie iabes Asthma, Catarrh, Cough, Aerial parts 
Pulmonary oedema 
Iris spp. Irsa Asthma, Dyspnea, Pneumonia, Rhizome (cooked in wine) 
Thoracalgia 
Lepidium sativum L. Hor( Asthma, Cough Aerial parts (with honey) 
Linum usitatissimum L. Katan Cough (wet), Haemoptysis Seed (with honey/ roasted) 
Liquidambar orientalis L. Meyeh sayeleh Cough, Catarrh, Dysphonia, Resin 
Thoracalgia 
Marrubium vulf!are L. Farasyun Cough, Lung ulcers Aerial parts 
Mentha piperita Na'na Haemoptysis, Pleurisy Aerial part 
Myrtus communis L. Moord Cough, Haemoptysis, Thoracalgia Fruit (concentrate) 
Papaver somniferum L. Khashkhash Catarrh, Cough (warm) Seed, oil (with honey) 
Plantago ovata Forssk. Bazr-e ghatoona Pleurisy Seed 
Portulaca oleracea L. Baf!hlatol-hamf!ha Catarrh, Cough, Haemoptysis Leaf, seed (with sugar) 
Punica f!ranatum L. Romman Cough, Dysphonia, Thoracalgia Fruit (with almond oil) 
Seil/a maritima L. Sgheel Asthma, Cough, Dysphonia, Bulb (with honey) 
Haemoptysis 
Sesamum indicum L. Samsam Cough, Lung ulcers Seed, oil 
Trif!onella foenum-waecum L. Holbeh Asthma, Cough ( cold) Leaf, seed 
Urtica dioica L. Aniere Asthma, Cough, Orthopnoea Leaf ( cooked), Root, seed 
Vicia (aba L. Baf!hela Cough, Dysphonia Fruit, flour (with oil/sugar) 
Viola odorata L. Banafsaj Catarrh, Cough, Pleurisy, Flower 
Pneumonia 
Ziziphus jujuba Mill. Onnab Asthma, Cough, Dysphonia, Fruit 
Thoracalgia 
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Table 2. Some Laooq formulations cited in Persian pharmaceutical texts. 
Linctus Ingredients 
(Laooq)* 
Ailment(s) Preparation 
Almond Liquorice (Glycyrrhiza glabra L.), Tragacanth gum Cough, Dysphonia, The medicaments should be mixed 
(Lawz)QA (Astragalus tragacantha L.), Arabic gum (Acacia Laryngitis with almond oil and then kneaded 
senegal Willd.), Almond seed [Prunus dulcis (Mill.) with rose syrup and starch (Jullaab). 
D.A.Webb] 
Cabbage Wild cabbage (Brassica oleracea L.), Grape (Vitis Dysphonia, Decoction of cabbage should be 
(Kalam)QK vinifera L.) Laryngitis mixed with grape juice and kneaded 
with honey. 
Cottonseed Cottonseed (Gossypium herbaceum L.), Poplar fruit Catarrh, Components should be kneaded with 
(Habol (Populus sp.), Fenugreek (Trigonella foenum-graecum Dysphonia, grape concentrated juice after 
ghatan)QS L.), Linseed (Linum usitatissimum L.) Laryngitis pounding. 
Giant Wheat flour (Triticum aestivum L.), Poppy seeds Cough, All these medicines are powdered and 
Thorny (Papaver somniferum L.), Liquorice extract ( Glycyrrhiza Haemoptysis, sieved and then kneaded with 
(Tabaashir)CM glabra L.), Almond seed [Prunus dulcis (Mill.) Lung ulcers, frothless honey and cow butter. 
D.A.Webb ], Gum Arabic (Acacia Senegal Willd.) Thoracalgia 
Ginger Ginger (Zingiber officinale Roscoe), long piper fruits Dysphonia Ingredient should be ground and 
('lanjebil)QS (Piper longum L.), Saffron (Crocus sativus L.), starch mixed with starch. Mixture should 
then be boiled with honey until the 
desired consistency is achieved. 
Harmal Linseed (Linum usitatissimum L.), Harmal seed Cough, Dyspnoea The ingredients should be pounded 
(Es/and)™ (Peganum harmala L.) and then kneaded with honey. 
Herb Hyssop Herb Hyssop (Hyssopus officinalis L.), Gladiolus root Catarrh, Cough Ingredients are to be boiled in water. 
(Zoofaa)QG (Gladiolus communis L.) (chronic), The extract should be sweetened with 
Dyspnoea sugar and kneaded with honey 
subsequently. 
Jujube Jujube (Ziziphusjujube Mill.), Lasura (Cordia myxa L.), Bronchitis, Cough, All ingredients should be decocted 
(Onnab)QK Raisin (Vitis vinifera L.), Liquorice (Glycyrrhiza glabra Laryngitis and kneaded with honey. 
L.) 
Linseed Linseed (Linum usitatissimum L.), Frankincense Cough (chronic), All medicaments are to be pounded 
(Kataan)QA (Boswellia serrata Triana & Planch.), Caraway (Carum Dyspnoea and sieved and then kneaded with 
carvi L.), Cardamom (Elettaria cardamomum (L.) frothless honey. 
Maton) 
Pediatric Liquorice (Glycyrrhiza glabra L.), Tragacanth gum Bronchitis, The quince mucilage should be mixed 
(sebiaan)™ (Astragalus tragacantha L.), Arabic gum (Acacia Laryngitis with other ingredients. The mixture 
arabica (L.) Willd ex Delile ), Quince ( Cydonia oblonga should then be kneaded with honey or 
Mill.), Sugar almond oil. 
Rose Rose flower (Rosa x damascene Mill.), Tragacanth gum Cough, Medicaments should be mixed and 
(Vard (Astragalus tragacantha L.), Poppy seeds (Papaver Haematemesis, kneaded with grape concentrated 
Ahmar)QG somniferum L.), Giant Thorny (Bambusa Pneumonia, juice. 
arundinacea Retz. (Wang), Saffron (Crocus sativus L.), Thoracodynia 
Liquorice (Glycyrrhiza glabra L.), Starch 
* I. CMCanonofMedicineisoneofalmost450treatiseswrittenby Hossein Aghili Khorasani Shirazi. Twenty chapters on pharmacy 
Persian scientist and physician lbn Sina [ A vicenna] in 1024 AD. The and phannaceutical practice are organised in the first part followed by 
book contains 5 volumes. In the last, lbn Sina listed more than 300 28 parts on dosage fonns based on active components alphabetically. 
compolUld formulations with comments on their application and 5. QS: Qarabadin-e-salehi was written by Mohammad Saleh 
effectiveness. Ghaeni Heravi in 1766 AD. It is a lithograph manuscript in 
2. QA: Qarabadin-e-azam is a lithograph manuscript written by traditional Persian pharmacy. Over 200 different pharma-
Hakirn Azamkhan in 1853 AD which was organised based on ceutical dosage forms involving preparation methods and 
Pharmaceutical dosage forms. The book has an index having related diseases have been mentioned alphabetically in the 
compolilld formulations in line with the diseases and body organs.37 book. In the beginning part of the book a brief description of 
~- QG: Qarabadin-e-ghaderi was organised by Ahmadshah Ammi pharmaceutical basic foundations is given. 
m 1714 AD. The pharmaceutical dosage fonns and the disea&! types 6. TM Tohfat ol Moemenin is a comprehensive pharmacopoeia of 
are differentiated from head to toe. Dosage forms related to fevers and simple and compound remedies in Persian which was written by 
skin disorders are defined in the last part of the manuscript Muhammad Mumin Daylami Tonkaboni in 1670 AD. The book 
4. QK: Qarabadin-e-kabir is the largest Persian phannaceutical contains 763 simple herbal, animal as well as mineral drugs followed 
manuscript that was written in 1772 AD by Seyyed Mohammad by descriptions of compound remedies. 
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Over the past century drug research has contributed the 
most to the progress of medicine, but the value of 
r~medies used in traditional medicine as a source of drug 
dis~overy cannot be neglected. New techniques have 
ennched the standardisation armamentarium so that the 
traditional dosage forms could be used in today's system 
of medicine. Information on these dosage forms and 
preparations are found in manuscripts, namely 
Qarabadins (traditional pharmacopeias), which can be 
considered as a source of drug discovery in traditional 
medicine. In this paper, the historical basis of a traditional 
dosage form, Abkama, is discussed. Abkama is a liquid 
dosage form mentioned as an anti-infectious formulation 
in many traditional sources. Preparation of this 
formulation is considered in this paper as found in five 
most famous traditional Persian medical lists, including 
Qarabadin-e-Salehi (1766AD), Qarabadin-e-Qaderi 
(1714AD), Qarabadin-e-Baghaee (1861AD), Tohfat-ol-
Momenin (1670AD), Canon of Medicine (1025AD) and 
Qarabadin-e-Kabir (1772AD). The term Abkama and its 
related preparation method and clinical uses were 
reviewed. Also, a literature search in PubMed, ISI and 
~oogle-scholar was done to find previous related 
mvestigations in this field. Based on these data, it appears 
that the method of preparation of Abkama is similar to the 
co~v~n~onal fermentation methods for production of 
antJbiotJ.cs. It can be considered as the first report of 
preparation of antibiotics throughout history. 
Introduction 
~ith the advancements of chemistry, pharmacology, 
biotechnology and the clinical sciences over the past 
~entury, drug research has played the most important role 
m the progress of medicine. 1 Records show that the use 
of plants as medicaments dates back to human antiquity. 2 
What we know today as traditional medicaments are the 
medicinal plants and animal products that human beings 
have used as remedies for millennia. 3 Based on their 
lo~g-term use, traditional remedies have an advantage in 
~mg selected as starting points in the area of drug 
discovery.4 Any non-Western medical practice could 
generally be defined by the term traditional medicine.5 
According to the World Health Organization 60-80% of 
the world's population, mainly the developing countries 
depended primarily on traditional medicines in the yea:. 
2002.3 In western countries however, the interest and 
acce~tance of traditional medicines is increasing. 6 
Asian governments are investing significant amounts 
of resources in screening programs of the Traditional 
Chinese Medicines with the hope that these clinical trials 
would lead to the development of new drugs.7 Going 
through the world history of medicine undoubtedly one 
of the most influential systems of medicine is Islamic-
Iranian m~cine. 8:9 Re~ently there are studies indicating 
that expenrnentab.on m the field of medicine in its 
mod_em fo~, inclu~g clinical trials and drug-potency 
studies, has its roots m the Medieval Islamic era, 10 which 
shows the value of the surviving documents. There are 
thousands of manuscripts available from medieval Persia 
which could be used as sources to initiate drug discovery 
efforts. Although there are precise documents available, 
the great potential of this system of medicine remains 
neglected. 
Qarabadin books are the traditional lists of a registry 
of drugs (pharmacopeias) containing methods of 
preparation of different traditional dosage forms and their 
uses.11 •12 There are many Qarabadin books available 
from medieval Persia. Once the literature is translated 
into today's language, the precise methods of preparation 
could be noted, which could be a good starting point in 
the development of new drugs. One of the formulas 
which could be observed in different Qarabadins was the 
Abkame dosage form, whose interesting features made us 
believe it can be used as an evidence-based starting point 
in drug discovery studies, thereby opening new windows 
to therapeutics. In this study, we report on the methods of 
preparation of Abkama, extracted from different 
Qarabadins. 
Subjects and Methods 
In this study six important traditional pharmaceutical 
manuscripts were examined to extract the required 
information aboutAbkameh, as below: 
Qarabadin-e-Qaderi was compiled by Ahmadshah 
Arzani in 1714 AD. The pharmaceutical dosage forms 
were differentiated from head to toe in line with the 
disease types. Dosage forms related to fevers and kin 
disorders were defined in the last part of the manuscript. 13 
Qarabadin-e-Kabir is the largest Persian pharmaceutical 
manuscript, written in 1772 AD by Seyyed Mohammad 
Hossein Aghili Khorasani Shirazi. Twenty chapters on 
pharmacy and pharmaceutical practice form the first part, 
followed by 28 parts on dosage forms based on active 
components arranged alphabetically. 14 
Qarabadin-e-salehi was written by Mohammad Saleh 
Ghaeni Heravi in 1766 AD and is a lithograph 
manuscript in traditional Persian pharmacy. Over 200 
different pharmaceutical dosage forms involving 
preparation methods and related diseases are described 
alphabetica11y in the book. At the front of the book is a 
brief description of pharmaceutical basic fmmdations. 15 
Tohfat-ol-Moemenin is a comprehensive pharmacopoeia 
of simple and compound remedies in Persian which is 
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written by Muhammad Mumin Daylami Tonkaboni in 
1670 AD. In this book 763 simple herbal, animal and 
mineral drugs are described. The compound remedies are 
given in the following chapters. 16 
Qarabadin-e-Baghaee was organised by Mohammad 
bagha khan, an Indian physician who wrote this book in 
Persian and published in 186 lAD. The book contains the 
common dosage forms of the writer's era in alphabetic 
order. The book has 12 chapters for each system of the 
body and the last chapter is about dermatology and 
cosmetics. 17 
Canon of Medicine. The fifth volume of the Canon of 
Medicine, the large medical encyclopedia which was 
written by Avicenna in 1025AD, is Qarabadin and 
specifies procedures for preparation of compound 
drugs.is 
Also, a literature search in PubMed, ISI web of 
knowledge and Google scholar was done to find related 
previous investigations in this field. 
Results 
Methods of preparation of Abkama 
Abkama is an ancient dosage form mentioned in the 
gastrointestinal section of most Qarabadin books. It was 
first invented by Chaldean and Egyptian people. The 
details of the methods of preparation of Abkama, based 
on five different Qarabadins, are listed in Table 1. All of 
these methods appear to have some general 
characteristics, which are summarised here: 
Bread is baked from fine barley or wheat flour and water, no 
salt or yeast is added and then it is ground along with specific 
herbs. All the ingredients are mixed with water or vinegar to 
make dough, which is placed under the sun in the summer for 
20 days until it becomes black or green in color. Some liquid 
should be sprinkled on this mixture and it should be stirred at 
the beginning, middle and end of each day. Then, it should be 
dissolved in a solvent and placed in another container and 
kept for two weeks and shaken daily if effervescent, then kept 
still for the air bubbles to disappear. After two weeks it is 
filtered and the filtrate is collected and used for treatment.13,Is 
Is Abkama an antibiotic preparation? 
The details in the preparation methods of Abkama 
suggest that Abkama may be an antibiotic. The process 
could easily be compared to what we know today as 
antibiotic production by fermentation.19 The dough could 
be considered as the carbon source. In other methods of 
preparation of Abkama, such as those mentioned in the 
Canon of Avicenna, proteins have also been used as the 
starting substances, 18 which could also be considered as 
the carbon source of the antibiotic. 19 The black or green 
co_lour could be an indication of the presence of 
rrucroor?anisms in the mixture. The summer sun might 
be cons~dered as the heat source, and stirring the system 
would msure even distribution of the nutrients and 
oxygenation of the system. Overall, this information 
suggests that Abkama is most likely an antibiotic 
preparation. 
The other fact that makes one believe Abkama is an 
antibiotic formulation is its listed therapeutic uses. This 
formulation has been used orally in stomach disorders. '3 
Table 1. Methods of preparation of Abkama 
according to five Qarabadin manuscripts. 
Qarabadin-e- Salehi (1766 AD) 
The "."arm fresh barle~ bread is put in a pottery 
contamer, covered until becomes green in colour, 
t~en ground and sieved. Dough is made using 
vmegar and put under the sun, kept moist by 
vinegar and grape juice each for ten days, dried 
under the sun, and tablets are made from the mass 
which are used later for the preparation of the 
formulation. For two months from 23rd of June to 
23rd of August, these tablets (approximately 414g) 
should be placed under the sun in vinegar 
(approximately two kg), and a combination of herbs 
such as Zingiber officinale Roscoe, Piper nigrum 
L., Cinnamomum zeylanicum L., Cuminum 
cyminum L., Bunium persicum (Boiss.) B. Fedtsch. 
and Eugenia caryophyllata Thunb should be 
added.[1 51 
Qarabadin-e- Qaderi (1714 AD) 
Dough is made from approximately 420g of fine 
barley or wheat flour and water, no salt or yeast is 
added. It should be baked and the bread ground 
with 420g of powdered Mentha pulegium L., 
approximately 60g of salt, 105g of Bunium 
persicum (Boiss.) B. Fedtsch. and 420g of 
Pimpinella anisum L. All the ingredients are mixed 
with water to make a dough, which should be 
placed under the sun in the summer for 20 days 
untill it becomes black in colour. Some water 
should be sprinkled on this mixture, and it should 
be stirred in the beginning, middle and end of the 
each day. Then, it should be dissolved in water and 
placed in another container and kept for two weeks 
and shaken twice a day, in the morning and night. If 
effervescent, it should be kept still for the air 
bubbles to disappear. After two weeks, it is filtered 
and the filtrate is collected in another container. The 
residue is subjected to the same process for two 
more times, and the second and third filtrate is 
mixed with the frrst)I3J 
Qarabadin-e- Baghaee (Published 1861AD) 
Both of the above methods are mentioned.l17J 
Tohfat-ol-Momenin (1670 AD) 
In the summer time, bread should be baked from 
barley flour and Mentha pulegium L., then ground 
and mixed with an equal weight of Mentha 
pulegium L. and salt and a quarter of its weight of 
Foeniculum vulgare Mill. Few other herbs might be 
added according to the nature of the disease. Dough 
is made from the mass using water and kept und_er 
the sun for 20 days, stirred every day and kept moist 
until it becomes black in colour. The black mass 
should be dissolved in water, placed in a glass 
container and keot under the sun for few davs.l161 
Qarabadin-e-Kabir (1772 AD) 
Same as Tohfat-ol-Momeninl 14l 
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It is only recently that we know the role of Helicobacter 
pylori in the mediation of gastric disorders.20 It has also 
been used as an enema for the treatment of intestinal 
ulcer17 and as an anthelmintic formulation. 16 Other 
therapeutic applications of Abkama are as a gargle for 
treatment of tonsil inflammation, 14 topically for the 
eradication of ghorooh al khabisa (meaning creeping 
ulcers), which are defined as wounds with a warm feeling 
and secreting a watery substance, and for the treatment of 
rabid dog bites.21 It has been used in the form of eye-
drops as a prophylaxis for smallpox damage to the eye.18 
Another therapeutic use of this formulation is in the 
treatment of obesity. 16 Today it is proposed that an 
environmental factor that regulates obesity is intestinal 
microorganisms.22 According to recent investigations, a 
change of saliva bacterial species in overweight women 
could be considered as a biological indicator of 
developing an overweight condition.23 
Conclusion 
What can be concluded from Abkama s various medical 
applications is that this dosage form has been used in the 
treatment of many infectious diseases in general. And 
also it indicates that centuries before the discovery of 
micro-organisms and antibiotics, the role of these were in 
a way understood as a cause and cure of what we know 
today as infectious diseases. 
Interesting concepts are realised through this research, 
such as although the role of Helicobacter pylori in 
gastritis was revealed by two Australian scientists, RJ 
Warren and BJ Marshall in 1983,20 in medieval Persian 
medicine some kinds of gastric disorders were 
categorised with other infectious diseases. Today, obesity 
is not categorised under infectious diseases but recent 
findings show a possible role for micro-organisms in 
developing some forms of overweight conditions, which 
could also be observed in Traditional Persian 
categorisations. Abkama 's formulation and application 
could be a potential research area for biotechnologists, 
pharmacologists, chemists and clinical researchers. 
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Book Review 
Herbs and Healers from the Ancient 
Mediterranean through the Medieval 
West: Essays in Honor of John M. Riddle 
Anne Van Arsdall and Timothy Graham (Editors) 
Farnham, Surrey: Ashgate, 2012, pp.394. ISBN 978-1-
4094-0038-7 (hardback price: £70.00). 
Many scholars now believe that the medicine 
practiced during ancient and medieval times has been 
greatly underestimated, and that practitioners' 
knowledge of medicinal plants and their rational use 
was much more sophisticated than previously 
thought. As a result there is much research currently 
underway by historians, plant biologists and others to 
see if there are further secrets to be unlocked. 
One of the pioneers of this research is John M Riddle 
at the University of North Carolina. Riddle's books 
include Dioscorides on Pharmacy and Medicine (1985) 
and Eves Herbs: A History of Contraception and 
Abortion in the West (1997). This book, a compilation of 
essays on subjects close to Riddle's heart, is the fourth in 
Ashgate's 'Medicine in the Medieval Mediterranean' 
series. The book takes a broad historical sweep, from the 
first century BC to the late Middle Ages, and has a wide 
geographical spread, from central Asia to western 
Europe. The opening chapter, by John Scarborough, 
provides a scholarly account of pharmacology and 
toxicology at the court of Cleopatra (around 70 to 30BC). 
It describes the roles of several of her physicians, 
including Philotas of Amphissa and one called Olympus 
who was present when the queen committed suicide. 
Other colourful characters featuring in this book 
include the healers Gariopontus of Salemo and 
Constantine the African. The latter was an eleventh 
century monk, the importance of whom in the history of 
European medicine can hardly be over-stated, as Winston 
Black demonstrates. Black suggests that Constantine 
should be credited with bringing rationality back into 
medieval medicine, as a result of his translations of 
Arabic and Greek medical works, along with original 
contributions. 
Black examines the influence of one of Constantine's 
key works, his Liber Graduum (the book of degrees), the 
earliest medieval text in Latin to embrace Galen's theory 
of simples. Black explores references to Constantine in 
north European medical verse. In another chapter, Faith 
Wallis discusses the reasons why the Liber Graduum 
never gained admission to the Articella (the medieval 
compilation of medical texts), but nevertheless had a 
significant impact upon it. 
In his chapter John Crellin reflects on Riddle's Eve s 
Herbs, and on interpreting evidence about therapeutic 
effectiveness. Maria Amalia D ' Aronco, editor of The Old 
English Illustrated Pharmacopoeia, examines attempts 
to identify the plant known as elehtre; it is usually 
considered to be the lupin because of its colour ( amber or 
electrum ). The ubiquity of herbs and herbal healing in the 
medieval world is illustrated by the extent to which they 
were satirised in Middle English texts, explored in a 
chapter by Linda Ehrsam Voigts. And Karen Reeds 
assesses the claims for Saint John's Wort in the age of 
Paracelsus. She notes that the glandular dots in its leaves 
are so distinctive that any description or picture that 
involves them can reasonably be assumed to be 
Hypericum peiforatum. 
The final chapter provides a review of existing 
resources available to researchers, including the Anglo-
Saxon Plant Names Survey (ASPNS) and the Dictionary 
of Old English Plant Names (DOEPN). It then describes 
the development of an important new internet-based 
system to facilitate collaboration, the Medieval Plant 
Survey (MPS). This data base includes not only plant 
name indices listing nearly 10,000 plant names, but also 
large numbers of historical texts, ingredients mentioned 
in medical formularies, and online sources. 
Some parts of the book are, however, less readily 
accessible than others; some 24 pages of Latin text are 
reproduced in full, and one chapter ( on fifteenth century 
Silesian manuals for treating battlefield wounds) is in 
German, although a short abstract is provided in English. 
There are some 26 pages of tables providing detailed lists 
of substitutes, part of a chapter in which the author 
revisits the practice of substitution in ancient pharmacy. 
A further 16 pages provide tables giving the alternative 
terminology used in four important manuscripts from this 
period, including the Circa instans. 
This then is a scholarly work which will be of 
considerable interest to researchers working in this field, 
including historians and plant biologists. But the book 
also offers much of interest to pharmaceutical historians. 
It makes important contributions to our knowledge about 
how medical and pharmaceutical ideas moved across 
national, linguistic and cultural borders; about how they 
were translated, modified, adapted and improved, 
between Greek, Latin and Arabic; and about how th~y 
came to lay the early foundations for pharmacy m 
Britain. 
The book shows also that Anglo-Saxon medicine had 
a rational basis and elaborated the medical tradition of 
classical antiquity. There are many examples in ancient 
botanical tradition of identical names denoting different 
plants, and conversely of different names being attributed 
to the same plant. Whilst the names of herbs have proved 
prone to change over time, their medicinal uses tend to 
remain remarkably constant over millennia. . . 
Those with an interest in the history of plant medicmes 
will thus find much to interest them in the contributions 
in this book. But it also illustrates that, when it comes to 
the history of herbs and healers, there is still much to do. 
Pharmaceutical historians have already made important 
contributions in this field, but there are many further 
insights they will be able to provide. 
Dr Stuart Anderson 
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Letter to Editor 
Origin of Bezoar or Pat-zahr in Persian 
Medicine 
I saw an interesting article entitled 'Porcupine Stones' by 
Dr Christopher JDuffin in the last issue [43(1)] of Pharm 
Hist (Lond.) 1 As he mentioned, Bezoar has a root in the 
Persian language. According to the Webster dictionary, 
the origin of this word is 'Middle French, from Medieval 
Latin, from Arabic dialect bezuwiir, from Arabic biizahr, 
from Persian piid-zahr, from piid protecting (against) + 
zahr poison. '2 It was originally Piit-zahr in ancient 
Persian and was changed to bezoar when it went to the 
West; therefore I thought a brief historical description 
about this word would be interesting for readers and 
researchers of the history of pharmacy. 
Piit-zahr was an ancient Persian word. In Sassanid 
Pahlavic language, the official language of Persia in 
Sassanid dynasty (224-637 AD),piit means anti andzahr 
means poison. Therefore Piit-zahr means anti poison or 
antidote.3 In Traditional Persian Medicine, Piit-zahrs 
were a group of drugs with antidote activity including 
mineral (stones) and animal ingredients. Herbal antidotes 
were called Teriaq. 4 In Makhzan-ol-Advieh (Storehouse 
of Medicaments, a late medieval Persian manuscript), the 
mechanism of action of bezoars and Teriaqs were 
described as absorbing poisons to the antidotes and also 
deactivation of poisons effects by antidotes. 4 The most 
famous Piit-zahr in ancient Persia was derived from the 
stomach of a kind of goat, namely boz e padzahr saz 
(bezoar goat) (Fig. 1 ). This goat (Persian Wild Goat, 
Capra aegagrus) is called as Kri-h-i in Greek5 and Pazan 
in Persian.6 It seems that the mass derived from its 
stomach made from indigestible materials such as hair 
possesses antidote activity. Goats' hairs were cut off by 
herbal thorns in their pasture and they eat them. These 
hairs and other indigestible materials became stone-like 
masses in their stomach. These masses have antidotal 
properties, probably by absorbing poisons in the 
stomach. 
In its passage to the West, its meaning was changed 
over time and nowadays bezoar is described as 'a ball of 
swallowed foreign material (usually hair or fibre) that 
collects in the stomach and fails to pass through the 
intestines'. 7 The relation between the current meaning of 
bezoar and its origin can be clarified by this explanation: 
Bezoars made from hairs and other things in the stomach 
are like Piit-zahr made in goats' stomach by hair and 
indigestible materials. 
Arman Zargaran; ;Research Office for the History of 
Persian Medicine and Student Research Committee, 
north Ghaani street, Shiraz, Iran; Postcode: 7139748479; 
Tel/fax: +98 7112304279; email: zargarana@sums.ac.ir 
Hassan Yannohammadi, Research Office for the 
History of Persian Medicine, email 
yarmohammadihassan@yahoo.com 
Abdolali Mohagheghzadeh: Department of 
Traditional Pharmacy, Faculty of Pharmacy and 
Pharmaceutical Sciences Research Centre, Shiraz 
University of Medical Sciences; email 
mohaghegh@surns.ac.ir 
References 
1. Duffin CJ. Porcupine stones. Pharm Hist (Lond.) 
2013; 43(1): 13-22. 
2. www.merriam-webster.com/dictionary/bezoar 
3. Farahvashi B. Farsi to Pahlavi dictionary. 3rd 
Edn. Tehran: Tehran University. 2002. [in Persian] 
4. Aghili Shirazi MH. Makhzan-ol-Advieh [Store-
house of Medicaments]. Tehran: Intisharat va 
Amoozesh Enghelab Islami Press. ( 1771/1992) 
5. Crete Wild Goat. World association of zoos and 
aquariums. Available at: www.waza.org/en/zoo/visit-
the-zoo/sheep-goats-chamois-and-musk-ox1254385523/ 
capra-aegagrus-cretica 
6. Firouz E, Potts DT. Ibex, Persian. Encyclopedia 
Iranica. Online version, available at: 
www.iranicaonline.org/articles/ibex-persian 
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Figure 1. Left: beaker with bezoar goat painting, found in Susa (southwestern Iran), ea. 3500 
BC, kept in McClung Museum of natural history and culture, Knoxville, Tennessee; 
right: a bezoar goat. 
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History of the external 
pharmaceutical use of Amber 
Dr Christopher J Duffin 
Sutton, Surrey 
Amber is an organic gemstone with a long folklore 
pedigree. Known from deposits ranging from Late 
Triassic1 to Miocene in age, the most familiar examples 
today are from the Oligocene/Miocene of the Dominican 
Republic2 and the Eocene of the Baltic area.3 In classical 
times amber was deemed remarkable because of its low 
density, thermal properties and ability to hold a static 
charge.4 The colour was pleasing and distinctive, it was 
easy to work and it also was possible to polish the stone. 
In north-west Europe and Mediterranean countries, a 
brisk trade grew up with the Baltic area,5 such that amber 
artefacts are found at archaeological sites in an almost 
unbr?ken timeline from Roman through Anglo-Saxon, 
Mediaeval and Renaissance times to the present day. 
Explanations for the origins of the stone were wide-
ranging and varied in classical and mediaeval times. 
Some thought it represented the congealed rays of the 
setting sun, the Roman poet Ovid recorded a Greek myth 
that amber droplets were the tears of the Heliades 
( daughters of Apollo mourning the death of their brother 
Phaeton), and Pliny records Sophocles' opinion that 
certain birds in Africa shed amber beads in their faeces. 6 
Roman and Greek mythology cite the golden apples of 
the Hesperides, covered in amber dew, while Lithuanian 
legends recount that amber washed up on the shores of 
the Baltic Sea is all that remains of an amber palace 
destroyed by Perkunas, the god of thunder. 7 
In reality, amber is fossilised resin. Resins are viscous 
~q~ds exuded by a range of trees, especially cycads, 
Jumpers and conifers, containing a range of complex 
hydrocarbons, particularly volatile fluid terpenes and 
occasionally . essential oils. The volatile components 
make the resm strongly and often distinctively aromatic· 
as they evaporate, the resin becomes more viscous anct 
gra.dually h~dens. The resins are secreted from special 
resm g~ands m_ the cortex of the tree as lightly antiseptic, 
protective flmds. Modem resins exploited for their 
various chemical and physical properties include Gum 
Arabi~ (obtained from sub-Saharan species of Acacia), 
Frankincense (from trees of Boswellia) and Myrrh (from 
the myrrh tree, Commiphora myrrha). Following burial 
!e~enes contin~e to be liberated, and complex polymer~ 
1satJ.on of residual hydrocarbons under increasing 
pressure and temperature leads to the formation firstly of 
copal, and eventually amber. 
Amber has a long history of medicinal use from 
classical times to the present. Uniquely amongst those 
geological materials with historically pharmaceutical 
applications, it was prepared in a wide number of ways 
and prescribed for a huge range of disorders. This paper 
gives a brief review of the external application of amber 
in relatively unmodified form in medicine. 
Amulets 
In its modem sense, 'amulet' refers to an object endowed 
with magic powers which are persistent in protecting the 
bearer's person or belongings from evil spirits or the Evil 
Eye. It is obvious from Pliny's Historia Natura/is however, 
written sometime shortly before the Roman official's death 
in 79 AD, that the original Latin name extended to objects 
which preserved the bearer from troubles, including those 
of supernatural origin, as well as having medical or 
prophylactic properties.8 Pliny (Fig. 1) refers to the 
amuletic powers of amber thus:9 
Even today, the country women of Lombardy and those 
along the Po wear necklaces and collars of amber beads, 
mainly to adorn themselves, but in part also for their own 
health; for they believe that it prevents the inflammation of 
the tonsils and other diseases of the throat and the pharynx; 
Figure 1. Portrait of Pliny the 
Elder (AD 23-79). Reproduced by 
kind permission of the Wellcome 
Library, London. 
Figure 2. Portrait of Albertus Magnus 
(1193 or 1206- 1280). Line engraving by 
T. de Bry, 1597. Reproduced by kind 
permission of the Wellcome Library, London. 
Figure 3. Portrait of Jan Baptist van 
Belmont (1579-1644). Wikimedia 
Commons. 
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for the people of that region are subject to goitre, about the 
fleshy parts of the throat, caused by the local water which 
breeds the disease. It is, however, true that a necklace of 
amber beads worn about the necks of little babies is a great 
protection against secret poisons and a counterchann against 
witchcraft and sorcery. Callistratus says that such necklaces 
are good for all ages, to preserve the wearer from fantastic 
illusions and fears that drive one out of his senses: further, 
amber, whether taken in drink or hung about one, cures 
strangury ... He says of this yellow amber that if it be worn 
as a collar about the neck it cures fevers and heals diseases of 
the mouth, throat and jaws. 
Around 1262, Albertus Magnus (?1193-1280; Fig. 2), 
the famous Dominican Friar and philosopher, recom-
mended the wearing of amber in order to help maintain 
chastity, and to ease difficulties during childbirth, 10 advice 
reiterated by Matteo Silvatico,11 the famous doctor of the 
Salemo School ( circa 1285-1342) in his medical 
compendium. Felice Passera (1610-1702), a Capuchin 
monk from the Brescia Infirmary suggested that amber 
should be worn as a necklace or collar, or carried in some 
way in order to impede conditions of the head and throat. 12 
The canying of an amber amulet, often on the wrist, was 
seen as a sensible precaution by Passera against catching 
the plague. It was also believed to have spiritual efficacy 
against every evil; when worn tied to the collar by young 
boys it was effective against spells and enchantments, 
sorceries ('male:ficij') and demons, subduing all evil 
spiritual influences including those causing night-time fears. 
These themes are also embodied in amber amulets 
collected and reported from 20th century Spain and Italy 
by Walter Hildburgh (1876-1955). Necklaces of smooth 
and faceted amber beads were there used as prophylactics 
for teething problems, as well as to protect against injury 
caused by 'fascinaci6n' .13 In addition, a faceted amber 
bead strung together with a bead of milky glass was w?m 
by Basque women in order to protect them agamst 
disorders of the breasts. Furthermore, the wearing of an 
amber necklace 'assuredly cures that most torturing pain 
called the cramp . . . as many thousands have 
experienced', as well as being efficacious against 
soreness of the eyes. 14 
Carnillus Leonardus, 16th century physician to Ca~ar 
Borgia, notes that 'If laid on the left Breast of a W1t:e 
when she is asleep, it makes her confess all her evil 
Deeds ' . Amber supposedly also 'fastens teeth that are 
loosened' and has the noteworthy property of being able 
to identify an adulterous spouse: 15 
If we would discover whether a Woman has been corrupted, 
let it be laid in Water for three days, and then shewn to her, 
and if she is guilty, it will immediately force her to make water. 
The very threat of plague encouraged the use of m8:°y 
hopeful prophylactics and remedies. The Flerrush 
chemist and physician, Jan Baptist van Helmont (157~-
1644; Fig. 3) espoused the idea ofutilising the magnetic 
powers of stones to cleanse the body of toxins. The 
disease itself was believed to enter the body by virtue of 
a form of magnetism: 
in time of the plague, he draws in, through the invisible pores 
of the skin, the pestilential Atomes exhaling from th~ 
infected. For Nature, which at all other times is wont to admit 
nothing but wholsome and alimentary juice, and with great 
diligence and exactness to sequester that juice, from the 
inalirnentary and excrementitious parts of it; at this time, 
yeelding and wholly submitting to its magnes, greedily sucks 
in the pestiferous aer, and invites death into the inmost closet 
oflife.16 
As a defence, van Helmont recommended the wearing of 
'preservatory' amulets of emerald or amber which, by 
virtue of their durability are ' too hard for the humane 
magnes' and thereby 'conquer and destroy his attraction, 
and by that superiority of attraction, become the most 
certain . . . Counterpoisons to the fatal contagion of this 
plague'. 
Although often taken internally, especially as Oil of Amber, 
for various 'cold disorders of the brain', the external use of 
amber for a variety of nervous disorders was still being 
proposed as late as the mid-nineteenth century. 
'Mademoiselle V' suffered from a convulsive disorder for 
over 14 years and was treated by a Dr Gerard. He found that, 
by getting her to wear an amber necklace weighing 70g, he 
was able to prevent the convulsions that were taking place 
throughout her body. His experimental approach indicated 
that this treatment was effective only if she wore the necklace 
at the base of her neck; if she lay it over her clavicles, or 
moved it to just beneath her lower jaw, the sympto~ 
reappeared. On replacing it in the optimum therapeutic 
position, her tremors ceased within ~ matter of3 _or 4 s_econds. 
Gerard, highly encouraged by his success m ~ case, 
promptly set about trying to identify whether amber ~ght be 
used in a similar fashion in the treatment of related diseases. 
Unfortunately, he found that there was no relief in cases of 
epilepsy, sciatica, or cramp. A patient with extreme nervous 
depres.sion did record some improv~ent, but the _fact that he 
prescnbed opium concurrently wtth the weanng o~ the 
necklace may have been significant. Gerard gave a thirteen 
year old girl a necklace to wear in the wake of a three-week 
long bout of chorea, but the doctor noticed no irnJJr?vement 
in her condition, even after wearing the necklace continuously 
for a period of 10 years. Gerard was reluctantly forced to 
admit that the successful treatment of Mlle V using an amber 
necklace although noteworthy, was a unique case; he 
supposed that her favowable response to contact with_ the 
amber beads about her throat might be indicative of a uruque 
tibility to terrestrial electric :fields.17 7 Kunz (1856-1932), the esteemed mineralogist of 
Tiffany & Co., recounts an example of contem~ ~ 
belief in the efficacy of amber beads.18 Reputedly hvmg 
to 106 years old, a Jewess ofR~sian extraction.living in 
the USA ascribed her longevity to the weanng of a 
necklace of large amber beads. She was given the beads 
by her mother, another centen~an. The Jewess 
apparently died a few days after passmg the necklace on 
to her own daughter. 
Amber amulets were also carried against ocular 
ailments particularly in Scotland. The MacGregors of 
Glencoe' kept four beads as a charm against b_lindness, 
whilst in the north east of the country weanng such 
' lammer' beads was deemed to afford a cure for sore eyes 
as well, in Tweedside, as sprained limbs. In the same area, 
one such bead was regularly used to clear chaff and other 
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Figure 5. Portrait of Nicolas Monardes (1569). 
Wikimedia Commons. 
Figure 4. Title page of The byrth of mankind (London, and temper them with red wyne, making of it a plaster, the 
1552), translated by Thomas Raynald from an original which so tempred put into a little round bag the quantitie of a 
work by Eucharius Roesslin, the Elder. Reproduced by mans thombe, the which she shal put into the privie partes. 
kind permission of the Wellcome Library, London. Plasters or salves 
foreign bodies from the globes of the eye of both humans Nicolas Monardes (1493-1588; Fig. 5), the. Sp~h 
botanist and physician, recommended amber for mcl~1on 
and livestock. Also, an eighteenth century smuggler from in a 'Stomatick Emplaster' which 'stays Vonu~g, 
Galloway wore an amber bead which he used for curing A tte 
sick children, diseased cattle and other sick animals; strengthens the Stomach, helps Digestion, causes ppe_ 
treatment involved dipping the bead three times into water, and expels Wmd'. The other ingredients in this prep~ton 
which was then given to the sick person or animal to drink. 19 were tacamahaca ( a balsamic resin obtained from vanous 
species of North American and East Asian pop_lar trees), 
Pessaries Storax (aromatic, resinous exudate of the Mediterranean 
Thomas Raynald (fl. 1539-1552) the 16th century Turkish Sweetgum Tree,Liquidambarorientalis) and 'Oyl 
Oxford printer and physician, suggested a radical ofMastich' (resin of the low, shrubby Mediterranean tree, 
treatment for excessive menstrual bleeding in his volume Pistachia /entiscus).11 
entitled The Byrth of mankind (Fig. 4). The patient was to A 'Diaphoretick Emplaster' is credited to the _German 
be tied up in a carefully prescribed manner, and a cupping alchemist, Adrian von Mynsicht (1603-1638; Fig. 6). In 
glass placed on the untreated ventral abdominal surface. addition to 'yellow Amber', this contained yellow wax, 
At the same time, a variety of ingredients was inserted solidified coniferous resin ('colophony'), and a host of 
into the vagina in order to stem blood flow, as follows:20 aromatic gums and resins (gum Bdellium from 
Fyrst then to stynte and restrayne the outragyous fluxe of Commiphora spp.; gum ammoniac from Dore_ma 
flowzes, it shall be very good to bynde the armes strayghte ammoniacum; Galbanum from Ferula sp~.; Jurup~r 
and strongelye, and not the feete or handes, as some unwise Gum, Mastic and Frankincense), mostly dissolved Ill 
men do teache, and then to set a ventose, boxe, or cuppynge th · nn· The efficacy of vinegar and mixed toge er m turpen e. glasse with fyre (whyche is called boxinge) under the brestes d trated by the the salve in drawing out 'flegm' was emons 
without any scarafication: laying on also lynnen clothes drops of 'watery humors' which remained on the plaster 
dipped in vynegre on the belly between the navel and the . ·-" It was 
· al · th 1 h th hi h when 1·t was removed from the skin swiace. . secretes: conveymge so mto e p aces soc e ynges w c . . t, 'Flegmatlck 
have vertue to restrayne blood: as the flower and rynde of recommended in cases of ~c1atlc~, gou_ . abl 
pomegranate, amber, terra sigillata, bole armeniacke, sanguis Tumours from the French Disease (syphilis - prob Y 
draconis, hematites, the red rose, white frankincense, & the wart-like lesions developed during the secon~ 
galles: al those thinges or as many of them as ye can stage of the disease), swelling of the feet, broken an 
conveniently gette: beate them into powder in lyke portion, dislocated bones, pains, bruises, and scurvy.22 
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Figure 6. Portrait of the 
German alchemist, Adrian 
von Mynsicht (1603-1638). 
Reproduced by kind permission of 
Figure 7. Portrait of William Salmon (1644-
1713). Line engraving by W. Sherwin, 1671. Figure 8. Portrait of Georgius Agricola 
Reproduced by kind permission of the Well come ( 15 7 4). Reproduced by kind permission of the Wellcome Library, London. 
Library, London. the Wellcome Library, London. 
Poultices or cataplasms 
William Salmon (1644-1713; Fig. 7) was a prolific 17th 
century author who published on everything from 
medicine, surgery, anatomy and pharmacology, through 
astronomy, gardening, cookery and astrology to religion. 
Although using the title 'M.D.', there is some doubt over 
his qualification, and there is a suspicion that he was a 
'dishonest practitioner or charlatan'. He recommends a 
cataplasm containing amber, yeast, nutmeg, mint, cloves, 
cubebs, (fruits of the Pepper, Piper cubeba), xylo-aloes 
(a rather exotic aromatic wood from Indonesia), all 
mixed together in wine vinegar. Warmed and repeatedly 
applied to the crown of the head, it supposedly helped 
'palsy of the Tongue' (a rare disease caused by lesion of 
the hypoglossal XII nerve23), 'giving it Motion and 
Speech', as well as acting as a catarrhal decongestant. 24 
Rulandus (Martin Ruland the Elder; 1532-1602) 
favoured a cataplasm against catarrhs and 'Flux of the 
Rheum', applied to the crown of the head after it has been 
shaved, and consisting only of strong yeast and 
powdered amber. 
Fumigant 
Albertus Magnus (circa 1262) recommends the burning 
of amber in order to drive away serpents, much as jet 
(Gagates) was utilised in classical and mediaeval times,25 
while Camillus Leonardus notes that inhaling the fumes 
of burnt amber cures epilepsy.26 
Following a long discussion on the origins of amber, 
Georgius Agricola (also known as Georg Bauer, 1494-
1555; Fig. 8) states that, in addition to being used as a 
replacement for incense as a fumigant for 'clearing fetid 
or contaminated air', burnt in lamps to obtain a brighter 
and longer-lasting flame, cast onto funeral pyres, and 
used as an ingredient in ink:27 
In medicine it has the property of coating and having been 
drunk stops bleeding no matter where it occillS. It will stop 
vomiting, flux of the womb, discharge from ulcers, head 
discharges, and cure tonsillitis and throat irritations. It 
strengthens the viscera and other parts of the body. Since it is 
sweet smelling it is good for the heart and will stop heart 
tremors. The fumes of white amber will drive away epilepsy. 
So much regarding European amber. 
Thomas Raynald takes up the theme of its beneficial 
use in childbirth and gynaecological problems in an 
English translation of Eucharius Roesslin's (1513) Der 
schwangeren Frawen-und hebammen Rosen garten. He 
recommends putting amber on the embers of a dying fire 
'to sussume the nether places' because the fumes 'yelde 
a goodly savoure, by the which the nether places open 
theym selfe, and drawe downewarde'.28 
Salmon recommends taking powdered amber in a 
quarter of a pint of white wine every day for a week in order 
to treat falling sickness (epilepsy). For the rather different 
'fundament-falling' (presumably rectal prolapse) he 
recommends to ' take bits of amber, and in a colsestool put 
them upon a chafing dish of live charcoal, over which let 
the patient sit, and receive the fumes '.29 
The Scottish physician and author, William Buchan 
(1729-1805; Fig. 9) commends the use of amber vapour as 
an inhalant 'when the nose aboW1ds with moisture'. He 
goes on to suggest the use ofa 'snuff made of the leaves of 
marjoram, mixed with the oil of amber, marjoram and 
aniseed' for 'moistening the mucus when it is too dry' . In 
the event that the 'nerves which supply the organs of 
smelling are inert', he suggests anointing the forehead with 
balsam of Peru mixed with a little oil of amber. The former 
simple is the resin of the leguminous Peru Balsam or Tolu 
tree (Myroxylon balsamum), which is still used today on 
account of its well established antiseptic properties. 
Herman Boerhaave (1668-1738; Fig. 10), the famous 
Dutch botanist and physician based at the University of 
Leiden, recommends an unusual treatment for rickets. He 
suggests beating an ounce each of amber, incense, Mastic, 
Benzoin (aromatic balsamic resin obtained from trees of 
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Figure 9. Portrait of William Buchan. 
Stipple engraving by J. Thomson after J. 
Wales. Reproduced by kind permission of the 
Wellcome Library, London. 
Figure 10. Portrait of Herman 
Boerhaave (1668-1738). Mezzotint 
by G. White. Reproduced by kind 
Figure 11. Portrait of William 
Bullein (died 1576). Copied from a 
woodcut prefixed to his Government 
of Health (1559), rendered by W. 
Richardson in 1805. Reproduced by 
kind permission of the Wellcome Library. permission of the Wellcome Library. 
Styrax spp.) and Olibanum (Frankincense) into a fine 
powder which was then spread over burning coals. 
Woollen cloths or flannels were then suspended in the 
smoke which was produced and then rubbed over the parts 
of the body which were to be treated. 30 Indeed, powdered 
Amber was combined with a range of other aromatic 
ingredients, such as Calamus Aromaticus (Sweet Flag), 
Cyprus Wood, Storax, Labdanum, Pomander, Privet and 
Ambergris, and kept in closely stoppered glass bottles for 
putting into aromatic bags for perfuming clothes. It was 
also worked into Odoriferous Troches for perfuming 
'Chambers and Rooms of Entertainment' and yielding 
scents that 'are very wholesome to the Brain'.31 A dash of 
amber was also added to White Hippocras wine in order to 
enhance its aroma.32 
In an attempt to explain the supposed therapeutic 
effects of various materials classed as 'Fetids', including 
amber, a Dr Pitt (dates unknown) suggested that their 
fumes 'raise or increase the irregular Motions of the 
Spirits' in the brain or nervous system, whose 
movements would otherwise result in 'Hysterical 
Affections and Convulsions'. 33 
Ointment 
William Bullein (died 1576; Fig. 11), cousin of Ann 
Bolleyn (the second wife of Henry VIII, executed in 
1536), used amber in conjunction with a range of 
precious stones for the treatment of poisoning and a 
range of other diseases.34 His recipe for 'Electuarium de 
Gemmis' consisted of white pearls, little pieces of 
sapphire, jacinth, comelian, emerald and garnets, 
reddened coral, amber, shavings of ivory, and thin pieces 
of gold and silver. These were mixed with a range of 
herbs, including saffron, cardamom, ginger and 
cinnamon. In order to render the mixture into a syrup or 
electuary, the ingredients were then added to honey. This 
must have been an extremely expensive medicine to 
produce; it is little wonder that Bullein treated the 
Figure 12. Portrait of John Wecker from the title page of 
Secrets of art and nature (1600). Reproduced by kind 
permission of the Wellcome Library, London. 
nobility. He commends the syrup not only as a wide-
ranging cure for physical diseases and states of mind, but 
also as an acceptable perfume: 
This healeth cold diseases of the brayne, harte, stomake, and the 
Matrice, it is a medicine proved against the trembling of the 
harte, fayntyng and sounyng, the weakness of the sto~ke, 
pensifenes, solitarines, kinges and noble men have used ~ for 
their cornforte, it causeth them to be bolde sprited, the bodie to 
smell well, and ingender to the face good colour. 
Johann Jacob Wecker (1528-1586; Fig. 12), a B8:5el 
physician, published a rich source of prescriptions w~ch 
include amber as an active ingredient. The followmg 
recipe, taken from his Eighteen Books of Secrets, sh?w~ 
that amber ointment was used for 'the whites 
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(leucorrhoea), so-called because of the whitish genital 
discharge of viscid mucus in women:35 
For the whites an Unguent. Take red Coral!, Myrrh, bark of 
Frankinscence, juyce of Roses, Cyprus Nuts, leaves of wild 
Pomegranates, Mastick, Frankinscence, Amber, Spicknard, 
Galla Moschata, Coriander prepared, of each one scruple. Oyl 
of Roses, Mastick, Spicke Rue, of each half an Ounce, with a 
little Wax, make an Unguent. Roscellus. 
Balsam 
Balsams are soothing restoratives, usually based upon 
aromatic resins. In a recipe for a balsam used in the 
treatment of wounds, Wecker combines amber with a 
number of botanical essential and volatile oils as follows:3:6 
A Balsam for Wounds of the same Mans. Take pure 
Turpentine one pound and half, oyl ofBays, Galbanum, gum 
Arabick, gum Ivy, of each one ounce; Frankinsence, lignum 
Aloes, Galanga, Cloves, Nutmegs, middle Comfrey, 
Cinamon, Zedoary, Ginger, white Dittany, of each six drams, 
Storax liquid two ounces, Musk, Amber, of each one dram: 
puder what must be pudred and mingle them: add to them 
Aqua vitae seven pound, put them into a glazed vessel well 
stopt for eight days, then distil them first with a gentle fire, 
until the Oyl begins to drop, then increase it until you have 
distilled it all; then part the Oyl from the water and keep it. 
Quilts and pillows 
Thomas Fuller (1654-1734; Fig. 13), British physician 
and preacher famous for his book of proverbs, 
recommends that amber, together with a selection of 
fragrant herbal ingredients be quilted into the fabric of a 
night cap which was then smoked in burnt amber and 
other resins as follows:37 
Take Male Piony root 2 drams; Spanish Angelica root 1 
dram; Florentine Orris, Lavender flowers, each half a dram; 
Arabian Stechas flowers I dram; Cloves, Nutmeg, Mace, 
each I scruple; Storax calarnite, Labdanum, Amber, Balsam 
ofTolu, each I dram; Oil of Rosemary 5 drops; reduce it to a 
gross Powder; which being mix'd into Cotton, is to be quilted 
in a silk Cap according to Art. Every Night at Bed-time, let 
this Cap be surned fumed and warm'd with the smoak of 
Amber, Olibanum, Balsam of Tolu, or the like, Sprinkled 
upon Coals. Its of signal use in Humid, Pituitose Affections 
of the Head, in cold, customary, rheumatic Pains of the same. 
And its believ' d to recreate the Spirits, and roborate the Brain. 
Externally, Passera recommended that it be worn as a 
?ecklace or collar, or carried in some way in order to 
unpede conditions of the head and throat. 38 As a further 
treatment for throat problems, particularly inflammation 
and tumours, it was suggested that amber be heated in a 
bowl and the vapours inhaled by the patient. The golden 
colour of amber heralded its usefulness against fevers, and 
:,vhen mixed with apple and medicinal Rose Oil it was used 
Ill the treatment of diseases of the ear, much as first recorded 
by Pliny. Various gynaecological disorders suffered were 
treated by rubbing Oil of Amber on the pudendum. 
Modern availability 
A variety of amber medicinal products for use in external 
~tments is still available from the Baltic region. An 
~ternet search will, for example, yield results for amber 
omtment (an analgesic for rheumatoid arthritis, neuralgia 
and muscle pain), amber tincture (applied externally for 
~ ' 
·~ !iJ. 
Figure 13. Portrait of Thomas Fuller. Line engraving 
by G. Vertue after I. Tyrnewell. Reproduced by kind 
permission of the Wellcome Library, London. 
headaches and migraine) and amber oil (for scalds, skin 
allergies, insect bites and stings, rheumatic and muscle 
pain) from Polish suppliers.39 From Lithuania it is possible 
to purchase pillows filled with amber ( exploiting its high 
thermal conductivity and recalling the quilted caps ofFuller 
1710), amber incense and amber cosmetic powder. 40 
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Soothing skin medicines (i.e. creams/ointments/lotions 
etc1), or at least the wish for them, must be as old as 
human skin feeling the abrasive effects of wind. The 
ancient civilisations of Mesopotamia and Egypt, with 
their hot dust-laden winds, must have used them. There 
would also have been skin diseases, such as eczema and 
psoriasis, to treat; plus usage for leg/arm ulcers and sores. 
Additionally, there were the external skin manifestations 
from epidemic diseases to treat (such as plague, leprosy 
and syphilis) that have periodically swept through 
humankind. 
Lip salves containing lead have been found in 
Mesopotamian Ur of c. 2600 BC.2 Later, from c. 1900 
BC of the Babylonian period ofUr, some cuneiform clay 
tablet fragments have been found that were part of a 
doctor's personal medical archive. They give (but are not 
as yet totally translated) recipes for skin problems and 
practical treatment advice, without any 'magical' 
content. 3 Also in ancient Mesopotamia there were five 
words that could be translated as 'leprosy'; one of them 
may have been correct, whilst the others probably 
referred to various skin problems.4 
From ancient Egypt only 14 (relatively intact) medical 
papyri are currently known; they range in date of writing 
from c. 1850 BC (Kahun papyrus) to the second century 
AD (Crocodilopolis Medical book). The most well 
known, with the most recipes listed (877), is the Ebers 
papyrus of c. 1550 BC. 5,6 This last papyrus gives various 
recipes for the skin, such as: crushed together in a 
poultice and applied to skin ulcers were galena (lead 
sulphide), ox fat, chips of malachite ( a green basic copper 
carbonate) and honey; and, perhaps less invitingly, a 
cleansing face cream made of bullock's bile and ostrich 
egg, beaten up with fresh milk.3,7 Balanos oil, castor oil 
and goose fat were all used as skin emollients (i.e. to 
soften and/or moisturise the skin), and were sometimes 
mixed with other materials ( e.g. :frankincense, malachite) 
and used in bandages applied to the skin in order to 
control infection or promote healing.6 
Other skin remedies, in various papyri, were for skin 
beauty care and for controlling or removing wrinkles and 
other signs of old age. Also, specific skin diseases are 
difficult to identify owing to problems with obtaining a 
correct translation of some of the words used. However, 
what is surprising is how few skin recipes are actually 
given in the papyri. Given their climate and the generally 
ubiquitous nature of skin ailments in any society one 
would have thought that there would be a large corpus of 
such remedies (along with associated spells/rituals/ 
incantations). Perhaps they await discovery or 
translation, or perhaps they were so well known that few 
were actually written down?8 
Hippocrates of Cos (active 5th century BC, Greece) is 
often seen as the first to introduce rational science (i.e. 
acute observation and associated deductions) into 
medicine. Attempts were made to understand the 
underlying mechanisms of skin disease.9 Materials used 
included the yellow sulphide of arsenic (the mineral 
orpirnent) in a paste used on skin ulcers, and pine tar was 
used to treat a skin disease that may have been psoriasis. 10 
Later Roman physicians recommended various salves to 
treat often well described skin diseases; for example the 
author Celsus (active 1st century AD) gives for incipient 
scabies 'agria' (the 'savage one') a salve consisting of zinc 
oxide, saffron, verdigris (probably a basic copper 
carbonate), white pepper and a preparation made from 
unripe grapes.9 Later, Galen of Pergamon (d. c. 200 AD), 
who is mostly remembered for his 'humours ' theory of 
medicine, is also credited with inventing possibly the first 
really effective (i.e. for actually softening and cleansing the 
skin) 'cold cream'. It consisted of an oil (usually olive oil), 
beeswax and rosewater. 11 Various herbal remedies were 
also used for treating the skin in the Roman time period, for 
example: as a treatment for psoriasis the froth of the 
(crushed) benies of the buckthorn (lycium) plant was 
applied to the skin. 11 
Mention should also be made of the Roman habit of 
bathing in, usually communal, bath houses. On the one 
hand such bathing would have reduced or removed skin 
parasites (e.g. scabies-inducing lice) and the oil later 
applied to the skin would have acted as an emollient and 
so aided 'dry skin' problems and other mild kin 
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conditions. However, on the other hand, as the bath water 
was often used by many people before being changed 
then cross-infections would have occurred, especially for 
someone bathing with an open wound or sore.3 
When the Dark Ages (c. 500 to 1000 AD) settled over 
Europe (here taken to be England and the western 
European countries) then the expansion, and even 
practice, of medicine declined significantly. There were a 
few 'lights' in the darkness; the monasteries largely 
retained their libraries and some continued to make 
copies of new documents brought by travelers; plus, most 
importantly, the West's medical ideas ( especially Galen's) 
had traveled east to Arabia. There they were modified, 
added to and recorded along with their own materia 
medica and also with medical information from India, 
Persia and even China. 
Arabian (skin) medicines included such herbal 
remedies as: Arctium Zappa (burdock) for eczema, 
Galium aparine (cleavers) for psoriasis and Aloe vera 
(aloe) for fungal infections and vitiligo. Also, mercurial 
ointments were used to treat scabies (probably first 
introduced by Rhazes, Muhammed ibn-Zakariya al-Razi, 
865 to 925 AD) and were also used to treat 'pox' 
(probably smallpox), 'itch' (probably scabies, though the 
word was used to cover almost all irritating skin 
conditions), impetigo and even leprosy (though this was 
sometimes confused with vitiligo) by Avicenna (Abu Ali 
al-Hussain ibn Sina, 980 to 1037 AD).12, 13, 14 
The path of the revival of medicine and its practice in 
Europe, from the end of the Dark Ages to the start of the 
Renaissance (c. 1300 AD), was tortuous, multi-stranded, 
slow and came largely from the east. First there were 
travellers from the east with (medical) manuscripts that 
were copied by the monasteries, and then more knowledge 
came with the returning Crusaders from the Holy Land in 
the 11th, 12th and 13th centuries. Also, the papal decree of 
1130 AD forbidding nuns and priest who had taken their 
vows from performing the 'distracting' practice of medicine 
meant that such practice passed into the hands oflay people. 
Thus were slowly established 'schools' (of medicine), 
public hospitals and the 'mind-set' to use this returning 
knowledge. 15 Even the dissolution of the monasteries in 
England (1536 to 1541), where some manuscripts were 
destroyed while others were given or sold into private hands 
and some became the core of later cathedral libraries, was 
not the major disaster it might have been as much 
information and manuscripts had already been dispersed 
out of the monasteries. 
Mercurial ointments for use against scabies had 
certainly come from Arabia to Europe by the beginning 
of the Renaissance, the most popular being 'Unguenturn 
Saracenicurn' ('Saracen's Ointment'). 16 Thus when 
syphilis (whose external skin symptoms could be similar 
to those of scabies) first became an epidemic in Europe in 
about 1495 AD such ointments were almost immediately 
used on its skin lesions and found t6 work as a cure for 
the disease. However, these ointments were not always 
used as first recommended; that is, gently, slowly and 
carefully. Thus much pain, and some deaths, resulted 
from mercury poisoning. 11 
Over the next few centuries, from the late Renaissance 
(i.e. c. 1500 to 1600 AD) to the start of the Victorian 
period (1837) via the Early Modem and Enlightenment 
periods, the various skin diseases were treated with both 
more readily accessible (i.e. English rather than Latin) 
herbal recipes18 and various 'heavy-metal' compounds 
(that is where the metal has a density of greater than 5 
glcm3; such as lead, mercury and arsenic ). 10, 16 There was 
also a slow general improvement in personal hygiene, and 
soap was increasingly available (though sometimes only 
used for washing clothes and household surfaces), which 
would have tended to reduce the incidence of some skin 
ailments. Additionally, in the late 18th century of England 
and Germany skin diseases were given a consistent 
scientific classification system, which in turn led to specific 
remedies being suggested for specific diseases. By the end 
of the first half of the 19th century there was the start of the 
new specialist medical discipline of dermatology.9 
The Victorian period and the first part of the 20th 
century saw both the old remedies (above) being used for 
skin ailments, and new ones based on organic chemistry 
(i.e. carbon-based compounds, either extracted from 
natural occurring materials or synthesised in a 
laboratory). By the 1880s and 1890s many such new 
compounds were being used/tried. For example, newly 
extracted coal tar ( as a salve) was being used for 
psoriasis, the recently patented 'Vaseline' (petrolatum/ 
petroleum jelly) was being used as an emollient, either by 
itself or mixed with other compounds, 19 and some anti-
pruritic lotions contained man-made (dilute) salicylic, 
carbolic, benzoic or hydrocyanic acids.9, 10, 20 
So, eventually, came the beginnings of modem 
antiseptics and antibacterial drugs in the early-to-mid 
20th century. Thus both the underlying disease and any 
Figure 1. The CJ Park Pharmacy shop-front in 1909. 
(© The Park Pharmacy Trust) 
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external skin manifestation could (usually) then be 
readily treated. 
Samples and Analytical Methods 
The two skin medicine samples ( one ointment, one 
cream) studied by us were originally on display in the 
'Merchant's House' and also at Thom Park Lodge (HQ 
of the Park Pharmacy Trust), both in Plymouth, UK.21 
They represented part of the final stock of the 'CJ Park 
Pharmacy' shop, which was owned and run (at No. 23 
Mutley Plain, Plymouth) by Mr Charles Armstrong Park 
(son of Mr Charles James Park), when it closed for the 
last time on the last day of December 1983. 
A Mr RA Saunders was the first to open a pharmacy at 
No. 1 Mutley Plain in 1864. Then this shop, with all its 
internal fittings, was sold to Mr C J Park and opened for 
business under his management in 1880. Around 1897 he 
moved the business to No. 12 (later re-numbered to 23) 
~utley Plain (see Figure 1; which shows the shop front 
m 1909 and where the fifth figure from the left, standing 
on the shop step, is Mr CJ Park). After his death in 1933 
the business was initially owned and run by his son (CA 
Park) and daughter Muriel; both, like their father were 
pharmacists. Later the business was solely own~ and 
~ by the so~, until its closure in December 1983 (see 
Figure 2; which shows the inside of the shop shortly 
before the final closure, with Mr C A Park and Dr Jan 
Knight, the latter looking at the pharmacy's oldest 
prescription books).22,23 
Figure 2. The inside of the CJ Park Pharmacy shop in 
December 1983. (© The Park Pharmacy Trust) 
One of the samples studied is labeled 'Eczema Ointment' 
(see Figure 3), and was designated byus as sample 'MIIl '. 
The actual ointment is a yellow-brown, fairly viscous solid, 
as expected for an ointment, 1 and has a slight smell of 
menthol, or perhaps eucalyptus. Unfortunately no 
~ufacturer's name could be seen on the (only partially 
legible) ~abel. What can be read is: 'An excellent remedy 
for ~ kinds of f:czema' and 'Directions. Apply a small 
quan~ty ~f the omtment two or three times daily.' The 
c:on~er 1s a screw-top collapsible tube probably made of 
tm with a pasted-on label. Just readable at the bottom of 
the label are the words: 'Always start squeezing from this 
end'. All of this suggests to us a first manufacturing date 
of c. 1895 (i.e. 1890 to 1900). 
. The other sample studied is labeled 'Emollia Cream' (see 
F1gure4), and was designated byusas sample 'MH2'. The 
actual cream is red-orange in colour, has no obvious smell 
and is not as viscous a solid as sample MH 1, as expected 
for a cream, 1 and was usually sold in small circular 
~~board tubs. It was reportedly made to a secret recipe, 
IIlltlally formulated by Mr C J Park and then continued to 
be made to the same recipe by his son for many years. 
Exactly when it was first made is W1clear, but we feel that 
the most likely date is c. 1885 (i.e. 1880 to 1890); that is 
within Mr C J Park's first ten years as a practising 
pharmacist in Plymouth. According to family history it was 
hi~y recommended for use for 'dry skin' problems, and 
possibly also for eczema Even after Mr CA Park had 
retired there were frequent requests for it from previous 
customers. 
Both samples were chemically characterised by Low 
Vacuum Scanning Electron Microscopy (L VSEM) and 
by X-Ray Powder Diffraction (XRPD). The former 
technique gives quantitative elemental composition, 
from both the usual 'area scans' (i.e. over a rectangle of 
200 to 400 µma side) and also by 'spot scans' (i.e. over a 
circular 'spot' of 2 to 3 µm in diameter). The latter 
technique gives semi-quantitative identification of the 
crystalline compounds present. 24 
Also, some 'wet chemistry' experiments were done on 
one sample (MH.2), and their details are given below. 
Results 
The LVSEM analytical results are given in decreasing 
order of weight percent of the elements present (with those 
in brackets being at less than I% each) from a 
representative 'area scan', with any additional 'spot scan' 
results being mentioned separately later. The XRPD results 
for the compounds found are listed in decreasing order of 
their (approx.) percentage presences and where these 
values are given after each compoW1d/group of compoW1ds. 
Sample MHl (see Figure 3) 
LVSEM: C, Pb, Hg (Cu, Cl, 0 , N, Si). 
XRPD: Major compounds: White lead [basic lead 
carbonate, 2PbC03.Pb(OH)2] and one (or more) 
amorphous compound(s) (80 to 90% overall); 
Minor compounds: Cerussite (lead carbonate, PbC03) 
and/or Plattnerite (lead dioxide, Pb02); Ammoniated 
Figure 3. The 'Eczema Figure 4. The 'Emollia Cream' Mercury (mercuric ammonium chloride, HgNH2CI) (5 to 
Ointment' sample (MIIl). sample (MH2). l0% each); 
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Small amount: (i.e. just above the detection/resolution 
limit of our instrument, taken to be 2%) compound 
Calomel (mercurous chloride, HgCI) (2 to 3%). 
Sample MH2 (see Figure 4) 
LVSEM: C, Pb, Hg (Cu, 0, Cl, Si). 
XRPD: Major compounds: Amorphous compounds 
and calomel (80 to 90% overall); 
Minor compounds: Sassolite (boric acid, H3B03) (10 
to 15%); 
(Probable) small amount compound: Litharge (red-
orange form of lead monoxide, PbO) (2 to 3%), where 
the uncertainty arises from there being several 
weak/overlapping peaks present that make its 
identification difficult/uncertain. 
There was also a small broad peak at about 2 degrees 
two-theta in its XRPD data, and a possible interpretation 
of it will be mentioned in the Discussion and Conclusions 
section. 
Later detailed LVSEM work, using 'spot scans', was 
done on both samples. Looking at mercury-rich regions 
showed, for both samples, Hg:Cl values of approx. 1: 1. 
The lead-rich regions of both showed the presence of Pb, 
C and 0 , though some of the carbon was very probably 
from the base material. When the base material was itself 
studied only carbon was found for both samples. 
Additionally, several 'wet chemistry' experiments 
were done on small amounts of sample MH2. To test for 
the possible presence of the (red) organic colourants 
alkanet (root) and cochineal some dilute sodium 
hydroxide and dilute hydrochloric acid were added 
separately to small amounts of the sample. Both of these 
colourants change colour with changing pH (to blue for 
alkanet root, for pH > 7; and to yellow for cochineal, for 
pH< 4). No such colour changes were observed. Also, to 
another small amount of the sample excess dilute 
hydrochloric acid was added and after light 
shaking/mixing the mixture was gently heated. If a 
carbonate was present then ( carbon dioxide) gas would 
have been observed when the acid was first added but 
none was observed. On gentle heating some gas may 
have been released. 
Discussion and Conclusions 
As only carbon was found, using the LVSEM technique 
on the base material regions of our two samples, then this 
shows that these base materials are petroleum products. 
Paraffin wax is one such product; it can be yellow in 
colour, is usually largely amorphous and is usually 
regarded as being a mixture of hydrocarbons. However, 
depending on its age and origin, it can contain a small 
amount of oxygen-containing molecules --- which can be 
difficult to 'see' using the above technique. 25 When used as 
an ointment base it was sometimes mixed with a little 
petroleum jelly (Vaseline) to reduce its viscosity and so 
improve its (skin) spreadability. Our MHl sample is 
described as an ointment, and given its relatively high 
viscosity then its base is taken to be (largely) paraffin wax. 
As petroleum jelly is much less viscous than the wax then 
it is suitable for use in creams, such as for our MH2 
sample. The jelly was sometimes mixed, to further reduce 
the cream's viscosity, with a little liquid paraffin. As 
already mentioned Vaseline was used both by itself (as a 
skin emollient) and for a variety of other skin problems 
when mixed with various 'active ingredients' .19 The 
jellyNaseline is also largely amorphous. 
Thus the yellow-brown colour of sample MIU couldbe 
solely caused by the paraffin wax used in its manufacture. 
However, there could also be a small amount of lead 
dioxide (Pb02), which is chocolate-brown in colour, 
present in the sample (see the previous Results section). 
Whilst lead carbonate would be expected to be present (as 
an impurity in white lead), the presence of several 
weak/overlapping XRPD peaks means that the lead 
dioxide could also be present. 
The proposed identity of the (amorphous) lead 
compound present in sample MH2 rests on several 
'indications', both chemical and historical. Our LVSEM 
'spot scan' results on the lead-rich regions in the sample 
shows that they contain lead, oxygen and carbon. From 
other recipes of skin remedies of the time period (i.e. late 
19th and early 20th centuries) this result then suggests the 
presence of one of the following compounds: lead 
acetate/sub-acetate (i.e. the basic form of the acetate), basic 
lead carbonate/lead carbonate and a lead plaster (here 
taken to be impure lead oleate, see below).26,27,28 As no gas 
( carbon dioxide) was evolved when room-temperature 
dilute hydrochloric acid was added to the sample then the 
presence of a carbonate can be ruled out. Also, as the 
sample exhibited none of the expected physical properties 
( e.g. efflorescence, crystallinity) of an acetate/sub-acetate 
then it can probably also be ruled out. This leaves the lead 
plaster (sometimes: emplastrum plumbi, lead plaster-
mass, lead soap, Diachylon plaster-mass, Diachylon). It 
was first made by heating a mixture of olive oil, water and 
litharge. 1, 29 Later this recipe was modified by dilu~on 
with more olive oil or with the newly discovered Vaseline. 
Other ( often lead) compounds, in small amounts, would 
sometimes be added.3o, 31 However, the main chemical 
ingredient of the final plaster would nearly alway~ be 
(impure) lead oleate. This compound, even if only partially 
or slightly crystalline, should have an observable XRP~ 
peak at about two degrees two-theta,32 which in fact IS 
seen. Also, the sample's red-orange colour could ~ily be 
achieved by adding a slight excess of litharge ~unn,g the 
making of the lead plaster ( and as the 'wet chermstry tests 
for the two most likely red organic colourants gave 
negative results). Additionally, a (lead) soap would_ ~et as 
a suitable emulsifying agent in the making and stability of 
acream.1 
Lead plasters have been used for centuries to treat 
bruises, sores and ulcers.33 They were also so used, an_d to 
treat skin diseases such as eczema, in later time penods 
and even on into the 20th century.27· 31 However, 1~ 
poisoning most likely did sometimes occur, especially if 
the plaster covered the skin for some time. Even now, lead 
poisoning does occur from the long-term use of a 
'Diachylon ointment'. 34 . . 
White lead has been used as a face cosmetic, to gi~e 
'pale allure', for centuries. It has also been used for ~kin 
remedies because of its known astringent action. 
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Unfortunately lead poisoning can occur from excessive 
usage.28,31 ,35 
The two mercury-containing compounds, amrnoniated 
mercury and calomel, found in our samples also have a 
history of being used to treat various skin diseases ( e.g. 
eczema and psoriasis). 10• 27• 36 They do have antiseptic 
properties, but are not now used because of the danger of 
mercury poisoning, which unfortunately does still 
sometimes occur. 36• 37• 38 
Boric acid was used in skin medicines as an antiseptic, 
antifungal and as a preservative until it was recognised 
(in about the rnid.-20th century) as being toxic ifused in 
excess. 26• 39 
Thus the two skin medicines studied here, one 
ointment and one cream, have both been found to contain 
lead and mercury compounds. For the 'Eczema 
Ointment' (MII1) sample they are primarily white lead 
and amrnoniated mercury, with smaller amounts of lead 
carbonate and/or lead dioxide and calomel. For the 
'Emollia cream' (MH2) sample they are primarily (very 
probably) a lead plaster (i.e. impure, and largely 
amorphous, lead oleate) and calomel, with a smaller 
amount of boric acid; its red-orange colour is most likely 
given by a just detectable small amount of litharge. 
Whilst there is still some uncertainty about the identity of 
the amorphous lead compound present in this sample, we 
feel that the various 'indications" mentioned previously 
do strongly point to it being a lead soap/plaster. The base 
materials used in both samples are petroleum products; 
for MHl it is mostly or entirely paraffin wax (possibly 
mixed with a small amount of petroleum jelly), and for 
MH2 it is mostly or entirely paraffin jelly (Vaseline; 
possibly mixed with a small amount ofliquid paraffin). 
Both samples were very probably first made in the late 
19th century, and were then made to the same recipes for 
the pharmacy's customers for many subsequent decades. 
However, in the present day such medicines, regardless of 
whether they actually were efficacious, would not be 
approved for use owing to their lead and mercury content. 
So, whilst abrasive winds and the proverbial 'itch' need no 
longer threaten as they once did, these two medicines can 
no longer be used as they now threaten. 
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A History of the Barbiturates: The 
Lure, the Controversy, the Poison 
Timothy Peplow MBBS BSc 
Imperial College, London 
How did a drug once so lauded for its safety become a 
component of the modem-day lethal injection? The 
history of the barbiturates is brimming with controversy, 
debate and intrigue, and this article follows the early 
turbulent course of the barbiturates, from their rise as the 
saintly 'harmless hypnotic in 1904 through to the court 
cases and high profile suicides, controversial animal 
trials, and a blazing debate over the pages of two British 
medical journals on the safety of this so-called 'bottled 
death'. The history of the barbiturates between the 1920s 
and 1960s is detailed in existing articles, and thus we 
know how the barbiturates came to be used in epilepsy 
and anaesthesia. This article aims to address the deficit in 
the history of the earlier years of the barbiturates, from 
their introduction in 1903 through to the labelling of 
barbiturates as prescription-only in 1935. 
Physicians in the early 20th century did not meet with 
consensus regarding their views on the safety of the 
b'.11"biturates. This disagreement resulted from, in part, 
differences in the specialisation and thus experiences of 
those who took part in the debate. It could be said that the 
high prevalence of barbiturate use was due to a collective 
view that these drugs provided easily accessible and 
harmless relief from the dreaded condition of insomnia. 
It was the opinion of others, however, that such 
indiscriminate use would lessen the willpower and moral 
integrity of the person, entering them into a destructive 
and inescapable habit. 
Introduction 
The therapeutic uses of the barbiturates in the present day 
ar~ mainly restricted to the treatment of certain types of 
~pilepsy, emergency treatment of convulsions, and as 
mtravenous inducers of anaesthesia. Pentobarbitone is 
used for human and veterinary euthanasia, and is a 
com~onent of the lethal injection. The dangers of 
barbiturate use are apparent to many medical 
professionals, owing to a large number of reports on their 
dangers and abuse as recreational drugs since the 1950s. 
The history of the barbiturates between the 1920s and 
1960s is detailed in existing articles, and thus we know 
how the barbiturates came to be used in epilepsy and 
'.11"1aesthesia. 1-3 These sources are published in clinical 
Journals, and document the clinical features and chemical 
structures of the various barbiturate drugs. There has, to 
~e author's knowledge, been no previous detailed 
his~ory of the earlier years of the barbiturates, a period 
which encompasses the introduction of Veronal 
[bar~itone] as a sleeping aid in 1903, the labelling of 
barbiturates as poison and prescription-only, and the 
debates over the safety of this class of drugs. 
In this article I aim to address this deficit by answering 
whether physicians in the early 20th century met with 
consensus regarding their views on the safety of the 
barbiturates, and determiriing why physicians argued for 
~d against the regulation of barbiturates as a poison. I 
aun to answer why people used barbiturates with such 
frequency in the early 20th century and what effect the 
indiscriminate use of barbiturates had on society. I also 
aim to assess whether the fact that all barbiturates were 
classified as poisons in 1935 had any effect on their 
prevalence of use. It is important to examine the answers 
to these questions because they may be translated onto 
the issues, which include safety and addiction, 
surrounding controversial drugs of the modern age. 
Veronal as Hypnotic 
Barbituric acid, from which the barbiturates are derived, 
was first synthesised in Germany in 1864 by Adolf von 
Baeyer4. Barbituric acid, however, had no 
pharmacological action of its own. Verona! (also known 
as barbitone, barbital, or diethyl-malonylurea) was 
introduced into the UK by German manufacturer Bayer 
in 1903. It was the first barbiturate to be used 
therapeutically. Verona) appears in Squire :S Pocket 
Companion, a manual of the British Pharmacopeia, in 
1904, and is described as a hypnotic that can be used in 
neurasthenic insomnia as well as sleeplessness following 
mild pain. 5 The dose suggested is 5 to 20 grains. 6 Verona! 
appears again in the British Pharmaceutical Codex 
1907. 7 It is described as a hypnotic said to act only upon 
the central nervous system, found especially suitable for 
use in insomnia associated with cardiac disease. The dose 
recommended is 5 to 15 grains.8 Neither text, however, 
gives any mention of Veronal poisoning. 
The British Pharmaceutical Codex 1911 also 
documents the use ofVeronal in nervous insomnia.9 The 
1911 edition, however, highlights that poisonous 
symptoms have been noticed even with doses of 10 
grains. The Codex also gives details on administering 
strychnine, a stimulant, in the event ofVeronal poisoning. 
However, this possibility of poisoning was not 
recognised by the manufacturers when they introduced 
the drug in 1903. Verona! was marketed as a safe and 
reliable alternative to the current sleep-inducing drugs of 
the time, which included the bromides, a class of 
soporifics with a series of problems relating to high 
toxicity, long half-life and the capacity to accumulate in 
tissue. 1 A Gennan advert for Verona) from 19049a ) 
promoted Verona! as a new hypnotic drug that can be 
used reliably and without unpleasant side effects to treat 
insomnia, depression and anxiety. The safety of Verona! 
was also promoted in the medical press in Britain, which 
during this period was aflame with glowing reviews of 
the new hypnotic. The British Medical Journal (BMJ) 
wrote in 1903 that no unpleasant side-effects with 
Verona! had been noted and that it should be introduced 
into clinical practice. 10 
Thomas Watt, a physician, praised the safety of 
Verona! in a letter to the BMJ in 1904:11 
I have taken it frequently myself, and from my experience 
with myself and the patients I have come to regard it as the 
safest and surest, and in every way most satisfactory, 
hypnotic I have ever met. 
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Later in 1904, however, an anonymous letter to the 
BMJ entitled 'Verona!: A Warning' aimed to caution 
those doctors who employed the hypnotic. 12 The author 
warned that Verona), although a good hypnotic, took time 
to act and seemed to have a cumulative action 13. 
A year later in 1905, Kress, a German physician, 
introduced the concept of veronalism to the BMJ. 14 Kress 
wrote that the cumulative action of Verona! had been met 
with by many clinicians, and that Veronal can have many 
unpleasant or dangerous actions: 
Among the symptoms which it has produced are sickness and 
delirium, rash, giddiness, headaches, sweating, collapse, 
motor restlessness, orthotonos and titanic twitching, 
cumulative action and prolonged sleeplessness, comatose 
condition. 
Kress recommended others to be careful in prescribing 
Veronal, and to be content with the smallest possible 
doses. 
In the BMJ (1909), a court case of suicide by Veronal 
overdose is discussed. A medical witness to the case 
stated that the tablets were prepared in seductive form 
and were on sale without restriction by chemists, and the 
public seemed to think that they could take any number 
of them with safety. 15 
These reports of death from Veronal overdose 
extended from the medical press into the public sphere. 
In November 1909, the Daily Express newspaper carried 
an article entitled 'Verona! Dangers' which, in response 
to the death of a barrister due to an overdose of Verona!, 
quoted a doctor who said: 
[Veronal] is obviously a more dangerous drug than was at 
one time supposed. I think it should only be sold on a doctor's 
prescription. 
The article also quoted a chemist, who said: ''The sale of 
Veronal is largely on the increase. I am sorry to say there 
are no restrictions on the sale". The coroner of the case 
observed: "These cases are becoming very familiar. 
People should be prevented from obtaining this drug 
except under very great restrictions.''16 
These concerns were echoed three years later in a 
Daily Express article (January 1912), again on a death 
involving Verona!. The article quoted the coroner of the 
case, who noted that "[Veronal] is becoming a very 
serious danger to the public." The coroner added that "it 
has been shown conclusively that it is not a drug which 
people ought to obtain so easily" and "a great 
responsibility rests on those chemists who do a roaring 
trade in it."17 
The Daily Express wrote in 1913, under the headline 
'The Warning ofVeronal Tragedies':18 
There are many people nowadays driven almost to distraction 
by nervousness [ . . . ] and in particular by sleeplessness, who 
tum in desperation to some dangerous drug such as Verona!, 
to pull them through a more than usually trying period. The 
second dose is taken easily - then the third and fourth, and 
before the victim realises the fact he or she is a slave to the 
drug. 
By the end of 1913, Verona! had taken hold as the new 
fashionable drug to take. It could be seen that the taking 
of Verona! resulted in moral corruption of an individual 
and was thus an indication of the moral breakdown of 
society. Insomnia was feared, and Verona! was the cure. 
'Verona! is the new thing and the old poison', said the 
Daily Express. 19 A pill that could so easily be taken to 
send a person to sleep and forget his troubles was 'like 
nectar straight from high Heaven, a blessed antidote, a 
sweet release'. However, as the Daily Express warned, 
'first a little, then more, is the inexorable rule,' until 'the 
wreck of what was once a man's free will be destroyed, 
brain power atrophied, knows no law but that of the 
craving which must be satisfied at any cost.' 
Since the Pharmacy and Poisons Act 1868, the [Royal] 
Pharmaceutical Society of Great Britain had the power to 
deem a substance a poison, subject to approval by the 
Privy CounciF0• Henceforth, in order for a pharmacist to 
qualify and be able to dispense a scheduled poison, such 
as arsenic, they had to pass exams set by the 
Pharmaceutical Society to become either a Chemist and 
Druggist or a Pharmaceutical Chemist. 
An unsuccessful attempt to add Verona! to the Poisons 
Schedule was made in 1912, whereby a resolution was 
given to the Privy Council by the Council of the 
Pharmaceutical Society to add di-ethyl barbituric acid to 
Part II of the Poisons Schedule. However, this did not 
mete with approval by the Lords of the Privy Council.21 
The reasons for this initial disapproval by the Lords of 
the Council are not obvious. However, Sir William Glyn-
Jones, secretary of the Pharmaceutical Society, wrot~ in 
1926 that every occasion of pharmaceutical legislation 
since 1851 has been a matter of compromise between 
conflicting interests.22 On the one hand, some believed 
that to ensure public welfare, those men who dispensed 
and supplied poisonous substances should be properly 
trained and certified. On the other hand, other persons 
believed that this would simply create an undes~ble 
monopoly for the trained pharmacists, and ~echarucal 
precautions such as poison cupboards should mste~d ~e 
taken. Further difficulties in such matters can lie Ill 
balancing the responsibility of the state with the liberty of 
the individual. 
Veronal as Poison 
A mysterious case of poisoning by Vero~al overdose 
created a large amount of public interest Ill 1913. !he 
mystery surrounded the death of Hugh Eric Trevaruon, 
aged 27, a relative of the Earl of Strathmore and Lord 
Northland. . b 
Six weeks prior to the death of Mr Trevaruon Y 
Verona! overdose he had moved in with a friend named 
Mr Albert Roe. Mr Trevanion had been taking Verona! to 
treat insomnia for the past six years.23 A post-mort~m 
examination showed that on this occasion Mr Trevaruon 
had taken at least 150 grains [9.8g]. The inquestwas_h~dld 
· . d Cl e to question whether Mr Trevaruon had committe sw 
or whether he was murdered by his friend Mr Albert R~e, 
. ft hi ore to whom Mr Trevanion had prev10usly le s en 
fortune in his will. . . 
The Hove case created much public interest, achieV!Ilg 
a lot of publicity in both the national press and ~e 
medical press, a point noted by an article in the Chemist 
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and Drnggist. 24 The Times and the Daily Express both 
carried numerous articles giving information on the 
inquest, and the case even gained international interest 
with the New York Times carrying an article on February 
2nd 1913 about the case, entitled 'Poison Killed Earl's 
Relative. '25 
In response to the suicide of Mr Trevanion and other 
cases of suicide/accidental death by Veronal overdose, 
the jury added a rider to the effect that Veronal and allied 
substances should be placed on the Poisons Schedule, 
and should only be available on prescription by a medical 
professional. 26 
An editorial article in the BMJ wrote that the death of 
Mr. Trevanion was important in highlighting some 
important features of Veronal poisoning, namely ataxia, 
hallucinations and tremor.27 This article holds 
significance as an indication of broadening definitions of 
harm, as it identified side effects apart from death that 
occurred with Veronal poisoning. The same article stated 
that it was a matter of urgent importance to protect the 
public against themselves by restricting the freedom with 
which Veronal, which was introduced by German 
chemists as a 'harmless hypnotic', could be bought from 
a pharmacist. This article therefore held the view that the 
increasing prevalence of barbiturate use was due to the 
public, through ignorance of medical matters, purchasing 
and self-dosing barbiturates rather than over-prescription 
by the medical profession. 
The claims made in this editorial were not without a 
defensive response from the pharmaceutical industry. 
Bayer argued that they had never claimed Veronal to be a 
'harmless hypnotic', but maintained that they had said 
Veronal was 'relatively harmless in therapeutic doses'. 
They did, however, concede that it was very potent and 
had 'untoward effects' when used indiscrirninately.28 
The high profile Trevanion inquest and the jury's rider 
added impetus to a second proposal in 1913 to add 
Veronal to the Poisons Schedule, and the Lords of the 
Council were thus compelled to pass this second 
resolution.21 From April 12th 1913, all derivatives of 
barbituric acid were placed on Part II of the Poisons 
Schedule, and deemed poisons within the meaning of the 
Pharmacy Act 1868, as amended by the Poisons and 
Pharmacy Act 1908. This meant that Veronal tablets were 
now subject to the following restrictions: 
• They can only be dispensed or sold by retail by a qualified 
pharmacist and 
• When sold by retail they must be labelled with the name of 
the article, the word 'poison', and the name and address of the 
seller 
However, these new regulations still placed no 
restrictions on members of the public buying Veronal 
without prescription. For some in the medical profession, 
such as Sir William Willcox, these new regulations on 
barbiturates were still not enough. 
Veronal as a Prescription-Only Drug? 
Sir William Willcox (1870--1941), a toxicologist and 
medical adviser to the Home Office, had supported the 
attempted resolution in 1912 through personal 
correspondence to the Privy Council.29 He also appeared 
as a Home Office expert in the Trevanion inquest in 
1913. After the inquest, Willcox wrote a paper in the 
Lancet on Veronal poisoning, stating that the average 
minimum fatal dose ofVeronal could be regarded as 50 
grains [3.25g] of Veronal although cases of death had 
been reported with doses as small as 10 grains [650mg]. 
Willcox quoted the figures of the Registrar-General for 
deaths from Veronal poisoning occurring in England and 
Wales as being 13 in 1909, and 15 in 1910, but stated that 
the actual number of cases might be higher than the 
statistics showed.Jo 
A report of a meeting of the Section of Therapeutics 
and Pharmacology of the Royal Society of Medicine 
appeared in the BMJ in 1927.31 Willcox spoke about the 
effects of acute barbiturate poisoning, which were 
headache, vertigo and ataxia, followed by a deep sleep 
after which the patient might die from a sudden 
development of massive pneumonia. Willcox also 
expanded on the category of chronic effects of barbiturate 
use, stating that, from his experience, patients who took 
Veronal every night were liable to show moral changes, 
become delusional and depressed, and develop suicidal 
tendencies. Dr FA Pickworth, a physician and researcher 
into mental disease at Hollymoor laboratory in 
Birmingham, gave animal experimental evidence to 
prove Willcox's theory that the continued use of 
barbiturate drugs would cause definite pathological 
changes within the central nervous system. 
At the meeting, Willcox warned that the barbiturates 
should only be given by prescription, marked 'not to be 
repeated' and the total number of doses ordered should 
not exceed six. Willcox also warned that the 'widely 
circulated advertisements' for barbiturates 'frequently 
recommended the drugs for continued administration 
without calling attention to the toxic effects which might 
result from their use.' . An advert for Veramon (which 
contained barbitone) and Medinal (barbitone sodium) by 
Schering Co, circa 1925, stated that Medinal is a 'safe 
and non-habit forming hypnotic'. Willcox also asserted 
that addiction to barbiturates did occur due to careless 
administration. 
Sir Maurice Craig (1866-1935), a consultant 
psychiatrist, stated his disagreement with Sir William 
Willcox in a letter to the BMJ in I 927, a move that would 
begin a series of increasingly heated exchanges, later to 
become known as the 'Battle of the Barbiturates ' .32 In 
Craig's experience, sleeplessness was not a symptom but 
one of the most common causes of mental disturbance. 
Craig's practice, for the past twelve years, had been to 
administer the smallest possible dose of Medina! every 
night for up to a year, until the mental health of the patient 
had been restored. Craig wrote:32 
I have never known any bad results from the effect of the 
drugs. On the contrary, I have known many persons saved 
from serious mental breakdown and preserved in mind and 
body to continue their several occupations [ .. . ] As to 
addiction, from my own experience and from any evidence 
that I have been able to obtain from other medical men, this is 
practically non-existent. 
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Craig vehemently opposed any attempt to label the 
barbiturate drugs as dangerous because, in his clinical 
experience, this would have been entirely without 
justification. Craig continued to argue that to label a drug 
as dangerous would discourage a doctor from using these 
drugs that Craig so adamantly believed were of great use. 
Furthermore, if a nervous patient were warned that the 
drug they were due to take was dangerous, this would 
worsen the anxiety of the patient and thus counteract the 
ability of the drug to relieve their insomnia. 
Sir William Willcox replied to Craig in a letter to the 
BMJ, writing that according to the Registrar-General for 
England and Wales there had been 253 deaths from 
poisoning by barbiturates between 1906 and 1925 
inclusive33. Willcox went further to say these figures may 
be far lower than actual, due to some Verona! deaths 
being labelled as deaths due to narcotic poisoning or 
pneumonia. Willcox used evidence from other clinicians' 
experiences to stress that there was often clear evidence 
of addiction to the drug, arguing that Craig had simply 
not yet witnessed addiction to Verona! in his patients 
because addiction was only discovered when the drug 
was withheld. 
Other physicians argued alongside Craig to maintain 
that barbiturates should not be classed as dangerous. 
Lionel Weatherly, a psychiatrist, had never witnessed a 
case of 'drug habit' with barbiturate drug use, and 
implored other alienists to come forward to 'help all 
those who believe sleep and relief from mental pain are 
necessities'. 34 William Stuart-Low, a surgeon, argued that 
Medina! had been indispensable for patients with 
sleeplessness from nasal obstruction, and had never seen 
any marked addiction to Medina! when used over long 
periods35. Robert Gillespie, an eminent psychiatrist, 
claimed that Dr Pickworth's animal trials, used as 
evidence by Willcox, were flawed, as36 
• Cats were unsuitable subjects, as the barbiturates do not 
induce sleep in cats 
• The doses given to the cats were disproportionately large to 
those given to man 
• The animals were not allowed to recover before they were 
killed and observed for histological change. 
Craig felt the emphasis Willcox had laid upon the 
danger of the barbiturates was jeopardising their great 
therapeutic value, and argued that the cases of suicide 
that had been quoted by Willcox could not be proven to 
have been due to depression induced by prolonged 
Verona! use. Craig asserted that it was the sleeplessness 
(for which the patients were taking Verona!) that had 
caused depression that led to suicide, rather than the 
effect of taking Verona! itself. Like Gillespie, Craig 
seriously questioned the nature of evidence obtained 
from animal trials and whether such evidence could be 
extrapolated into clinical practice, while continuing to 
deny the existence of any cases of Verona! addiction. 37 
The debate between Craig and Willcox over the safety 
of the barbiturates then disappeared from the BMJ, but 
ignited once again in the Lancet in 1934. Craig still 
maintained the non-existence of barbiturate addiction, 
with the exception of a few individuals who were 
generally susceptible to addiction. He argued that 
subjecting these drugs to further restrictions would only 
make the patient fearful of treatment and distract them 
from following the advice of their physician. 38 
William Stoddart, a psychiatrist, stated that the 
confusion had resulted from a failure to identify the 
precise meaning of 'addiction', leading to a 
misunderstanding between an 'addict' and someone who 
was simply in the 'habit' of taking a hypnotic every 
night. 39 Willcox still maintained his position on arguing 
for further restrictions to be placed on barbiturates, and 
was supported by Sir James Purves-Stewart, a 
neurologist, who described syndromes of mesencephalic, 
cerebellar, and spinal paralyses resulting from repeated 
therapeutic doses ofbarbiturates.40,41 
In the same 1934 issue of the Lancet, Gillespie set out 
to determine the possible dangers of the barbiturate drugs 
and to definitively state whether there was any possible 
relationship between therapeutic dose and lethal effect.42 
Gillespie concluded from surveying all records of 
barbiturate-related death in medical literature that, up to 
the end of 1932, there was no case on record in which 
barbiturates given in therapeutic doses had caused death 
in the absence of complicating factors. Gillespie also 
quoted the Registrar-General's statistics for 1931, to 
show that there were only 13 cases of suicide by 
barbiturates in that year, 0.26% of all suicides, and 20 
suicides from barbiturates in 1932. Indeed, the 1931 
Registrar-General statistics showed that barbituric acid 
came eighth out of a list of 12 types of poisonous agent 
used for suicide. Willcox, however, stated that these 
Registrar-General figures for fatal poisoning expressed 
only a fraction of cases of dangerous poisoning from the 
barbituric acid derivatives, since a large number of 
patients were saved by medical treatment. 43 . 
The debate between Willcox and Craig was a conflict 
between two leading figures in different fields. As an 
expert toxicologist, Willcox defined harm in terms_ of 
pathological changes to the body. During his time acting 
as a medical witness in criminal cases, Willcox would 
have observed many deaths caused by barbiturat~ 
overdose, and would have been exposed to the coron~rs 
repeated exasperations over the ease at which 
barbiturates could be purchased. Craig on the other hand, 
as an expert physician, defined harm in terms of what he 
saw in his clinical experience. If Craig saw no harm from 
barbiturates in his clinic in terms of symptoms, then he 
would assert that the barbiturates were safe to ~e. 
Perhaps Craig's reluctance to accept Willcox's beliefs 
laid in Craig's unwillingness to be supplanted from 
authority in a field in which Willcox was not a part · 
Outside of the pages of the ~edical pr~ss, soI?~ 
authors of medical textbooks held vtews cons1sten_t w! 
those of Craig. Hugh Crichton-Miller, a i:isychialrl! 
wrote that Verona! craving was merely ~ven by 
intense desire for sleep and a fear of insomma.44 
New Barbiturates New Indications . 
' · · di nons In the meantime new barbiturates with new Ill ea 
had been develo~ed. Phenobarbitone, for which the trade 
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name was Lurninal, was discovered in 1912.45 Alfred 
Hauptmann had, by chance, found phenobarbitone 
capable of preventing epileptic seizures, and regarded 
phenobarbitone as free from harmful side-effects even 
when used continuously over several months. Jn 1921, 
Golla concluded in a landmark paper that phenobarbitone 
treatment was superior to the existing bromide treatment 
and that there were no cases of formation of drug habit 
with the drug.46 Chronic phenobarbitone therapy was 
from then on seen as the most appropriate treatment for 
epilepsy, and so was a fertile testing ground for Willcox's 
ongoing theory that mental derangement occurred with 
chronic barbiturate use. 
In 1934, Richard Handley, the director of the David 
Lewis Epileptic Colony in Cheshire, wrote on the use of 
the barbiturates in epilepsy.47 Handley acknowledged the 
dangers of acute barbiturate poisoning and, as a 
precautionary measure, would not prescribe more than 
eight days' medicine at a time, since even if the whole 
eight days dose were taken at once, this would be merely 
a soporific dose. However, Handley openly denied the 
beliefs of Sir William Willcox that chronic barbiturate 
use would cause definite degenerative changes within the 
central nervous system and lead to mental disorders such 
as depression. Despite the large amounts of 
phenobarbitone prescribed, he had seen no single cases 
of addiction. Handley wrote that he could quote many 
cases of colonists who, after ten or more years of regular 
phenobarbitone dosage, showed no such degenerative 
changes, concluding: 
One must believe that if any degenerative change occurs in 
such a case it is not produced by the phenobarbitone, but by 
the disease itself or by some other treatment. 
Handley therefore acknowledged the dangers of acute 
barbiturate poisoning, but discounted any claims that 
addiction or chronic poisoning could occur in barbiturate 
treatment for epilepsy. 
The manufacture of barbiturate drugs, in time, became 
no longer limited to German pharmaceutical companies. 
When America entered the war in 1917, Congress passed 
the Trading with the Enemy Act which allowed 
American companies such as Abbott Laboratories to 
produce the German barbiturates.48 By 1922, the volume 
of business had never been greater for the company, with 
their biggest selling item being Verona!. 
Nembutal (pentobarbitone) was later developed as a 
basal anaesthetic by Abbott Laboratories in 1930.48 Cecil 
~owntree, a London surgeon, wrote in 1932 that the 
mtroduction of the intravenous injection of Pemocton or 
Nembutal was the greatest advance in the practice of 
anaesthetics during his professional life. 49 
Sir William Willcox spoke at a meeting of the Medical 
Society of London in 1931 to discuss the use of 
barbiturates in anaesthesia from a toxicological point of 
view.50 Willcox said that while Nembutal was indeed a 
quickly acting barbituric acid compound with an effect 
that was more transient that others of this group, great 
caution must still be taken in its use and dosage. 
The thiobarbiturates, introduced in 1935 by Abbott 
Laboratories, rapidly displaced the older barbiturates 
such as Nembutal for use in anaesthesia, due to their very 
short onset of action. 1•3 During the time period when it 
was employed in anaesthesia, Nembutal was not deemed 
dangerous if used in skilled hands. Indeed, Willcox 
himself believed that basal anaesthetics, when used as an 
adjuvant to general anaesthesia, were a useful addition to 
modem therapeutics. 51 Goodman and Gilman wrote that 
accidental poisoning may occur when the barbiturates 
were used for intravenous anaesthesia by a person not 
sufficiently experienced. s2 
However, while these landmark discoveries of 
barbiturate applicability in epilepsy and anaesthesia were 
occurring, the danger of barbiturate use in insomnia was 
becoming more evident year by year. Articles that 
reported on cases of suicide and commented on the 
dangers ofVeronal continued to appear in newspapers. In 
1935, the Daily Express described barbiturates as 'the 
easy bottled death that anyone can buy'.53 Another 
headline in the Daily Express read 'Death sold over the 
counter - Another Victim', with the article stating:54 
The toll of human life claimed by baibiturate drugs mounts higher 
[ .. . ] Although the customer is supposed to be known to the 
chemist, Daily Express representatives have proved by personal 
purchases that some chemists are willing to 'know' anyone. 
An opinion column in the Daily Express, with 
reference to the sale of Verona!, read 'If you peddled 
loaded revolvers like that to unhappy people, temporarily 
despairing, there would be trouble. •ss 
The Chemist and Druggist, in the interests of 
pharmacists, attacked such newspaper articles, writing 
that such exaggerations by ignorant stunt journalists 
would lead to the passing of more unnecessary acts like 
the Dangerous Drugs Act. 56 
Against a background of medical press dissent and 
national press indignation towards the barbiturates, the 
Poisons Board became inclined to resolve the situation. 
As such, in May 1935, barbituric acid and its derivatives 
were included in the Fourth Schedule of the Pharmacy 
and Poisons Act 1933. The barbiturate drugs were 
therefore to be supplied to the public only on presentation 
of a prescription written by a medical practitioner. 57 
Further Discussion 
Sir William Willcox's campaign had finally culminated 
in the barbiturates becoming prescription-only drugs in 
1935, twenty-three years after he first announced their 
dangers in the BMJ. However, these new restrictions on 
barbiturates did not have quite the effect that Willcox and 
other proponents had hoped. Barbiturate use and abuse 
still continued in the UK, and by 1952 barbiturate 
overdose with suicidal intent had become so common 
that a classification system was put in place in the 
emergency services.58 Demand for barbiturates had risen, 
and the manufacture of barbiturates in Great Britain 
expanded rapidly. By 1950, the output of barbiturate 
drugs was four times that of 1938.59 
Many physicians, not fully understanding the dangers 
of the barbiturates, would freely prescribe them to 
patients.6() Patients could also order barbiturates without 
prescription from Ireland, where there were no 
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regulations governing barbiturate purchase.61 In the 
month of September 1949, 9.4% of prescriptions under 
the National Health Service were for barbiturates, and 
prescribing physicians could be easily misled by the large 
number of adverts promoting the safety of barbiturate 
drugs.60 While many new barbiturate drugs had been 
developed over the years, the advantages of the new 
barbiturates over the older ones were unconvincing. 62 
Pharmacology textbooks still denied the dangerous 
and addictive potential of the barbiturates, with 
Goodman and Gilman writing in 1941 that 'addiction to 
the barbiturates, in the strictest sense of the word, 
probably does not occur' _63 
The barbiturates eventually fell from use in insomnia 
in the 1960s after the introduction of the 
benzodiazepines. By this time, the evidence for 
barbiturate addiction and causation of mental 
degeneration had mounted beyond dispute. In 1961, 
Harry Beckman, author of Pharmacology: The Nature, 
Action and Use of Drugs, wrote that 'the taking of 
barbiturates for hypnotic or sedative purposes is a much 
abused thing which can easily lead to serious addiction' 
- a stark contrast to the writings of Craig and others who 
had earlier denied the existence of addiction. 64 
Barbiturates were slow to be realised as drugs of 
addiction due to years of confusion between the 
definitions of addiction, habituation, tolerance and 
dependence.65 As Willcox had warned Craig, withdrawal 
symptoms were rarely identified in patients because the 
barbiturates were prescribed for long periods in 
individual patients, and if symptoms of withdrawal did 
occur they were mistaken for the recurrence of the 
condition the barbiturates were used to treat. 
This article can thus complement the existing literature 
on the history of the barbiturates to show that controversy 
was inextricably intertwined with the landmark 
developments of barbiturate use in epilepsy and 
anaesthesia. A point for further discussion could be to 
determine the extent to which the pharmaceutical 
companies, the medical professionals, pharmacists, the 
government, and the public themselves were responsible 
for the indiscriminate use of barbiturates before 1935, 
and to what extent the poison regulations in 1935 altered 
the responsibility of these parties. 
Conclusion 
In conclusion, physicians in the early 20th century had 
differing views on the safety and potential for addiction 
of the barbiturates. The controversy surrounding 
barbiturates resulted, in part, from a difference in 
personal experience and profession. A toxicologist such 
as Sir William Willcox, exposed to the harsh realities of 
barbiturate-induced suicide in the courtroom, had 
contrasting views to a psychiatrist such as Sir Maurice 
Craig, to whom barbiturate addiction was not visible as 
he, in his clinical experience, had not yet witnessed 
withdrawal in his patients. Craig also placed too much 
conviction in the therapeutic value of the barbiturates to 
let them be subjected to regulations that would, in his 
opinion, negate their remedial effect. 
From the opinions held in newspaper sources, it can be 
seen that barbiturate use was high, as they were relished 
as a quick and easy remedy to sleeplessness caused by 
the stresses of life, but barbiturates did not treat the 
underlying mental cause. As the newspapers realised, 
however, such indiscriminate use would lessen the 
willpower and moral integrity of the person, entering 
them into a destructive and inescapable habit. The fact 
that all barbiturates were classed as poisons and became 
prescription-only had little effect on their prevalence of 
use post-1935. Before 1935, Willcox had campaigned to 
protect the public from themselves, but after 1935 the 
responsibility of such indiscriminate barbiturate use 
could surely only rest in the hands of the medical 
profession who prescribed them. 
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Book Review 
An 18th Century Physician's Handbook. 
Edited by Cockayne, EE and Stow, NJG. 
Published by the Editors and the Suffolk Medical History 
Society, 2012. Pp161. ISBN 978-0-9573248-0-0. Price 
£17.50 
Dr Edward Cockayne (retired General Practitioner) and Mr 
Noel Stowe (retired pharmacist) have transcribed an 18th 
centmy doctor's notebook. The author is unknown but the 
editors believe him to be William Bohun (1681-1743), a 
physician livin in Beccles. The editors also believe that the 
An 18th Century 
Physician's Handbook 
Edited by : 
E.E. Cockayne:. DIMSA 
6'N.J.G. Stow, ffill,....S 
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notebook was written as a preparation for a textbook as one of 
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the book: 'The Rationale of the Symptoms or Appearances in 
the Morbic State of a Humane Body considered mechanically 
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Medical equipment taken on 
expeditions during the heroic age of 
Antarctic exploration: Sledging 
Cases 
Dr HR Guly FRCP, FCEM 
Retired consultant in emergency medicine, 
Derriford Hospital, Plymouth 
This paper describes the medical cases taken on sledging 
journeys of the expeditions of the heroic age of Antarctic 
exploration and their contents. 
On the early Antarctic expeditions, nowhere was the 
balance between having adequate medical supplies and 
their weight more important than when sledging. 
Whether a sledge is pulled by dogs or man, there is a limit 
to what can be pulled and every kilogram of medical 
equipment means a kilogram less food or fuel. The 
southern journeys of the Nimrod and Terra Nova 
expeditions both lasted over four months over rough 
terrain so some supplies were needed but it would be 
hoped that the requirements for medicine would be small, 
as not only should explorers be medically screened 
before going to Antarctica but it is also clear that they 
were reassessed before the sledging teams were chosen. 
Presumably the drugs and equipment chosen were 
considered the bare minimum to treat any emergencies 
that might occur in such a population. 
Sledging medical cases 
Figure 2. Canvas medical case taken on Terra Nova 
expedition and medicine case taken by Shackleton on 
his Furthest South sledging expedition. 
Reproduced by kind permission of Science Museum. 
No . 117. 'TABLOID ' ARAND MEDICINE POCKeT · CASE 
This Case, ,,.•hich is some-
what larie, and more comprt• 
hensive than 1be No. 11.5 
Case, conlains sixteen I oz. 
phials of '1'abloid ' Brand 
products, etc. In Cowhide, 
Piisl. in, Crocodile, Morocco 
and other fine leathers. 
No. .. ,. ' TA BLO ID' B I AHO M ED ICI NK POC KET•CA,R 
.lh:uiueme1.u.1 : '7! X -f )( I tn . 
The Discovery expedition was lent two of the no. 137 
medical cases' (see fig 1) for sledging but this is just a Figure 3. Burroughs Wellcome No 117 medicine case. 
drug case and they would have needed additional storage From: Anon. The Evolution of Antiseptic Surgery. 
for dressings, drugs for injection and ophthalmic use, and London: Burroughs Wellcome & Co, 1910: 125. 
other equipment. canvas with a strap to go all round it and which could act as 
.--------------------~ a handle. It should be no more than a six inch (15 cm) cube 
NO. 137. 'TAIILOID' B!lAND MEDICINE SADDLE-CASE 
:-io. 137. 'TABLOID' BRANu 
M£D1CtNE SADDLE-CASE 
In Cowhide or Pigskin , :>leasure-
ments: 7t X 4t X •~ in. Fitted 
in the same way as Xo. 117 Ca.~ 
(su Jnge 125), with sixteen; o<. phials 
of' Tabloid ' Rrnnd products, etc. 
Figure 1. Burroughs Wellcome No. 137 medicine case. 
From: Anon. The Evolution of Antiseptic Surgery. 
London: Burroughs Wellcome & Co, 1910: 127. 
The drug case that Shackleton took on his journey 
towards the South Pole on the Nimrod expedition2 (fig 2) 
also looks like a BW 'Tabloid' medical case 137 and this 
expedition, too would have needed additional storage. 
Dr Atkinson says that the Terra Nova took ' 12 No. 117 
special cases designed by Dr. Wilson'.3 In fact the 117 
medical case (fig 3) was a small case containing 16 
different medicines and commercially available and just 
formed part of the contents of the sledging medical case. 
The canvas sledging case (figs 2 and 4) was designed by 
Dr Edward Wtlson, presumably based on his experience of 
the Discovery expedition. He asked for a case made of stiff 
and should be lightweight but should be extendable so that 
it could hold more, if required. He illustrated what he 
wanted with a drawing4 and the case was mad~ _by 
BW &Co. This would have contained the 117 medicme 
case. The No. 117 case is very similar to the ~37 case wi~ 
both cases containing 16 half-ounce ( 15-g) phials of drugs. 
Figure 4. Canvas medicine case taken on Terra Nova 
expedition and contents. 
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I 1 D Tab e I d . ru2s ms e t2m 2 cases 
Terra Nova Nimrod ITAE 
As described by: As described bv: 
Atkinson Canterbury Shackleton Canterbury Museum Museum 
Aromatic chalk & opium * * * * * 
Aspirin/Xaxa * * * 
Caffeine compound * * 
Calcium lactate 2 2 
Kola compound * * See text * 
Sodium salicylate * * 
Tonic compound 2 * * 
Bismuth & soda * * * * * 
Digitalis tincture * * 
Opium * * * 
Soda mint * * * 
Calomel * * * 
Corrosive sublimate 
* * * * 
mercuric chloride) 
Laxative vegetable * Laxative pills' * 
Gelsemium Tincture * 
Boracic acid powder * * * * 
Sodium bicarbonate powder * * * 
* * Borofax 
* * Hazeline 
Iron & arsenic compound * * 
Quinine bisulphate * * 
Hemesin (adrenaline) * * 
Cocaine hydrochloride 2 
Zinc sulphate 2 
Aloin Compound * 
Chlorodyne * * 
Sulphonal * 
Bismuth pepsin, charcoal * 
Potassium chlorate * 
Ammonium bromide * 
Ginger essence * * 
Morphine sulphate * 
Easton's syrup * 
Blue pill & rhubarb * 
compound 
Antipyrine cpd (Phenazone) * (contmued) 
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Tab le l. D nu•s in sl.ed~DU!' cases ( co11tiruedl 
Terra Nova Nimrod ITAE 
As d escril ed b v: As d escril ed b v: 
A1k.inson Canierbury Shackleton Canierbury Museum Museum 
Coffee mint comnound 
Tannin compound 
Oui.nine hvclrochloride 
Salol (nhenvl salicvlate) 
Le ad with oci urn 
Paregoric (cam phorate d 
tincture of nni um) 
Ipecacuanha Compound 
Gingamint 
Trional 
Pyramidon 
(aminomirine) 
Ar=ol 
Ernest Shackleton's sledging medical equipment for 
the ITAE was 2 canvas sledging cases, each of which 
contained a No. 3 hypodermic case and a number 90 
ophthalmic case. 6 BW &Co would have used their 
experience gained from supplying one expedition for the 
benefit of later expeditions and I imagine that the canvas 
cas~ was probably the same as, or very similar to, that 
designed by Wilson. I also suspect that the Australian 
Antarctic expedition took the same cases as Dr 
Archibald McLean's diary describes them as 'Willesden 
canvas sledge cases of Burroughs Wellcome'7 and these 
are the same words as Wellcome used to describe 
Wilson's case. 
BW &Co proudly stated that "both Amundsen and 
Scott carried 'Tabloid' Outfits. So, whichever one of 
them had won, the 'Tabloid' Equipment would have been 
first at the South Pole as at the North Pole"B (Peary had 
taken a BW&Co case to the North Pole). In a 
photograph9 the case carried by Roald Amundsen 
appears to be a no. 137 medicine case. 
Drugs carried in sledging medical cases 
It is difficult to be certain what drugs were carried in the 
sledging cases but medical cases 117 and 13 7 both have 
room for 16 phials of tablets and in Wilson's sledging 
case, there was room for other drugs. On the Terra Nova 
e~pedition the drugs carried are given by Atkinson3 and 
this corresponds to the drugs supplied by BW &Co. 10 
How.ever a reference in the Canterbury Museum 
(~hristchurch, New Zealand)'' gives a slightly different 
hst of drugs that were carried on the journey to find the 
bodies of Scott and the others and on the ascent of Mount 
Erebus. I am not sure where this list came from but if it 
is correct, presumably the drugs were changed fo; the 
second sledging season based on their experience during 
the first season. 
These lists may not be complete as on the return from 
the South Pole, Wilson records in his diary: 'Dressing 
Evans' fingers every other day with boric Vaseline.' 12 
Although this was taken on the Terra Nova expedition, 
* 
* 
* 
* 
* 
* 
* 
* 
* 
>\< 
* 
there is no other mention of it in the sledging medical 
equipment. 
Shackleton, in the book "The Heart of the Atlantic" 
describes the medical equipment that he took on the 
Southern journey on the Nimrod expedition I3 and I have 
previously compared this with the equipment taken into 
the field by British Antarctic Survey field parties. 14 There 
are two things to be added to the information in that 
paper. Firstly Shackleton said that he had taken 
'ophthalmic tabloids'. I have no information on what he 
took but it is likely to be the same as that taken on the 
Terra Nova or the ITAE as described below. The second 
thing to add is that, in addition to the expedition medical 
kit, Dr Eric Marshall also took some 'Forced March' 
tablets, a BW &Co product containing cocaine and kola. 
This seems to have been on the initiative of Marshall 
himself rather than part of the formal expedition supplies. 
This is described below. 
This list, too, is very different from a list in the 
Canterbury museum. 11 These lists are compared in Table 
1 which gives the two versions of the Terra Nova 
sledging drugs, the two versions of the Nimrod sledging 
drugs and the drugs taken in the ITAE sledging cases. 
The ophthalmic drugs on the Terra Nova consisted of 
12 tubes of ophthalmic 'Tabloid' product DD.3 This was 
zinc sulphate gr 1/250 and cocaine hydrochloride gr 1/20, 
20 tabloids per tube, 1s which were for snow blindness. 
On the ITAE, the sledge case contained a No. 90 
ophthalmic case.6 I have described the ophthalmic cases 
and drugs elsewhere. 16 The non-drug contents of the 
sledging medical cases on the Terra Nova expedition are 
shown in Table 2. 
The non-drug contents of the ITAE6 and Australian 
sledging cases drugs are identical. The Australian drugs 
consisted of 'an assortment of tabloid drugs for general 
treatment' 17 and so are almost certainly very similar to 
those taken by Scott and Shackleton. 
While Scott, Shackleton and Amundsen planned 
sledging expeditions to the South Pole that lasted several 
months, the French expeditions were ship-based, 
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Table 2. The non-drug contents of the sledging 
medical cases on the Terra Nova expedition.3 
Field dressings 
Court plaster 
Adhesive plaster 
Pins, safety pins 
Artery forceps, sutures, tweezers, scissors 
Lancet 
Medicine dropper 
Ophthalmic dropper 
Camel hair brushes 
Eye shades left and right (these presumably were useful 
for snow blindness) 
scientific expeditions with much shorter sledge journeys. 
The contents of the medical kit for sledge journeys on the 
second expedition are shown in Table 3. 
Roald Amundsen said: 
We took a little travelling case of medicines from Burroughs 
Wellcome and Co. Our surgical instruments were not many: 
a dental forceps and- a beard-clipper. 19 
These dental forceps were used, as Oscar Wisting 
developed toothache on the return from the Pole.20 
(Shackleton did not have dental equipment in his 
sledging kit on the Nimrod expedition and Dr Eric 
Marshall broke Jameson Adams' tooth when he extracted 
it without appropriate instruments.)2 1 
Amundsen's Eastern Party of three people, who had a 
6-week sledging expedition, travelled even lighter, saying:22 
Our medical outfit was exceedingly simple. It consisted of 
nothing but a box of laxative pills, three small rolls of gauze 
bandage, and a small pair of scissors, which also did duty for 
beard-cutting. Both pills and gauze were untouched when we 
returned ... 
Alcohol 
Alcohol was also taken for its medicinal value. Thus 
Wilson wrote: 'No alcohol was taken on sledge journeys, 
except for a small can of brandy for emergencies. '23 
~sky was also used and the second French expedition 
1s reported to have taken 3.5 kg of rum for 3 people on a 
10 day sledging expedition, 18 which seems excessive. 
Cocaine and other stimulants 
On the internet there are many references to Shackleton 
and Scott using cocaine eg 'Intrepid polar adventurer 
Ernest Shackleton explored Antarctica propelled by 
tablets of Forced March '24 and "in 1909 Ernest 
Shackleton took 'Forced March' brand cocaine tablets to 
Antarctica, as did Captain Scott a year later ... "25 The 
truth is less exciting. 
On the return from the attempt to reach the South Pole, 
the four expedition members ran out of food before 
reaching a depot. Dr Marshall later described events: 
Between 25th and 27th [December] we turned rught into day 
with forced marches and brief rests, all food being exhausted, 
but twice we had sugarless and milkless tea or cocoa. Not 
until this moment did I produce 24 'Forced March' tablets 
(cocaine), and only then when I thought that we would make 
the depot before the effects of the last dose had ceased to be 
effective. 26 
Table 3. The contents of the medical kit on the second 
French (PourquoiPas?) Expedition.18 
Drugs 
Cocaine 
Laudanum 
Morphine for injection 
Quinine 
Caffeine 
Rhubarb 
Topical preparations and dressings 
Lead subacetate 
Vaseline 
Dressings for frostbite 
Diachylon (a medicated dressing) 
Dressings and pins 
2 packets of gauze 
3 bandages 
Surgical equipment 
Needles, forceps,suture 
Scalpel 
Artery forceps 
He described the same events in a letter to the British 
Medical Journa/27 and gave more information in 
correspondence saying: 
The 'Forced March' (Cocaine preparation) was issued from 
5.30 pm on the 26th, at hourly intervals, [the recommended 
dosage schedule] until the early morning of the 27th, the 
supply being exhausted ... While it lasted, the effect was 
dramatic and we had every hope of making the depot that 
rught. The final collapse of two members was due to the 
reaction and failure to obtain the food which I was reckoning 
on, but was not available until about 15 hours later. 28 
Stimulating the body to make it do more work in the 
absence of nutrients is clearly risky and because of the j 
failure to reach the depot while still under the influence 
of the 'Forced March', Marshall said that he was "still 
guessing whether the 'Forced March' nearly killed us or 
saved us!"29 After some of the party collapsed, Marshall 
went on alone to the depot to obtain the food they 
required and had some lumps of sugar. He went on to say: 
the effect of the 2 lumps of sugar, some 15 hours later, was 
equally dramatic, and if I was asked to choose between the 
relative merits of these two stimulants, under similar 
conditions, I should choose sugar.28 
This incident does not seem to justify the description of 
Shackleton exploring Antarctica 'propelled by tablets of 
Forced March. 
'Forced March' (also known as 'kola compound') was a 
combination of extracts of coca (active ingredient cocaine) 
and kola (active ingredient caffeine). 'Forced March' was a 
BW &Co trade name, but other companies also 
manufactured kola compound. The same drug was taken 
on Scott's and Shackleton's second expeditions and was 
certainly used by members of the Ross Sea Party section of 
Shackleton's expedition.30 It was also used by troops during 
the First World War. 
Easton syrup tabloids (Iron phosphate, quinine, strychnine) 
were also used as stimulants on this expedition, both by 
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Shackleton on his attempt to reach the South Pole31 and by the 
party that reached the South Magnetic Pole. 32 
Alcohol might be used in a similar way. Thus Dr 
McLean relates how a party of three men on the 
Australian expedition missed a depot and had to travel 67 
miles with minimal food. 
Fortunately, they had, as well, a small store of absolute alcohol, 
which was ordinarily used for lighting the primus stove. 
Without doubt, the stimulation of small quantities of the alcohol, 
taken from time to time, helped them in safety to the Hut.33 
There is very little information as to what drugs were 
actually used on the march. Snow blindness was 
common and the treatment of this has been described 
elsewhere. 16 Diarrhoea was also common, especially on 
the Nimrod expedition but we are not told how Marshall 
treated it though Edward Evans was treated with both 
brandy and aromatic chalk and opium when he collapsed 
with diarrhoea associated with scurvy on the Terra Nova 
expedition. 34 
We are also not told what analgesia was given for 
Adam's dental problem as mentioned above. Apsley 
Cherry Garrard had his heartburn. 'made ... better with 
the medical case' 35 251, perhaps with sodium 
bicarbonate or soda mint (sodium bicarbonate, 
ammonium bicarbonate and peppermint oil) but we are 
not told which. 
Acknowledgments 
This research was made possible by a Short Term 
Research Award in the History ofMedicine for Clinicians 
and Scientists from the Wellcome Trust, for a study on 
'Medicine during the Heroic Age of Antarctic 
exploration'. 
Authors address: The Shrubbery, Bedford Rd, 
Horrabridge, Yelverton, Devon, PL20 7QH. 
hguly@aol.com 
Endnotes and References 
1. Anon. List of 'Tabloid' brand products etc sup-
plied to the Antarctic Expedition, 1901. London: 
Wellcome Library MS WF/M/I/PR/E44. 
2. Anon. The Evolution of Antiseptic Surgery. Lon-
don: Burroughs Wellcome & Co, 1910: 110. 
3. Atkinson EL. Equipment and stores in Lyons 
HG (ed.) British (Terra Nova) Antarctic Expedition 
1910-1913: Miscellaneous Data. London: Harrison 
& Sons Ltd, 1924: 30-60 (p 54). 
4. Wilson E. Letter to Mr Dowdeswell, BW &Co, 5 
May 19 I 0. London: Wellcome Library MS 
WF /Ml 1 /PR/E449. 
5. Anon. Reference 2: 125-7. 
6. Anon. Items of Medical equipment for Sir Ernest 
Shackleton's Imperial Trans-Antarctic Expedition 
1914 London: Wellcome Library 
MSWF 1M/I/PR/E4 7. 
7. McLean AL. Diary 1 Nov 1912. Sydney: Library 
of New South Wales, MS MLMSS 382. 
8. Anon The Romance of Exploration and Emergency 
First Aid from Stanley to Byrd. New York: Burroughs 
Wellcome and Co, 1934: 67-8. 
9. Anon. The Dental art in ancient times. London: 
Burroughs Wellcome & Co, 1914: 60. 
10. Anon. Reference 1. 
I I . List of contents of the I 907-9 and 1910-13 expedi-
tions' medical chests. Christchurch, New Zealand: Can-
terbury Museum. MS 382. 
12. Wilson E. Diary of the Terra Nova Expedition to the 
Antarctic 1910-1912. London: Blandford Press, 1972: 
240. 
13. Shackleton E. The Heart of the Antarctic. London: 
Robinson Publishing, 1999: 250-1. 
14. Guly HR. Medicine in the heart of the Antarctic 
1908-2001. Emerg MedJ2002; 19: 314-7. 
15. Anon. Reference 2: 165. 
16. Guly HR. Medical supplies for the expeditions of the 
heroic age of Antarctic exploration: Ophthalmic prepara-
tions. Pharmaceutical Historian 2012; 42 (3): 46-50. 
17. Jacka F, JackaE (eds). Mawsonss Antarctic Diaries. 
London: Unwin Ltd, 1988: 179. 
18. Merle des Isles M-1. Les Compagnons du Pourquoi 
Pas? Paris: Paulsen, 2010: 235. 
19. Amundsen R. The South Pole. An Account of the 
Norwegian Antarctic Expedition in the "Fram," 1910-
1912. Vol. 2. Translated Chater AG. New York: John 
Murray; 1913: 19. 
20. Huntford R. The Last Place on Earth. London: Aba-
cus, 1999: 481. 
21. Shackleton E. Reference 13: 288-9. 
22. Amundsen R. Reference 19: 226. 
23. Wilson EA. The medical aspect of the Discovery's 
voyage to the Antarctic. Er MedJ 1905; 2: 77-80. 
24. Anon. http://www.cocaine.org/ accessed 30 Decem-
ber 201 I. 
25. Anon http://en.wikipedia.org/wiki/Cocaine ac-
cessed 30 December 2011. 
26. Marshall ES. An Antarctic episode. Medical Press 
and Circular 1943; 210: 359-62. 
27. Marshall ES. Deficiency Diseases: lessons from the 
past. Er MedJ 1942;1:770-1 
28. Marshall ES. Letter to Dr EJC Kendal 28 Novem-
ber 1950. Cambridge: Scott Polar Research Institute Ar-
chives MS 656/1-4. 
29. Marshall ES. Letter to Dr EJC Kendal 26 January 
1951. Cambridge: Scott Polar Research Institute Ar-
chives MS 656/1-4 
30. Gaze, Irvine Owen Diary 16th and 17th February 
1915. Christchurch NZ: Canterbury Museum MS 105. 
31. Shackleton EH TheHeartoftheAntarctic. Vo/2. 
Philadelphia: JB Lippincott 1909: 428. 
32. Shackleton EH Reference 32: 188. h-
33. McLean AL Bacteriological and other resear~ 
es. Australasian Antarctic Expedition 1911-14, Scz 
RepSerCvol VJJ,part4. Sydney 1919: 119. 
34. Cherry-Garrard A. The Worst Journey in the 
World. London: Picador, 2001: 409-10. 
35. Cherry-Garrard A. Reference 34: 251. 
72 Pharm Hist (Lond) 2013; 43 (4): 
https://doi.org/10.24355/dbbs.084-201802161454
Edward Joseph Shellard -
A Phenomenal Pharmacognosist: 
Part 1 
Peter J Houghton1 and J David Phillipson2 
1 Institute of Pharmaceutical Sciences, Kings 
College London, Franklin Wilkins Building 
2 Centre for Pharmacognosy and Phytotherapy, 
Department of Pharmaceutical and Biological 
Chemistry, UCL School of Pharmacy, 29-39 
Brunswick Square, London WC1N 1AX 
Edward Joseph Shellard was born on August 8th, 1913 at 
Minchinhampton in Gloucestershire and was educated at 
the Marling School, Stroud. He studied Pharmacy at the 
School of Pharmacy, London, and graduated in 1936. His 
academic career started at the Merchant Venturers 
Technical College, later College of Technology, Bristol, 
in 1946 and he then joined the staff of the Department of 
Pharmacy, Chelsea College, London in 1957, retiring in 
1978. He was known to many as Joe or even 'Jalap Joe' 
because of his early research into Convolvulaceous 
resins. Joe was a passionate advocate for his favourite 
subject, Pharmacognosy, and during his career received 
degrees and honours for his contribution to teaching and 
research. He obtained his PhD from the University of 
London in 1960 and was awarded Fellowships of the 
Royal Pharmaceutical Society, the Royal Institute of 
Chemistry and the Linnaean Society of London. The 
Warsaw Medical Academy awarded him an honorary 
DSc and he was an honorary member of the 
Pharmaceutical Societies of Bulgaria, Hungary and 
Poland. He was President of the Medicinal Plants section 
of the International Federation of Pharmacy (FIP) from 
1980--1984. 
These awards testify to his academic achievements but 
give little indication to his path through academia or 
about him as an individual. This article is based on an 
unpublished manuscript prepared by him, entitled 'My 
32 years in academia, 1946-1978' that is archived at KCL 
London. As authors of this article, and his former PhD 
students, we are able to attest to his strong leadership in 
academic Pharmacy and Pharmacognosy. He continued 
to give us support and encouragement throughout our 
careers. 1.2 Looking back through his career it is possible 
to chart the changes that occurred in Pharmacy and 
Pharmacognosy between 1946 and 1978. In particular he 
grasped the evolving analytical techniques that enabled 
him to provide a scientific background to the constituents 
of medicinal plants and to his special interest in 
Pharmacognosy. He changed the Pharmacognosy 
syllabus for undergraduate Pharmacy students, and 
Pharmacognosy research, emphasising the chemical 
constituents of medicinal plant drugs and not just their 
botanical characteristics. In doing so, his model was 
copied in many different countries and it is due to his 
enthusiastic efforts that Pharmacognosy continued as a 
distinct subject in many UK Schools of Pharmacy. 
The School of Pharmacy, Merchant 
Venturers Technical College, later the 
College of Technology, Bristol, 1946-1957 
Shortly after the end of World War 2 Joe was working for 
the phannaceutical company Genatosan but he was not 
happy with the emphasis on organic chemistry and 
chemical engineering. In June 1946 he applied for a 
lectureship in Pharmacognosy at the Bristol School of 
Phannacy because this was his favourite subject as an 
undergraduate. He replaced DJ Williams, who had founded 
the School in Bath in 1907, and became responsible for the 
teaching of Pharmacognosy and Forensic Pharmacy. At the 
time of his appointment William Cooper was Head of 
Pharmacy and George Moore, a pharmacist, was Head of 
Science. Space was in very short supply and Joe had no 
office. 
In 1949 the finance and management of the Merchant 
Venturers College was taken over by the Bristol City 
Council and it became the Bristol College of Technology. 
The 1948-9 session brought changes for the School of 
Pharmacy because the Pharmaceutical Society had 
introduced new regulations to phase out the 9 months 
course leading to the Chemist and Druggist (C&D) 
diploma and replace it with the Pharmaceutical Chemist 
(PhC) 2 year diploma. There was insufficient money 
available to take on additional staff needed for the new 
course and insufficient space to accommodate students in 
the longer course. The School of Pharmacy at Cardiff did 
introduce the PhC course but were unable to take the 20 
students already enrolled for the C&D course. Despite the 
problems that existed at Bristol, William Cooper asked Joe 
to draw up a modified timetable that would allow them to 
take in the 20 extra C&D students from Cardiff. The 
students were far from happy with the new timetable and 
this added further to the problems at Bristol. In addition, the 
Phannaceutical Society was not satisfied with the 
accommodation at Bristol and the level of staffing. The 
local Education Authority was not prepared to fund two 
additional members of staff for Pharmacy and could not 
make more space available for the College. It looked as 
though the 1950--1 session would be the last one for the 
Bristol School of Pharmacy. 
September 1950 marked the 21st anniversary of the 
move of the School of Pharmacy from Bath to Bristol and 
William Cooper, with Joe, considered what form of 
celebration could be arranged. William Cooper was 
concerned that the level of pharmaceutical education at 
Bristol, an important city, was not comparable with such 
cities as Manchester and Nottingham where Pharmacy was 
taught in the universities. They planned a grandiose dinner 
in cooperation with the Local Branch of the Pharmaceutical 
Society for March 1951 with guests including the Lord 
Mayor, the Vice Chancellor of Bristol University and the 
President of the Pharmaceutical Society. Although the 
dinner was a great social success it was a failure in not 
helping to raise the level of Pharmacy teaching at Bristol. 
The President of the Pharmaceutical Society did not help 
because in his speech at the dinner he emphasised the need 
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for more manpower for retail Pharmacy and played down 
the role of universities in pharmaceutical education. 
A further inspection by the Pharmaceutical Society 
followed shortly afterwards and this resulted in the 
appointment of two further members of staff to teach 
Pharmaceutics in the 1951-2 session. Joe anticipated that 
his teaching load would be reduced, but this was not to be 
because he also had to teach Galenical Pharmacy. In 
1953 William Cooper was elected as a member of the 
Council of the Pharmaceutical Society and this meant 
attending meetings in London as well as giving lectures 
throughout the country to Local Branches of the 
Pharmaceutical Society. Inevitably this added further to 
Joe's teaching schedule. 
During this session Joe was appointed as an external 
examiner in Pharmacognosy for the Pharmaceutical 
Society and this added to his status as a teacher of 
Pharmacognosy. 
Despite his heavy teaching load he commenced a 
research project examining samples of Brazilian Jalap 
obtained by DJ Williams prior to World War I. He wrote 
a research paper on his findings and submitted the 
manuscript for publication in the Pharmaceutical 
Journal. The paper was sent to Dr TE Wallis, School of 
Pharmacy, University of London, who was asked to act 
as a referee. Wallis invited Joe to visit him to discuss the 
research and thus began a long friendship between them. 
The paper was redrafted, submitted to the Journal of 
Pharmacy and Pharmacology and accepted for 
publication.3 This research paper was not only the first 
one from the Bristol School of Pharmacy but it was also 
the first one from the Bristol College of Technology. 
There was a practical application to this research because 
Vera Cruz Jalap and Ipomea were commercially 
available and officially recognised for medicinal use. 
Macroscopic and microscopic characters were 
investigated and chemical analysis by paper 
chromatography identified the sugars present. Other 
papers followed4•5 and not only did this research lead to 
the nickname 'Jalap Joe', but it also brought him into 
contact with postdoctoral students at the Department of 
Chemistry, University of Bristol, who later became 
professors of Chemistry in UK universities. 
Joe was a very sociable person and he enjoyed the 
company of other members of college staff in the 
lecturer's common room and he became their chairman. 
He was also active in the college branch of the 
Association of Teachers in Technical Institutes (ATII). 
William Cooper retired as Head of the Bristol School of 
Pharmacy in 1955. Joe applied for the headship but he 
was not surprised that he was not successful because, as 
an active member of the ATII, he had often been in 
conflict with several members of the selection 
committee. Mr DA Norton became head and the 
Principal promised Joe a Senior Lectureship. This did not 
materialise and Joe became very unsettled at Bristol. 
His final activities at Bristol were in connection with 
the British Pharmaceutical Conference held in 1957. 
William Cooper was chairman and Joe was in charge of 
printing and publicity. He and his wife Sylvia acted as 
hosts at Wills Hall of Residence where many of the 
delegates stayed. During the conference there was a 
debate on pharmaceutical education and Mr CW 
Maplethorpe, chairman of the Pharmaceutical Society's 
Education Committee proposed that the 2 year PhC 
course be replaced by a 3 year degree course. Joe took 
part in the debate and supported Mr Maplethorpe's 
proposal. A few years later the 3-year degree course was 
introduced as the entrance to the profession of Pharmacy. 
The Bath and Bristol Old Pharmacy Students 
Association was formed in 1952 and Joe became their 
secretary and treasurer. Although he resigned from the 
College in 1957 after 11 years on the staff, he was invited 
back the following year to give the DJ Williams 
memorial lecture to the Association, the School of 
Pharmacy and the District Branch of the Pharmaceutical 
Society. His lecture was entitled 'Pharmacognosy at the 
Crossroads'. He never forgot his links with Bristol and 
when he became chairman of the Board of Examiners in 
Pharmacognosy for the Pharmaceutical Society he 
enjoyed his visits back to the Bristol School. His post at 
Bristol was taken over by David Shaw, a fine musician, 
and they became good friends. When David left he was 
replaced by Dr Roland Hardman from Nottingham 
University and it was Joe who persuaded Roland to 
attend meetings of the Medicinal Plants Section of FIP. 
Roland later became a distinguished President of this 
group. 
The Bristol School of Pharmacy eventually became 
the School of Pharmacy, University of Bath, and again 
Joe met with his former colleagues when he was External 
Examiner for the B Phann degree. When Dr DA Norton 
retired as the Head of the Bath School of Pharmacy Joe 
was invited to make the presentation to him. He also met 
George Moore again, a pharmacist and former head of 
the Department of Science at Bristol College of 
Technology. George Moore was one of the founder 
members of the University of Bath and he became the 
Vice Chancellor. 
Department of Pharmacy, Chelsea 
College, London, 1957- 1978 
Joe joined the Department of Pharmacy, Chelsea 
College, as a Lecturer in 1957. He was shocked to find 
that Pharmacognosy was situated in a sma? and 
dilapidated out-building. When it rained heavily the 
building was flooded, as water came in via the roof. ~ 
DC Harrod (Dougie ), Senior Lecturer ~ 
Pharmacognosy, became Joe's immediate boss. !'!1is 
small building was divided into two by a partition 
forming two undergraduate laboratories and Mr Harrod 
had a desk within one of them. Practical classes were 
held for 1 st and 2nd year BP harm students, 3rd year 
students specialising in Pharmacognosy and 1 st and 2nd 
year PhC students. There was no separate space for Joe 
and he had to make do with a small desk in a comer of 
the smaller laboratory. He shared the teaching of practical 
classes with Georgina Jolliffe who was an Assistant 
Lecturer. Classes were held each day Monday to Friday, 
except Wednesday, with evening classes for those who 
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had failed previously and for those taking the 
Apothecaries Examination in Dispensing. 
Mr Harrod insisted that he gave all the lectures and that 
practical classes should stick exactly to the syllabus, i.e. 
macroscopical and microscopical characters of plant 
drugs. He made it clear that there would be no laboratory 
classes involving plant chemistry. This was a blow for 
Joe because he had written a small textbook Practical 
Pfant Chem~stry for Pharmacy Students, published by 
Pitman Medical Ltd.6 He had also written another book 
for 3rd year Pharmacy undergraduates, Exercises in the 
Evaluation a/Drugs and Surgical Dressings. 7 Mr Harrod 
informed him that these textbooks would not be 
recommended at Chelsea College. To add further to his 
concerns was the fact that Chelsea College would have 5 
new Senior Lecturers appointed when it became a 
College of Advanced Technology. Mr Charles Morton, 
head of the Pharmacy department, had promised Joe that 
he would have one of these Senior Lectureships, but he 
was not given one. He was not happy during his first term 
at Chelsea College and wished that he had not left Bristol. 
While he was at Bristol Joe had registered with the 
University of London as an External Student for a PhD 
but this had lapsed. He consulted his friend Dr Jim 
Fairbairn, Reader in Pharmacognosy at the School of 
Pharmacy, Brunswick Square and Dr TE Wallis, Curator 
of the Pharmaceutical Society's collection of plant drugs. 
Jim and Joe had been undergraduates together at the 
School of Pharmacy and Tommy Wallis had been their 
Pharmacognosy teacher. 
They both encouraged Joe to register for a PhD and 
helped him through the procedure. Tommy considered 
that there was scope for a detailed compendium of the 
anatomy and histology of all the Convolvulaceous drugs 
on the market because some of the resins were used as 
substitutes or adulterants of officially recognised 
medically used resins. Jim thought that chromatographic 
se~arations could be used to distinguish between the 
resms and if this were done in sufficient depth it would 
contribute towards a PhD thesis. 
It was at one of his visits to Brunswick Square that Joe 
met Dr Bogdan Karminski, lecturer in Pharmacognosy at 
th_e Faculty of Pharmacy, Warsaw, Poland (Figure 1). 
Little did he realise the influence that this would have for 
his future career. 
Joe dreaded his return to Chelsea in January 1958 but 
he decided to concentrate on research with what little 
spare time he had available. He examined samples of all 
of the Convolvulaceous drugs in the museum of the 
Pharmaceutical Society and compared them with 
commercial samples. He also utilised the large collection 
of material medica that Mr Harrod had made at Chelsea 
College, as well as liaising with colleagues from other 
Schools of Pharmacy. In addition he obtained samples 
from AH Millard, Chief Pharmacist to the Malay 
Government and Director of the Kuala Lumpur Botanic 
Gardens, who had been a former lecturer at the Bath 
School of Pharmacy. Another useful supplier of resins 
was Dr Rohatgi from Kanpur, India, who was a former 
research student of Tommy Wallis (Figure 1). 
Shortly after the start of the Spring term in 1958 his 
teaching load was reduced because Margaret Lees, a 
Jacob Bell scholar, was appointed as an Assistant 
Lecturer in Pharmacognosy. In June, his wife Sylvia, and 
two boys, Paul and Edward, moved from Bristol and 
joined Joe setting up home in Hounslow, Middlesex. 
When he returned to Chelsea for the Autumn term he 
Figure 1. Left to Right: Dr Bogdan Karminski and his 
wife Janina, Dr TE Wallis, Joe Shellard and Dave 
Phillipson at the British Pharmaceutical Conference, 
Liverpool, 1962. 
found that his colleague Georgina Jolliffe had been 
promoted to Lecturer and that there was a new Assistant 
Lecturer, John McGreal. Joe still had no lectures 
allocated to him and he asked Mr Harrod for lectures to 
be given him. He was surprised to be allocated 8 lectures 
on Crystallography for 3rd year students. He argued that 
this subject had no place in Pharmacognosy but Mr 
Harrod had purchased a crystallography microscope for 
the sum of £400 and so Joe reluctantly agreed to give 3 
lectures. As Mr Harrod was spending more time on 
departmental administration he needed to reduce hi 
teaching load and eventually Joe was given more 
lecturing time. Mr Harrod was the most senior member 
of staff, having been appointed in 1934, and Mr Morton, 
head of the Pharmacy department, relied on him to keep 
all of the student academic records. As Mr Morton was 
intending to retire he added more administrative tasks to 
Mr Harrod. 
It was at the beginning of the 1958 academic year that 
Dr AH Beckett, head of Pharmaceutical Chemistry, 
returned from a year-long visit to the USA. At the time 
this did not mean much to Joe but he soon began to take 
measure of Arnold Beckett. Arnold was without doubt a 
very active research worker and he headed a group of 
scientists including Drs Norman Harper, Alan Casey, 
George Kirk and Alma Simmonds. They were interested 
in the stereochemistry of morphine-like compounds and 
were postulating the structure of the morphine receptor 
with the aim of synthesising novel analgesics. Joe 
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planned to start his chemical investigation of Con-
volvulaceous resins but he had no access to a chemistry 
laboratory. His request to be able to work in one of Dr 
Beckett's laboratories was turned down and delayed the 
onset of this phase of his work. The two colleagues had got 
off to a bad start. 
The new Assistant Lecturer in Pharmacognosy, Mr 
McGreal, decided that Pharmacognosy was not for him and 
he resigned. Joe decided to look for a replacement and on 
the recommendation of Dr Steve Challen of Brunswick 
Square, he offered the position to Mar lion Poulter of Parke, 
Davis & Co., and she accepted. During 1959 Chelsea 
College was designated as a College of Advanced 
Technology (CAT) and an extension was built onto the 
Manresa Road building. In addition, the great hall was 
converted into two floors with new staff rooms and 
laboratories. 
Pharmacognosy acquired two new teaching laboratories, 
one for first and second year students, and one for third year 
students. Joe ensured that both of these laboratories were 
equipped for chemical work as well as microscopy. There 
was a combined office for the 3 lady pharmacognosists and 
eventually a small office for Joe. Mr Harrod had an office 
for Pharmacy administration and Mrs Chris Bates was 
appointed as his secretary. Mr Morton retired as head of the 
Pharmacy Department and Arnold Beckett was appointed 
as the new head of department. He had his own secretary, 
Miss Partington, who dealt with his research interests but 
had nothing to do with departmental administration. Arnold 
Beckett began to flex his muscles as head of the Pharmacy 
Department and decided that Pharmacognosy should be 
eliminated as a 3rd year option in the BPharm course as he 
considered it too old-fashioned. When Joe heard this it set 
the two of them on a collision course. 
It was well into the Spring term of 1960 that Arnold 
Beckett realised that Joe was active in research and was 
near to completing his PhD thesis. This must have 
impressed Arnold because he promised to make Joe 
responsible for Pharmacognosy and shortly afterwards Joe 
was promoted to Senior Lecturer. Joe was able to complete 
his chemical research using the facilities in the 3rd year 
teaching laboratory and he extended his investigation into 
the volatile components of the resins using gas liquid 
chromatography at Parke, Davis. He was helped in his 
research by Mr Tinley a much respected member of the 
staff in Pharmaceutical Chemistry. His thesis was submitted 
in early 1960 and after being examined by Tommy Wallis 
and Jim Fairbairn he was awarded his PhD in June.s 
Arnold Beckett set up a departmental committee with 2 
members each from Pharmaceutical Chemistry and 
Pharmaceutics and one from Pharmacognosy, namely Joe 
Shellard. Mr Harrod was the executive secretary and Chris 
Bates recorded the minutes of the meetings. Arnold Beckett 
kept the departmental budget and devoted most of the funds 
to his own research. At this time Chelsea College of Science 
and Technology was not a School of the University of 
London and was termed a 'Recognised Institution'. The 
BPharm syllabus and the examinations as well as the 
Higher Degrees were administered by the Board of Studies 
in Pharmacy under the control of Dr Frank Hartley, Dean of 
the School of Pharmacy, Brunswick Square, and his senior 
colleagues. Chelsea College was poorly represented in the 
Board of Studies. Arnold Beckett managed to obtain the 
status of 'Recognised Teacher' for Joe and his 
microbiology colleague Chris Bean. As a result they both 
became members of the Board of Studies in Pharmacy and 
were able to have input into the BPharm syllabus and 
examinations, Joe becoming an assistant Examiner in 
Pharmacognosy for the internal and external BPhann 
degrees. He became even more recognised for his 
expertise by becoming a member of the Pharmacognosy 
Committee of the Pharmaceutical Society and a member 
of the British Pharmaceutical Codex Committee. The 
members of the latter committee were mainly from 
industry and gave Joe a wider experience into the 
commercial aspects of medicinal plant drugs. 
Joe began to form his own research group in the early 
1960s and his first research students included Mr Osisogu 
from Nigeria, Miss MS Pillay from South Africa and Dr 
Parirokh Shadan from the University of Teheran, Iran. Mr 
Osisiogu made chemotaxonomic studies on Nigerian 
species of the Apocynaceae and he obtained his PhD in 
1963. Miss Pillay undertook microscopical studies and 
demonstrated in undergraduate laboratory classes. Dr 
Shadan made anatomical investigations of the leaves of 
Catha edulis (khat) and the results were published in the 
Journal of Pharmacy and Pharmacology in 1962.9 Joe had 
met her by chance one day whilst visiting Chelsea Physic 
Garden and she agreed to doing research with him. 
Undergraduate classes in Pharmacognosy at Chelsea 
College included visits to the Physic Garden where Joe 
went regularly and he became very friendly with the then 
Director, Mr McKenzie. 
His major research interest became the alkaloid 
components from species of the genus Mitragyna, a 
member of the family Rubiaceae, and this will be 
summarised briefly in Part 2. Albert Tackie, a lecturer 
from the School of Pharmacy, Kumasi, Ghana, was 
investigating the alkaloids of a Ghanaian species of 
Mitragyna under the supervision of Dr Becke~. Jo_e 
persuaded Dr Beckett that it would be more sensible if 
Albert Tackie did his research in a Pharmacognosy 
laboratory alongside others working on plant chemistry 
and where he could help in the supervision of the 
research. Three members of his Pharmacognosy staff, 
Margaret Lees (appointed Assistant Lecturer ~ 1958), 
David Phillipson (appointed Assistant Lecturer Ill 196~) 
(Figure 2) and Peter Houghton (appointed Lecturer m 
1972) became active researchers in his group. J~e ~as 
very quick in turning research results into sc1~nt1fic 
papers for publication in journals or for presentation at 
pharmaceutical conferences. Albert Tackie presented a 
short communication on Mitragyna alkaloids to ~e 
British Pharmaceutical Conference at Birmingham m 
1961 10 and David Phillipson presented papers in 1963 to 
the FIP Congress in Munster, Germany. 11•12 
fu the early 1960s two analytical techniques became 
available for analysing the complex mixtures 0~ 
compounds present in plants. Joe was at the forefront 0 
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this research, being the first to utilise thin layer 
chromatography (TLC) and an early worker to use Gas 
Liquid Chromatography (GLC). In 1961 Jim Fairbairn, 
Professor of Pharrnacognosy at the School of Pharmacy, 
Brunswick Square, agreed to share with Joe a British 
Council Scholar, Dr S Talalaj, from the Pharmacognosy 
Department, University of Warsaw. They were interested in 
the changing amounts and alkaloid content in Conium 
maculatum (hemlock) and were able to use GLC to 
separate and quantify the alkaloids present at different times 
of the day and the season of plant growth. 13 This research 
was done at Chelsea College. TLC and GLC enabled the 
separation of alkaloids from species of Mitragyna and 
facilitated the isolation of individual alkaloids as single pure 
compounds. Within a few years the technique of High 
Pressure Liquid Chromatography (HPLC) became 
available and further added to the ability to separate 
individual alkaloids. Joe was not only a pioneer for these 
analytical methods but was also a strong advocate for their 
use, giving lectures and conference presentations in the 
UK, Europe, the Middle East, Africa and Asia. He also 
initiated a series of practical courses demonstrating these 
techniques to other pharmacognosists. In the 1960s there 
Figure 2. Joe Shellard, Dougie Harrod, Tommy Wallis, 
Marlion Wright, Georgina Jolliffe, Dave Phillipson and 
Margaret Walker on the occasion of Tommy Wallis' 
85th birthday, 1961. 
that the College should remain at Chelsea. Joe moved a 
proposition at a meeting of the Council of Chelsea College 
that an application should be made to become a School of 
the University of London. The motion was narrowly passed 
and in August 1966 Chelsea College finally became a 
School of the University ofLondon. 
By the mid 1960s Joe Shellard was Chairman of the 
Pharmaceutical Society's Board of Examiners in 
Pharmacognosy at a time when the 2-year PhC course 
was being phased out and there were problems for those 
students who had failed their examinations. Local 
Branches of the Pharmaceutical Society were being 
organised into Regions and linked to specific Schools of 
Pharmacy. Chelsea College was the academic centre for 
the Chiltern Region and Joe became the careers officer. 
This involved him visiting schools in the region, and to 
help gain the students' interest in Pharmacy he would 
take with him microscope slides coated with silica gel as 
mini- TLC plates to demonstrate chromatographic 
separations of mixtures. His time was also spent in 
liaising with other departments at Chelsea College that 
were introducing a common first year syllabus for all 
students. This could not meet the conditions laid down by 
the Pharmaceutical Society for the BPharm degree and 
thus he found himself at odds with all of the other 
departments. His research and administrative duties were 
recognised in 1965 when he was appointed Reader in 
Pharmacognosy. 
It was during 1965 that Joe experienced retinal 
detachment and had to undergo surgery at a time when he 
was reading through drafts of David Phillipson 's PhD 
thesis. Despite all of the severe bruising around his head 
resulting from the surgery he turned his lively mind to the 
minutiae of thesis writing. One of his other staff 
members, Georgina Jolliffe, was studying for a PhD 
under the supervision of Dr M Don brow, senior lecturer 
in Physical Chemistry who was spending much of his 
time at the Hebrew University of Jerusalem. He accepted 
a professorship in Israel and thus left Georgina Jolliffe 
without a supervisor for her research. She was 
investigating the physico-chemical properties of grass 
were a series of innovations in physico-chemical pollens that caused hay fever 14•15 and, although this was a 
techniques such as lnfrared Spectroscopy (IR), Nuclear new field of research for Joe, he accepted to become her 
Magnetic Spectrometry (NMR) and Mass Spectrometry supervisor. Under his supervision the research was 
(MS) enabling the elucidation of chemical structures of extended into identifying the constituent amino acids in 
small amounts of compounds isolated from plants. Joe the pollens. 
readily embraced all of this technology in his Mitragyna In the summer of 1964 Joe visited his mother in 
alkaloid research. Minchinhampton and met a local pharmacist who 
As this research was developing at Chelsea College there wanted advice as to whether his son Peter could study 
:,vere major changes being proposed for Higher Education Pharmacy at Chelsea College. Peter Houghton became a 
m Science and Technology in the UK. In 1963, the Robbins BPharm undergraduate in 1965 and Joe took a great deal 
Report on Higher Education recommended that CATs of interest in his progress throughout the course. After 
became technological universities. This started a period of graduation in 1968 and his pre-registration year, in 1969 
unrest at Chelsea College as several scenarios presented Peter started his studies for a PhD underJoe's supervision 
themselves for future developments including new and eventually joined the staff as a lecturer in 
universities of Hertfordshire, South London, Stevenage and Pharmacognosy in 1972 when Margaret Walker ( nee 
Surrey. Joe was actively involved in the many meetings that Lees) resigned. 
took place through his role in the ATTI. The future of After David Phillipson had obtained his PhD in 1965 
Chelsea College was eventually settled in 1965 when the he reque ted leave of absence to spend a abbatical year 
Secretary of State for Education and Science let it be known at Ohio State University in the USA. This was granted for 
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the 1967/68 session so Pharrnacognosy at Chelsea was a member of Pharrnaceutical Chemistry complained that 
short of a staff member. Joe invited Norman Bisset to the barrel of free draught beer was now empty. In typical 
accept a one year temporary lectureship. Norman was Shellard fashion the answer was ' 'Don't bother me with 
researching the alkaloids of species of Strychnos at Gif-sur- such matters,just go and order another barrel in my name". 
Yvette, Paris, and had previously been an active researcher He gave wonderfully witty speeches at many social events, 
as a Colombo Scholar involved in the phytochemical often impromptu, and they always earned the message 
survey of Malaya. Norman accepted the temporary about the importance of Pharrnacognosy and left his 
lectureship and received his PhD in 1968. Joe did not want audiences with stomach ache through laughing. 
to lose such an expert in phytochemistry after one year and Each Christmas he invited his colleagues to a special 
it was as a member of the Council of Chelsea College that lunch with one invited guest and plentiful supplies of 
he noticed that there was one academic staff vacancy in the Hungarian Bull's Blood red wine. He was always very 
Pharrnacy Department. He persuaded Profesor Beckett to good acting on the stage and the pharrnacognosists gave 
advertise for a lecturer in Pharrnacognosy and it was not performances at the Pharrnacy Department Christmas 
surprising that Norman was appointed. It came as a Phollies. Several of these were based on the then popular 
complete surprise to David Phillipson that, on his return TV series 'Till death us do part' and Joe, who bore a 
from the USA, he found that he had a new colleague. Joe remarkable physical resemblance to the TV character, 
handled this situation very well and he encouraged both of played the bigoted Alf Garnet. On the first of these 
them to carry on with their research and publish research performances he was sat at the breakfast table, hidden 
papers while he 'watched their backs'. It is partly due to his behind a newspaper, with his wife Else (Georgina Jolliffe), 
attitude that they became close colleagues and friends. In daughter (Marlion Poulter), and his Scouse-Git son-in-law 
1968 there were 7 pharrnacognosists in the Department of (David Phillipson). As he slowly lowered the paper to 
Pharrnacy at Chelsea College, Joe Shellard, Dougie reveal the top of his bald head, then his spectacles, followed 
Harrod, Georgina Jolliffe, Norman Bisset, David by his moustache, then full face, the audience erupted and 
Phillipson, Margaret Lees (later Walker) and Marlion it was several minutes before the dialogue could be 
Poulter (later Wright). commenced. When he shouted at Else calling her a "silly 
As Chelsea College continued to expand, lack of space moo" the audience reaction went into overdrive with 
became a major problem and various additional premises stupendous cheering and clapping. Could this be the serious 
were acquired. One of these was at Hammersmith where academic, the strong believer in his chosen subject, the 
there was a pharrnacognosy research laboratory. Eventually researcher, the University administrator? In contrast he 
alterations were made to the main Manresa Road site presented in 1969 a special memorial lecture to Steve B 
enabling Pharrnacognosy to be housed in new laboratories. Challen at the School of Pharrnacy, Portsmouth, entitled 
In May 1968 the Queen Mother, Chancellor of the 'Twenty years of British Pharrnacognosy'. His grow!11g 
University of London, visited Chelsea College. Joe was expertise in chromatographic techniques led him to edit a 
able to discuss his views on homoeopathy, agreeing with book on quantitative paper and thin layer chromatography 
the Queen Mother. Georgina Jolliffe set up a microscopical in 1968. '6 He was a very strong advocate for his subject. . 
demonstration showing the characteristic trichomes of When Marlion Poulter resigned from his departm~t m 
Cannabis. There were undergraduate students at each 1970 it proved difficult to provide funding for _a full tune 
microscope and the Queen Mum was fascinated. Her visit lectureship replacement and so Joe ascertamed _w~at 
to the Pharrnacognosy laboratory was scheduled to last 6-7 funding was available. He instigated a scheme to mvtte 
minutes but lasted for 25 minutes. This resulted in her young pharmacognosists from Europe to spend 6 months 
agreeing to miss out the next laboratory where Professor at Chelsea College. He was constantly thinking about the 
Beckett was demonstrating the analyses of horse doping. content of his undergraduate courses and in 1971, after a 
This did not help the antagonism that was growing between busy schedule of external examining and visits abroad, he 
Professor Beckett and his Reader in Pharmacognosy. devised practical classes that required less memory for 
During the Easter vacation of 1970 Joe received a letter identifying plant drugs and initiated research-style 
from the Vice Chancellor of the University of London projects.'? 
informing him that the title Professor of Pharmacognosy In 1972 Margaret Lees (m. Walker) resi~ed an? ~ete~ 
had been conferred on him. He always enjoyed parties and Houghton took over her lectureship. DaVtd Phillip~ 
he organised a series of celebrations. He and his wife Sylvia accepted a senior lectureship at Brunswick Square ~ 
hosted a splendid meal in the Governor's dining room at Professor Fairbairn's Department of Pharmacognosy. His 
Chelsea College. They invited his pharrnacognosy position at Chelsea was taken by Dr Peter Hylands. . 
colleagues and their spouses, together with Dr Tommy There was a special ceremony at Chelsea Town Hall m 
Wallis and Professor Jim Fairbairn. After his long and July 1973 when Sir John Wolfenden (later Lord) was 
hilarious speech, Joe requested that there should be no other installed as the first President of Chelsea College. A 
speeches but Tommy Wallis refused to accept this. He not number of honorary fellowships were presented and Joe, 
only expressed his congratulations to Joe but also his as Chairman of the Board of Studies in Pharmacy, 
pleasure and pride in having two of his former students as introduced two of them, Professor Donald Hey and Mr 
Professors of Pharmacognosy in the University of London. Cyril Maplethorpe. tries 
A less formal party was organised for other members of As a result of his visits to Eastern European coLI? 
staff, colleagues and friends. When it was getting quite late and his work on the British Herbal Pharmacopoeia Joe 
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advocated that UK Pharmacy should become involved in 
Herbal Medicine. There was opposition to this from 
prominent members of the Pharmaceutical Society but he 
persuaded the Council of the Society to have a 
symposium on Herbal Medicine18 and it was held at 
Bradford University in May 1974. The text of Joe's 
lecture 'Herbal Remedies and the Pharmacist in Europe' 
was published privately. In the same year the text of his 
inaugural lecture as Professor of Pharrnacognosy, 'The 
Wheel has turned Full Circle' was also published 
privately (Figure 3).9 The centenary of the death of 
Daniel Hanbury, a founder member of the 
Pharmaceutical Society, was marked in April 1975 and 
Joe presented a lecture at the Society with Sir John 
Hanbury as chairman. 
the allocation of money for the Pharmacy Department 
was £36,000 for the year 1975-6 he was amazed. 
Professor Beckett had told his staff that there would be 
less than £10,000 for the year. When Joe presented this 
information to the heads of Pharmaceutical Chemistry, 
Pharmaceutics and Microbiology, they too were amazed. 
Opposition to Joe from within the Department of 
Pharmacy faded rapidly. One of the immediate problems 
that faced him as Assistant Head of Department was that 
3 members of staff had refused to collaborate with their 
section head in teaching practical classes to 
undergraduates, so Joe held a series of meetings to 
correct this situation. In September 1975, Dougie Harrod 
retired after a career at Chelsea College that had begun in 
1933. Despite their early disagreements when Joe joined 
Figure 3. British pharmacognosists with Cyril Maplethorpe and his wife on the occasion of Joe Shellard's inaugural 
lecture, 1974. L to R: Bill Evans, Billy Binns, Cyril Maplethorpe, Mrs Maplethorpe, Betty Jackson, Dave Phillipson, 
Joe Shellard, Frank Fish, Jim Fairbairn, Norman Bisset, Dougie Harrod, Peter Houghton, Peter Hylands, Roland 
Hardman, Georgina Jolliffe, Richard Schmidt, Margaret Walker, Liz Williamson, Fred Evans, Margaret Roberts. 
He liaised with a Swiss company, Biostrath, that 
specialised in the manufacture of herbal products. 
Permission to sell some of their products in the UK was 
refused by the Medicines Commission but Joe managed 
to help them secure approval for 6 of their 8 products. He 
also collaborated in the production of a film on the life of 
Paracelsus (Theophrastus von Hohenheirn, 1493-1541 ). 
The film came out in 1977 and Joe introduced it at a 
screening held at the Royal Institution. 
When Dr Malcolm Gavin retired as Principal of 
Chelsea College in 1974 he was succeeded by Professor 
David Ingram from Keele University. The new Principal 
commenced holding regular meetings with the Heads of 
Departments but Professor Beckett was often absent due 
to his frequent visits to the USA. Joe attended these 
meetings as a deputy but the Principal proposed that Joe 
should be made Head of the Pharmacy Department. 
Professor Beckett threatened legal action and so the 
Principal demanded to know when he would be absent 
from the college. He proposed that Joe be made 
responsible for Departmental resources including staff, 
space, equipment and also finance. Joe was made 
Assistant Head of the Pharmacy Department and this did 
not meet with the approval of some of his colleagues, but 
the Principal had his way. When Joe was informed that 
Figure 4. Mr Harrod's 80th birthday, 1990. L to R Dave 
Phillipson, Marlion Wright, Joe Shellard, Peter Houghton, 
Bob Hider, Georgina Jolliffe, Dougie Harrod and Margaret 
Walker. 
the staff at Chelsea, he respected Dougie and appreciated 
all of the work that he had done for departmental 
administration (Figure 4). 
In November 1975 a new hall of residence, The Malcolm 
Gavin Hall, was built at Tooting and the opening ceremony 
was a splendid occasion with notables including the 
Chancellor of London University, the Queen Mother. As 
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Figure 5. Pharmacognosy academic and technical staff and research students at 
Chelsea, 1978. 
she processed through the audience dressed in her 
academic robes she noticed Joe, stopped the procession and 
said to him "Oh, I remember you are the professor who 
believes in homoeopathy'' and continued talking to him, 
holding up the academic procession. 
Although Joe took on more and more administrative 
duties at Departmental and College level he continued to 
pursue his research interests, particularly into the 
alkaloids of Mitragyna species. By 1978, when he 
retired, the research groups in Pharmacognosy continued 
to make substantial contributions to the academic 
achievements of the Department of Pharmacy at Chelsea 
College (Figure 5). 
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To be continued in Part II. 
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Madras Medical Journal 
Professor Harkishan Singh 
Professor Emeritus, Panjab University, 
Chandigarh, India 
During my visits to different institutions within India and 
abroad in search of archival source material for my 
pharmaceutical history research, I chanced to come 
across certain obsolete journals which provided me with 
some useful information. I decided to write about these 
former periodicals. Before I discuss the Madras Medical 
Journal I will give a brief introduction to two other 
publications the articles on which have already gone on 
record. 
Indian Journal of Pharmacy 
While working at the National Library in Calcutta I came 
across references to the Indian Journal of Pharmacy, 
which was published from Calcutta towards the close of 
the nineteenth century. We in the pharmacy profession 
had known only one such title, which started appearing 
from Banaras in 193 9. 1 This intrigued me and I started to 
search for this older journal, but searches at different 
prominent Indian libraries and the Royal Pharmaceutical 
Society of Great Britain Library proved to be of no avail. 
However, to my pleasant surprise I was able to trace 
some issues of the Indian Journal of Pharmacy 
(Calcutta) at the College of Physicians of Philadelphia in 
Philadelphia, PA, in the USA. The existence of this 
journal stood confirmed. The journal started publication 
in January 1894 and the last issue found was for 
November 1896.2 It covered trade and professional 
interests. It can be safely said that the journal was the first 
pharmaceutical journal of British India. 
Indian and Eastern Druggist 
When I started my work on pharmacopoeia! history and 
was looking for source material at the Royal 
Pharmaceutical Society Library in London in August 1988, 
I was introduced to the Indian and Eastern Druggist, which 
was not known to me. The journal first made its appearance 
in 1920, not from India but from London, the capital of the 
British Empire.3 In 1937 the name of this journal was 
changed to the Indian and Eastern Chemist, and later in the 
year it started publication from Calcutta, and lasted there for 
about four years. 
Coming to the main theme of this article, it was during 
my visits to Madras (now Chennai) and work at the 
Connemara Public Library that this nineteenth century 
medical journal came my way.4,5 
The Madras Quarterly Journal of Medical 
Science 
The Madras Quarterly Journal of Medical Science 
started publication in 1860, and all the published volumes 
except the first volume were available to me at the 
Library. After the first volume two volumes were 
published every year. William R Cornish, Secretary to the 
Principal Inspector General of the Madras Medical 
Development, and WN Chipperfield, Professor of 
Anatomy and Physiology at the Madras Medical 
College, were the editors. Later, from volume four, the 
editorship was taken over by Howard B Montgomery, 
who was Garrison Assistant Surgeon, Fort St George, 
and Professor of Botany and Materia Medica at Madras 
Medical College. From the twelfth volume,Howard B 
Montgomery, now designated Secretary to the Sanitary 
OP . 
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,: . 
Title page of Volume Second of The Madras Quarterly 
Journal of Medical Science. 
Commissioner, was joined by Henry King, Acting 
Surgeon 4th District, Madras, for continued editing of the 
journal. 
Volumes one to twelve constituted the First Series of 
the journal for which a consolidated index was prepared 
(1868). The Second Series started in 1869 but only one 
volume was published. 'After an irregularly intennittent 
existence of thirteen volumes' the Madras Quarterly 
Journal of Medical Science was merged into the Madras 
Monthly Journal of Medical Science, which started 
publication from January 1870. The publishers remained 
Gantz Brothers, Adelphi Press, Madras all through, 
except for the last number ( 1873) which was published 
by Caleb Foster and Co., Madras. 
The format and arrangement of the Monthly remained 
similar to the Quarterly to a considerable extent.6 The 
first part was to consist of original matter, discussing 
questions of hygiene, medicine, and medical politics, and 
items of medical news; these and correspondence were to 
constitute the principal features in which the new 
periodical was to differ from its predecessor. Next there 
were reviews or notices of medical or scientific works. 
As before, information about original cases and extracts 
from other British, Continental, and American journals 
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was to be provided. Further, publication of all orders of 
the Government in Council or the Commander-in-Chief 
affecting members of the profession was to continue. The 
journal with its new embodiment started publication with 
high hopes. 
Six issues of the Monthly were completed in 1872 
somehow, but the journal on the whole did not receive 
much encouragement or patronage. 7,8 There were only a 
few regular contributors. The editors experienced 
difficulties in the conduct of the journal. They struggled 
against many adverse circumstances and finally to their 
dismay had to announce:9 
We have regretted much that the material that has lately 
found its place in this Journal has not been of that nature 
which we could wish, but we know that our subscribers will 
overlook our shortcomings in this matter when they are 
informed that our contributors have been steadily decreasing 
in number. We have lacked contributors more than 
subscribers to this JoW11al, and it is from want of suitable 
pabulum that we are unwillingly compelled to bring this 
publication to a close. 
The only medical journal in the Madras Presidency at the 
time and one of the oldest medical journals in India met 
an unnatural death. 
Author's address: 1135 Sector 43, Chandigarh 160022, 
INDIA;projharkishansingh@yahoo.co.in 
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Evans Medical of Speke, Liverpool 
Dr Peter M Worling 
Edinburgh 
If you Google 'Evans Medical' , among the results listed is 
Evans Medical pie 'one ofNigeria's largest phannaceutical 
manufacturers'. Clicking on this, if you get through, takes 
you to an American site with twenty five viruses, so you are 
advised not to go on to this site. Ftuther search reveals 
some scattered historical information about Evans Medical 
at Speke and there is also some information about Evans 
Medical pie, Lagos, although the financial results go no 
further than 2011. Not, I thought, much of a record for what 
was once a substantial manufacturing company. 
The beginning 
John Evans in partnership with his brother Edward opened 
a druggists business in Worcester, in 1809. This was 
successful but in 1818 John left his brother to establish a 
business in the vinegar trade and moved to London to join 
Kempson, Yates, Evans and Parkinson, wholesale 
druggists at 40 King Street, Snow Hill, as a partner. He was 
obviously ambitious and three years later in 1821 he 
formed his own company with Daniel Stable called Stable 
Evans and Company, with premises at 62 Wood Street ~d 
at London Wall. Stable left the partnership in 1823 but m 
1828 Sydney Lescher joined the partnership and the 
company with the title Evans and Lescher moved to 4, 
Cripplegate Buildings, London. 1 
In 1833 a major expansion of the business took pl_ace 
when J.S. Lescher moved to Livetp00l to develop prerrus".8 
at 15 Fenwick Street and then moved to 8, Lord Street. It ts 
assumed that as Livetp00l was a major port for imIJ<?rting 
the crude drugs that Evans were using in their busm".8s, 
they believed there would be an advantage in ~Vlllg 
premises in Livetp00l. The venture was obVtoUS)Y 
successful. The three sons of John Evans were employed m 
Livetp00l and when Lescher returned to London in 1_835, 
John Hilditch Evans was put in charge and the busmess 
renamed Evans Sons & Co.2 
The company followed the route of developm~nt as a 
wholesale and manufacturing druggist. Drug mills and 
· 1. 1846 laboratories were opened in Fleet Street, L1verpoo m 
and the company established a significant trade in Lon?on 
and the North. The Lord Street premises were moved mto 
premises belonging to the Bartk of England in ~anover 
Street in 1848. These had been damaged in a fire m 1847 
and a new building was erected on the site which became 
the headquarters of the company (Fig.I). . 1 The London branch was run separately from L1verpoo 
but a very close cooperation was maintained between th; 
two companies. A Canadian company Larnplough d 
Campbell of Montreal Canada was acquired in 1~66
1
: 1 renamed Evans Mercer and Co., and incoiporated m 
as Evans Sons and Mason Ltd. It does not seem to have had 
. th th an outlet for much influence on the parent o er an as be 
their products. The companies over the years_h~d an~~ 
of different partners and changes of name until m 190 
London and Livetp00l were amalgamated to form ~e 
company, Evans Sons, Lescher and Webb Ltd, whol e 
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and export druggists (Fig. 2), a name with which many will 
be familiar.3 
From the early 20th centrny Evans developed their 
company as a comprehensive wholesale distributor 
supplying a wide range of sundries as well as drugs 
(Figures 3,4). They were also interested in the manufacture 
and supply of the newer ethical medicines that were 
developed. A new venture was started in partnership with 
Liverpool University; originally called the Incorporate 
Institute of Comparative Pathology, with premises in 
Runcorn. This was acquired in 1911 and renamed in 1929 
the Evans Biological Institute. Its brief was to carry out 
research into animal and human diseases. It developed a 
range of interesting products starting with Atoxyl ( arsanilic 
acid) in 1905 as a treatment for trypanosomiasis (sleeping 
Figure 1. The Evans factory, Hanover Street, Liverpool. 
sickness). Other products included Hepatex Oral, a liver 
extract for permc1ous anaemia, sulphanilarnide 
(Streptocide) for puerperal sepsis in the 1930s, diphtheria 
and tetanus antitoxin, cholera and typhoid vaccine, and 
heparin (Pularin) and hyaluronidase. In 1922 Evans 
exhibited at the British Industries Fair and listed themselves 
as 'Manufacturers of Fine Chemicals, Drugs, 
Pharmaceutical and Toiletry preparations, Vaccines, Pills, 
Tablets etc.' 
In May 1941 the Hanover Steet premises were destroyed 
in an air raid and plans were drawn up to build a new 
Figure 2. Evans Sons, Lescher & Webb factory 
Figure 3. Evans Sons, Lescher and Webb advertisement 
during World War I. 
factory at Speke on a new site. This was completed in 1943 
(Figure 5) and started production in December. After the 
war the expansion of the company continued; overseas 
markets were developed and sub idiaries establi hed in 
India, South Afiica, Australia and Paki tan. 
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of Southwark Street. The 
business moved into 
new warehouses in 
Graham Street, Islington. 
Initially both 
companies supplied their 
standard drugs to 
chemists in many parts of 
the country. With the 
increase in business and 
reduced delivery times 
this became more 
difficult and retailers 
found it easier to 
purchase their supplies in 
smaller quantities from 
- - - · • ~ .,._ .... "'-·· -- local wholesalers. In 
~~.:.·7:~!:~ .. v.:::: ~ ,.,. I ;:-;:..-;·""..:· .. ,\j~'.:'.:: .. : .. ,,. d . th . dru ... .. .. u. 
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... ~_ .. ...,....... _ ...... _ ..
- ~ ---.-- ... · - - ·- .. expanded their wholesale 
L.._ ____________ ___J interests. In the case of 
Figure 4. Druggists sundries from Evans catalogue. Evans they followed the 
route of both acquisition 
and opening branches of the company in strategic locations. Evans continued to have a significant interest in 
wholesale distribution. At the end of the 1940s, following 
the introduction of the sulphonamides and the antibiotics, 
growth of new 'ethical' pharmaceuticals continued, with an 
ever increasing number of packs and forms. However the 
total volume was still small and the bulk of supplies by 
wholesale were galenicals, as liquids and powders, tablets 
and ointments. In the 1940s supplies were generally 
obtained and delivered from a local wholesaler, usually the 
next day in major centres of population and often only three 
times a week in the country, although urgent orders for 
dispensing items were sent by bus or carrier. 
With the introduction of the National Health Service 
in 1948, both volume and value increased together with 
increas~g competition. Wholesalers telephoned for orders, 
and delivery the same day became the norm. The major 
suppliers for standard drugs were Evans Medical and 
British Drug Houses. BDH had been formed in 1909 by the 
amalgamation of four London wholesalers: Baron, Harvey 
& Co.of Giltspur Street; Davy Hill & Co.; Hodkinsons; 
Clark & Ward of Park Street; and Heron, Squire & Francis 
EVANS MEDICAL BRANCH OPENINGS 
1946 New Apothecaries, Glasgow appointed agents, 
1963 acquired by Evans. 
1951 Philip Spender and Daker & Co, Gateshead. 
acquired 
1952 Evans Medical Ruislip, new branch opened. 
Don Bryan, Swansea acquired 
1958 Evans Medical, Kingswinford, Birmingham, 
opened 
1959 Evans Medical (NI) Belfast, established. 
1960 Gilbert Jackson, Sheffield, acquired. 
1961 Evans Medical, Heywood, opened. 
1962 Lofthouse and Saltmer, Hull. acquired. 
1964 Evans Medical, Footscray opened 
1965 Evans Medical, Enfield opened. 
1967 Evans Medical (Northern Ireland) opened. 
BDH countered mostly by the acquisition of well 
established wholesale houses. They formed a national 
network through the acquisition of Ferris, Bristol; J.R 
Gibbs, Bristol and Paignton; Bradley and Bliss, Reading, 
Bexhill, Sandwich and Croydon (Figure 6); Woolley and 
Arn:field, Manchester and Stockport; Knights of 
Nottingham and Birmingham; and Rowland James of 
Swansea and Cardiff. As a consequence Evans and BDH 
had wholesaling interests of something near equal size. 
Figure 5. 
This was the point where Glaxo became involv~. Aft~r 
the war Evans was quite successful at develop1?g therr 
business. They had been expanding their overseas mterests 
and their UK wholesaling activities were ~ro?table. 
Despite this the company was quite small, capitalised at 
only £3 million. They realised that as a consequence they 
were vulnerable to a takeover. In June 1960 they were 
approached by Fisons with a proposal for amalgamation. 
Evans chairman IVL Fergusson approached Glaxo as a 
Evans Medical at Speke, Liverpool. defensive measure and eventually it was agreed that Glaxo 
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- ,~- -i Evans and BDH amalgamating their 
wholesaling interests so that a larger wholesale 
group would have greater negotiating power. 
Sir Austin Bide, at that time Deputy Chairman, 
approached BDH to discuss the formation of a 
jointly owned company. BDH were 
sympathetic to this idea and in June a jointly 
owned company was fonned. It was called 
Vestric as this was a name that Glaxo had 
already registered as a trade name for 
veterinary products. The Board of Directors 
consisted ofFrank:W Griffin who was MD of 
BDH, AE Bide deputy chairman of Glaxo, 
Figure 6. BDH acquires Bradley & Bliss. Front row L to R: Treves Brown WA Kinnear as MD and KMN Fergusson, as 
BDH; N Jefferies BDH; GG Hammond Bradley & Bliss; F Griffin BDH; Finance Director (F_ig. 7). 
BD Bird Bradley & Bliss 4 A year later m August 1967 Glaxo 
· approached BDH to discuss a merger. BDH 
would acquire Evans as a subsidiary but its identity would had earlier entered into an arrangement with Mead Johnson 
be retained. & Co. of Indiana, USA, to collaborate in research and 
Sir Harry Jephcott was chairman of Glaxo at that time. marketing. Mead had taken a 35% holding in BDH and 
He had steered Glaxo successfully for many years and they had first of all to be consulted. They were however 
during this time made a number of acquisitions. These were agreeable in principle to selling their holding. The deal was 
because opportunities arose at the time and did not completed in January 1968 and Vestric the wholesaling 
necessarily fit in to an overall strategic plan. Acquisitions company, which included the Evans wholesaling interests 
included Matburn Holdings, a surgical equipment (Fig. 7), became a who Uy owned subsidiary of Glaxo. The 
manufacturer, Farleys Infant Food and Edinburgh manufacturing side of Evans Medical Speke and its 
Pharmaceutical Industries, which was acquired in 1963. subsidiaries became a separate division. Glaxo was now 
Macfarlane Smith joined Glaxo Laboratories while made up of nine operating companies, with in addition, 
Duncan Flockhart and Allied Labs became part of Allen subsidiaries and overseas branches, some competing in the 
and Hanburys. This brought the wholesaling interests of same markets (Fig. 8). 
Duncan Flockhart and Macfarlan Smiths into Glaxo which, Under the Chairmanship of Sir Harry Jephcott various 
added to the New Apothecaries acquired by Evans, gave strategies for the future development of the Group had been 
the group a substantial investment in wholesaling with a discussed, but the company developed as opportunities 
turnover in 1965 of£ 16 million. arose. When Sir Alan Wilson took over in the late 1960s he 
By 1965 the pharmaceutical retail market was changing. was conscious that as a pharmaceutical company research 
The number of independent pharmacies was falling and the and development had been underfunded and he increased 
retail groups were growing in importance and purchasing the spending as weU as increasing manufacturing capacity. 
power. Glaxo believed that there would be an advantage in Wilson was well aware of the complexities of the Group 
Figure 7. Vestric is fonned. In centre is WA Kinnear, to his right (witl1 pipe) i KMN Fergus on, Financial Director 
and son ofFergusson of Evan Medical. 
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Figure 8. Evans Medical at Ruislip. Peter Worling (2nd row, centre left without glasses) arrives to take over from 
manager Roy Lever, to his left. 5 
structure and in particular the disadvantage of the separate 
companies running their own business without reference to 
the overall aims of the Group. He introduced a more 
integrated structure by appointing main board directors to 
the subsidiary companies' boards. 
Sir Austin Bide was appointed Chairman in 1973 and he 
was responsible for a radical restructuring of the company, 
forming a holding company Glaxo Holdings. He retained 
the goodwill of the separate companies by keeping their 
names but introduced designated responsibilities for 
members of the main board for the separate companies so 
that an integration and rationalisation of their activities 
could be achieved. This led to significant cost savings and 
improved efficiency . 
When Sir Paul Girolami took over as Chief Executive in 
1980 his first job was to oversee the launch of Zantac and 
the move of Glaxo into the United States, both major 
undertakings. He then turned his attention to the structure of 
the Group. At a Chief Executives meeting in 1984 Girolami 
raised the question about the future development of the 
Group. He believed that the interests of the group were 
spread too wide and some concentration of effort into fewer 
areas should be considered. Various ideas were discussed; 
one idea was to pursue the development of two separate 
divisions. One would concentrate on the development of 
the ethical medical and prescription departments the other 
on developing a range of proprietary medicines for counter 
sale. This would ensure that the Group had a foot in both 
markets and in particular as the competition in ethical 
pharmaceuticals became more intense the counter 
medicines market would help to maintain turnover. In the 
end Girolami decided that Glaxo should concentrate its 
efforts and its investments in what he considered was its 
core market, the research and development of prescription 
medicines. It was decided that the companies who did not 
contribute to this basic aim should be sold.4 
ERC Farmer, Chief Executive of Glaxo Pharmaceuticals 
and Chairman ofVestric believed that one solution for the 
company was to structure it as a National Wholesale 
distributor for the industry with its shares being jointly held 
by a consortium of pharmaceutical manufacturers and he 
discussed this with members of the industry. A major 
problem was that Resale Price Maintenance had been 
abolished in June 1970. Ethical and proprietary medicines 
were exempted from the ban, but prices could no longer be 
maintained on a wide range of toiletries, perfumery, 
dressings and many sundry items. Although the proportion 
of NHS dispensing was steadily increasing, sales over the 
counter still accounted for some 40% of turnover in 1975. 
This range of products could now be supplied by other 
retailers at discounted prices. Pharmaceutical wholesalers 
realised that unless their customers could compete on price, 
there would be a loss of business and to help them compete 
a number of 'Voluntary Trading Schemes' were introduced. 
These offered monthly special offers and discounts to 
enable the retailer to compete. They were also aimed at 
tieing the retailer to the wholesaler. 
These schemes gave discounts on counter products 
where price maintenance no longer applied. In January 
1974 the wholesaler Unichem introduced a differential 
discount scheme with the rebate based on total turnover 
which effectively gave a discount on ethical medicines. 
Glaxo would not let Vestric discount medicines and sales 
and profit began to fall. Macarthys, a major wholesaler, 
introduced discounts and then eventually in January 1981 
Vestric introduced a discount scheme which offered 9% on 
purchases over £1,000 per month on manufacturers who 
allowed a wholesale discount of 15% and 6% on others. All 
wholesalers followed suit giving an average of 5% discount. 
To survive, the costs of operating the company had to be 
reduced. Branches with overlapping territories and the less 
efficient branches were closed. By 1984 over 78 wholesale 
branches were closed nationally and Vestric reduced the 
number of branches to 20. The cost of redundancies and 
branch closures resulted in a turnover of £25 million 
producing a loss. Manufacturers who had been appro~ched 
to join in a consortium were not interested in proceeding to 
invest in what appeared to be a loss-making business. 
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GLAXO GROUP 1971 
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Figure 9. Glaxo Group 1971. 
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Discussions were held with a number of wholesale 
companies, both in the UK and in Europe, and eventually 
VestricLtd. was sold toAAH Ltd. in 1984.sThis company 
owned a group of retail shops and a wholesaler, Hills. They 
had regional coverage and were interested in developing 
their wholesale service on a national basis. Glaxo were 
therefore able to dispose of all of their wholesaling interests 
including what had been the Evans Medical and BDH 
wholesaling companies. Glaxo were also able to dispose of 
Matburn (Holdings) in 1985, the group of three surgical 
engineering companies and Farley Health Products under 
which the baby food products had been consolidated. 
Evans Medical, Speke continued as part of the Group 
and were responsible for the manufacture of a wide range 
of pharmaceutical products. Investment had been made in 
the Speke factory which improved its productivity and 
efficiency. There were problems associated with the factory 
which were largely due to its construction during wartime, 
which had created a number of difficulties; nevertheless 
Evans Medical took over the responsibility for the Group's 
generic medicines business in the UK. 
Initially the turnover and profitability increased, mainly 
due to the introduction of new generic products and the sale 
of diamorphine. However, competition soon increased 
from small manufacturing units with low costs and this led 
to price reductions. Bernard Taylor, Group Commercial 
Director, introduced a range of branded generics under the 
banner of GX but this was not successful because 
customers were not prepared to pay a premium price for 
products generally available. The generic market was 
further complicated for Glaxo because they had generic 
products competing with some of their premium 
proprietary medicines, and it was decided to withdraw from 
the generic market. At one time some 2,000 products and 
packs were produced at Speke, the main profit coming 
from aerosol production and there was also a Biological 
Division responsible for producing vaccines. 
The problem of the future of Evans Medical was solved 
by a management buyout of the company, which was 
renamed Evans Health Care. Subsequently, Bernard Taylor 
resigned from Glaxo to take up an appointment as 
Chairman of a company Medirace. It changed its name to 
Medeva and in 1990 acquired Evans Health Care. They did 
not use the name Evans and it was no longer part of our 
phannaceutical industry. 
Authors address: p.worling@virgin.net 
The paper was presented for Peter Worling at the Spring 
Conference, Liverpool, March 2013 by Ainley Wade. 
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Book Review 
Herbs and Healers from the Ancient 
Mediterranean through the Medieval West: 
Essays in Honor of John M. Riddle 
Anne VanArsdall and Timothy Graham (eds), Farnham, 
SWTey: Ashgate, 2012, pp 394 (hardback price: £70.00). 
Many scholars now believe that the medicine practised 
during ancient and medieval times has been greatly 
underestimated, and that practitioners' knowledge of medi-
cinal plants and their rational use was much more soph-
isticated than previously thought. As a result there is much 
research currently underway by historians, plant biologists 
and others to see if there are further secrets to be unlocked. 
One of the pioneers of this research is John M Riddle at 
the University of North Carolina. Riddle's books include 
Diascorides on Pharmacy and Medicine (1985) and Eves 
Herbs: A History of Contraception and Abortion in the 
West (1997). This book, a compilation of essays on subjects 
close to Riddle's heart, is the fourth in Ashgate's Medicine 
in the Medieval Mediterranean series. 
The book takes a broad historical sweep, from the first 
century BC to the late Middle Ages, and has a wide 
geographical spread, from central Asia to western Europe. 
The opening chapter, by John Scarborough, provides a 
scholarly account of pharmacology and toxicology at the 
court of Cleopatra (around 70 to 30BC). Other colourful 
characters featuring in this book include the healers 
Gariopontus of Salemo and Constantine the African. The 
latter was an eleventh century monk, the importance of 
whom in the history of European medicine can hardly be 
over-stated, as Winston Black demonstrates. He suggests 
that Constantine should be credited with bringing 
rationality back into medieval medicine, for his translations 
of Arabic and Greek medical works, and his original 
contributions. Black examines the influence of one of 
Constantine's key works, his Liber Graduum (the book of 
degrees), the earliest medieval text in Latin to embrace 
Galen's theory of simples, and explores references to 
Constantine in north European medical verse. In another 
chapter, Faith Wallis discusses the reasons why the Liber 
Gracfuum neve: g_ained admission to the Articella (the 
medieval compilation of medical texts), but nevertheless 
had a significant impact upon it. 
In his chapter John Crellin reflects on Eves Herbs, and 
on interpreting evidence about therapeutic effectiveness. 
Maria Amalia D'Aronco, editor of The Old English 
ntustrated Pharmacopoeia, examines attempts to identify 
the plant known as elehtre; it is usually considered to be the 
lu~in _because of its colour (amber or electrum). The 
ub1qU1ty of herbs and herbal healing in the medieval world 
is illustrated by the extent to which they were satirised in 
Middle En~lish texts, explored in a chapter by Linda 
Ehrsam Vo1gts. Karen Reeds assesses the claims for Saint 
John's Wort in the age of Paracelsus. She notes that the 
glandular dots in its leaves are so distinctive that any 
description or picture that involves them can reasonably be 
assumed to be Hypericum peiforatum. 
The final chapter provides a review of existing resources 
available to researchers, including the Anglo-Saxon Plant 
Names Survey (ASPNS) and the Dictionary of Old English 
Plant Names (DOEPN). It then describes the an important 
new internet-based system, the Medieval Plant Survey 
(MPS). This data-base includes not only plant name indices 
listing nearly 10,000 plant names, but also large numbers of 
historical texts, ingredients mentioned in medical 
formularies, and online sources. 
Some parts of the book are, however, less readily 
accessible than others; some 24 pages of Latin text are 
reproduced in full, and one chapter is in German, although 
a short abstract is provided in English. There are some 26 
pages of tables providing detailed lists of substitutes, part of 
a chapter which revisits substitution in ancient pharmacy. A 
further 16 pages provide tables giving the alternative 
terminology used in four important manuscripts from this 
period, including the Circa instans. 
This then is a scholarly work which will be of 
considerable interest to researchers working in this field, 
including historians and plant biologists. But the book also 
offers much of interest to pharmaceutical historians. It 
makes important contributions to our knowledge about 
how medical and pharmaceutical ideas moved across 
national, linguistic and cultural borders; about how they 
were translated, modified, adapted and improved, between 
Greek, Latin and Arabic; and about how they came to lay 
the early foundations for pharmacy in Britain. 
The book shows also that Anglo-Saxon medicine had a 
rational basis, and elaborated the medical tradition of 
classical antiquity. Whilst the names of herbs have proved 
prone to change over time, their medicinal uses tend to 
remain remarkably constant over millennia. 
Those with an interest in the history of plant medicines 
will thus find much to interest them in the contributions in 
this book But it also illustrates that, when it comes to the 
history of herbs and healers, there is still much to do. 
Pharmaceutical historians have already made important 
contributions in this field, but there are many further 
insights they will be able to provide. Stuart Anderson 
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